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Quorum sensing (QS) plays a central role in virulence induction in the commensal 
pathogen, Staphylococcus aureus. This bacterium secretes an auto-inducer peptide (AIP), 
a small, cyclic peptide containing a thiolactone linkage as an indicator of its population 
density, and up-regulates virulence gene expression in response to high extracellular AIP 
levels. We have investigated two key biochemical events in S. aureus QS and revealed 
several underlying regulatory mechanisms. The first such event, formation of the high-
energy thiolactone in AIP, is unusual in that it occurs directly through proteolysis of the 
precursor peptide, AgrD, without free-energy input from ATP hydrolysis. We showed 
that this proteolysis is, in line with the thermodynamic prediction, unfavorable and 
strongly reversible in vitro. As a consequence, rapid degradation of the concomitantly 
released C-terminal fragment of AgrD is required to power efficient AIP production in 
vivo. This observation provides a novel connection between protein homeostasis and QS 
in S. aureus. The second study focused on the AIP-sensing receptor histidine kinase 
(HK), AgrC, whose auto-phosphorylation exhibits several remarkable properties in our 
reconstitution system based on nanometer-scale lipid-bilayer discs (nanodiscs). 
Activation of this receptor by its native activator, for instance, requires a membrane 
environment enriched of anionic lipids mimicking the electrostatic property of the S. 
	   	  
aureus cell membrane. This strong dependence on lipid composition might explain why 
homologous QS systems exist only in low-GC Gram-positive bacteria, or Firmicutes, 
whose cell membranes are predominantly highly anionic. AgrC also binds to ATP at an 
exceptionally weak affinity, likely due to its distinct adenine-binding pocket conserved 
only in a small subfamily of HK receptors existing also exclusively in Firmicutes. The 
low affinity to the nucleotide cofactor likely enables AgrC to sense the energy condition 
of the bacterium and shut down the QS regardless of the population density when energy 
starvation drives down the cellular ATP level. Even more intriguing is the plasticity of 
AgrC auto-kinase activity when bound to different ligands. This behavior contrasts with 
the generally accepted two-state model of HKs. To understand the plasticity of AgrC, we 
systematically perturbed the conformation of the AgrC kinase domain using a fusion 
protein strategy. We demonstrated that the conformational state of a helical linker 
preceding the kinase domain exercises rheostat-like control over the kinase activity. 
Using full-length AgrC embedded in nanodiscs, we showed that binding of activator and 
inhibitor peptides results in twisting of the linker in different directions. These findings 
provide the first view on molecular motions triggered by ligand binding on a membrane-
bound receptor HK. The smooth input-response landscape of the AgrC kinase domain 
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Chapter One: Introduction 
1.1 Quorum Sensing in Staphylococcus aureus 
1.1.1 Introduction to Quorum Sensing 
The concept of quorum sensing (QS) emerged out of the effort to understand the 
observation that an individual Vibrio Fischeri cell, when present within a quorum of cells 
from the same species, produces more light than in isolation (Figure 1.1a) (1). A series of 
elegant genetic and biochemical studies led to the conclusion that this bacterium produces 
a diffusive molecule, termed the autoinducer (AI), as an indicator of its local population 
density (Figure 1.1a, small triangles) (2-4). Expression of light-production genes requires 
high extracellular concentration of AI, and therefore occurs only within large populations 
(Figure 1.1a, right panel) (5). This “autoinduction” behavior, along with the discovery of 
similar regulatory principles in a spectrum of prokaryotic species, initiated a major 
paradigm shift in microbiology (6, 7). With the ever-increasing evidence of intercellular 
communication within and across species, prokayortes are no longer treated as the sum of 
isolated, unicellular organism but instead a community with constant information 
exchange (8). The signaling events that enable an individual bacterial cell to 
communicate with its surrounding quorum via chemical messengers are therefore referred 
to as QS. Importantly, autoinduction and QS are not used interchangeably in this 
dissertation. While the outcome of QS in pure cultures is almost always autoinduction, 
QS can have very a different impact on participant strains/species in mixed cultures or 
natural habitats (vide infra).   
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At high population densities, i.e., when a microorganism seizes dominance of a habitat, it 
may undertake a variety of collective actions to bolster its population fitness. For 
instance, some bacteria develop extracellular structures such as biofilms and/or capsules 
for adhesion and protective purposes to increase their survival under stressed conditions,  
 
Figure 1.1 Common features of bacterial quorum sensing 
(a) Population-dependent collective behaviors exemplified by the light production in V. 
fischeri. Diagram shows the situation at low or high cell densities. Cells and AI 
molecules are depicted by ovals and small triangles, respectively. Light production 
correlates to the AI level and occurs only at high population density. (b) Chemical 
diversity of bacterial AIs. See text for details. Note that DPD cyclizes into S-2-methyl-
2,3,3,4-tetrahydroxytetrahydrofuran (S-THMF), which condenses with boric acid in 
marine bacteria to yield the bicyclic S-THMF-borate. (c) QS in Vibrio harveyi integrates 
signals from self, kin and distantly related species. See text for details. IM, inner 
membrane; OM, outer membrane. (d) Autoinduction of S. aureus experiences an eclipse 
phase in a murine infection model. An autoinduction-dependent luciferase reporter was 
implemented in the bacteria. Panels show the intensity of bioluminescence at the 
indicated time points in a pseudocolor scale. Note that the population size was roughly 
constant between the 3.5-h and 72-h time points. The panel is adapted from citation (29).  
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while others breakdown existing biofilm to let individual cells progress to the planktonic 
stage of their life cycles (9). A spectrum of “common goods” are also under control by 
autoinduction, including cytolytic toxins and hydrolases for further exploitation of 
nutrients from the environment, secondary metabolites for defensive or metabolic 
purposes, or factors that benefit the bacterium’s mutualistic host (10-12). Besides these 
uniform behaviors, some bacteria also exhibit, at least partly in response to autoinduction, 
stochastic decision making to increase the phenotypic diversity and hence the robustness 
of the isogenic population. The most notable example exists in the community of Bacillus 
subtilis, in which high-density-related phenotypes including competence, motility and 
cannibalism are all controlled by stochasticity (13). Notably, however, for most collective 
behaviors listed above, premature actions at insufficient population would be 
energetically wasteful or counterproductive. As a result, the ability to sense the 
population density and make timing decisions for collective behaviors confers substantial 
evolutionary advantage to microorganisms, and is central to the phenotypic diversity of 
the prokaryotic world. Furthermore, QS-related behavior is also considered the driving 
force of speciation and the emergence of multicellularity (14-16). 
 
Because of the enormous diversity of prokaryotes, it is essential for individual species to 
distinguish AIs produced by its diverse neighbors and respond (or not respond) in such a 
way that benefits its own fitness. To achieve this specificity, bacteria from different 
taxonomic lineages have implemented AIs of an equivalent level of diversity, as well as 
receptor proteins to sense them in a highly specific manner. Most AIs known to date fall 
in one of a handful of categories, each featuring a characteristic “core” structure 
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generated by a distinct set of biosynthetic genes. Best characterized AI categories include 
linear, prenylated and (thio)lactone peptides in Firmicutes (17-20), acyl-homoserine 
lactones (AHLs) , furanone derivatives and alkylquinolones in Proteobacteria (2, 21, 22), 
and butyrolactones in Actinobacteria (Figure 1.1b) (23). While the core structure 
provides rough distinction of AIs at the phylum level, a much greater source of diversity 
is conferred by the starting-material variation in the biosynthesis. The structure of the 
ribosomally-synthesized, post-translational modified AI peptides in Firmicutes is dictated 
by their precursor sequence and the proteolytic processing sites, while that of AHLs 
largely depends on the fatty-acyl group preference of their respective LuxI synthase. 
Importantly, in both cases, the cognate receptors that sense these AIs are so specific that 
minimal alteration of the AI structure at certain positions may alter its potency or efficacy 
(24, 25). It is the strict specificity of the receptors that allows the bacteria to avoid the 
interference of ever-existing environmental noises.  
 
Despite the diversity of AI structures, inter-species crosstalk mediated by these chemical 
messengers is prevalent. Vibrio harveyi, a free-living marine bacterium, produces three 
distinct AIs and integrates their signals through a convergent phospho-relay signal 
transduction system (Figure 1.1c) (26). Intriguingly, while the HSL-type HAI-I is highly 
specific for detection by V. harveyi, the hydroxyketone signal CAI-I and the furanone-
type AI-2 are also produced in the closely-related Vibrio kins and an even broader 
spectrum of bacteria, respectively. Converging three signal-transduction systems 
detecting these AIs onto a central regulator enables this bacterium to weigh differentially 
the signals produced by self, kin and distantly related species for its decision-making 
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process. By contrast to the cooperative crosstalk in the genus Vibrio, quorum quenching 
(QQ), defined as the antagonism of QS by foreign chemicals, is also frequently described 
as the means of interspecies competition (6, 27). The antagonizing reagent varies from 
analogs of the native AI to biosynthetically/structurally unrelated compounds. Overall, it 
is generally accepted that interspecies communication plays a central role in shaping the 
ecological niche and the evolutionary trajectory of microbial organisms (28). 
 
Finally, it is noteworthy that the outcome of QS-related signaling is not solely dependent 
upon the population density or the extracellular AI concentration. Since QS induction 
often leads to a profound change in gene-expression pattern and hence an often more 
energetically expensive lifestyle, it is not surprising that checkpoints for cellular fitness 
are implemented upstream to the QS-mediated gene-expression regulation. In line with 
this notion, down-regulation of QS-induced behaviors after entrance of the stationary 
phase has been observed in a few staphylococcal and streptococcal species when cultured 
in liquid medium (29). In a murine Staphylococcus aureus infection model, activity of a 
QS-regulated reporter gene experienced biphasic induction and was eclipsed between the 
two induction phases due to the action of the host macrophages (Figure 1.1d) (30). 
Possible mechanisms of such checkpoints have been proposed, however, no consensus 
has been reached for any taxonomic phylum.  
 
1.1.2 Discovery of the agr locus 
Staphylococcus aureus is one of the low-GC gram-positive species in which 
autoinduction behaviors were earliest described. This commensal pathogen has been 
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known, since 1970s, to abruptly increase its extracellular protein secretion while decrease 
its surface protein production in the late-exponential phase when cultured in liquid 
medium (31). The chromosomal locus responsible for the global regulation of these 
proteins was first identified in 1982 using a transposon-insertion strategy (See Figure 1.2) 
(32). The mutant strain was found to possess an unaffected gene encoding alpha-
cytotoxin but to be incapable of secreting this toxin. Further investigation of this mutant 
revealed defect in up-regulation of a few other toxins and down-regulation of surface 
protein-A, and the locus of transposon insertion was therefore named agr (for accessory 
gene regulator) (33). The open reading frame (ORF) disrupted by the insertion encodes a 
DNA-binding protein, AgrA, whose expression was once thought to be driven by a weak 
promoter, P1, located immediately upstream to the ORF (Figure 1.2) (34). In 1988, this 
ORF was also found in a larger, QS-inducible polycistronic mRNA, in which three 
additional ORFs upstream to AgrA were identified to encode AgrB, AgrD and AgrC 
proteins  (Figure 1.2) (35). Meanwhile, the locus that encodes the delta-hemolysin (hld), 
an agr-regulated effector toxin, was mapped in close proximity to agr, and surprisingly, 
the mRNA transcript of the 26-amino acid (aa) toxin measures ~500-nucleotide (nt) in 
 
Figure 1.2 The genetic arrangement of the S. aureus agr locus.  
The DNA double strand of S. aureus chromosome is shown in two parallel lines, with the 
location of promoters indicated with arrows. ORFs in RNAII and RNAIII are colored 
boxes (not drawn to scale). Red bars on the DNA segment between P2 and P3 promoters 
indicate the AgrA-binding DNA elements. 
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length (Figure 1.2) (36). Intriguingly, the pleiotropic phenotype observed from the hld 
transcript deletion was similar to that of agr deletion, suggesting that this RNA plays a 
role in the global regulation of accessory-gene production (37). Following numerical 
order, the QS-inducible promoters governing transcription of the polycistronic agr 
operon and the hld transcript were named P2 and P3 and the their transcripts termed 
RNAII and RNAIII, respectively. These two operons are transcribed in back-to-back 
directions and promoter elements are located merely 41-nt apart from each other. Both 
operons and the intergenic regulatory elements are collectively referred to as the agr 
locus, due to their essentiality to the autoinduction behavior in S. aureus.  
 
Given the functions of Agr proteins predicted by bioinformatic analysis and the 
precedence of AIs in Gram-negative bacteria, the regulatory function of agr was expected 
to occur through the production and sensing of a diffusive chemical messenger (38). In 
1995, six years after characterization of the P2 operon, the first description of this AI was 
achieved upon biochemical fractionation and HPLC-MS analysis (39). This, 8-aa small 
peptide was named the AIP (autoinducer peptide). Edman analysis of this AIP revealed a 
sequence embedded in the AgrD ORF, while MS of the native peptide as well as 
treatment with iodoacetic acid and hydroxylamine suggested that the AIP contains a 
thiolactone macrocycle formed by the condensation between the carboxyl group at the C-
terminus and the thiol group on the side chain of a internal cysteine residue (see Figure 
1.1b) (20). In 1998 the Muir Group unambiguously confirmed this distinctive cyclic 
structure through chemical synthesis, thus completing the preliminary characterization of 
all agr gene products (25).  
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1.1.3 Basic architecture of the signaling circuit 
It is particularly remarkable that the genetic interaction among the four Agr proteins and 
the RNAIII had been correctly unraveled, through a combination of elegant genetic 
experiments and bioinformatics analyses, even prior to the characterization of the AIP 
(Figure 1.3) (38). In this early model, AgrB and AgrD produce or activate the production 
of the AI, while the AI activates the two-component, phospho-relay signal transduction 
system involving AgrC and AgrA. The active form of AgrA up-regulates the 
transcription of both P2 and P3 operons, thus closing a positive feedback circuit (through 
the activation of P2) and increasing the production of RNAIII. Function of AgrD and 
AgrB were specified later on as the AIP precursor and the AgrD-processing peptidase, 
respectively, however the basic architecture of the signaling circuit is retained.  
 
Figure 1.3 Architecture of the agr autoinduction loop and effector regulation. 
Left half: a diagram of the agr autoinduction loop. Colored arrows indicate enhancement 
of activity or abundance through transcription, translation, enzymatic reactions and/or 
biophysical interactions. Right half: regulation of agr effector protein production. See 
text for details.  
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For over a decade since its discovery, RNAIII had been considered as the only direct 
effector of agr autoinduction. Ironically, its mechanism of action had been enigmatic for 
an even longer period until Huntzinger et al. showed that it inhibits the translation of 
surface protein A (Spa) through interacting with, and mediating the degradation of, the 
spa mRNA (Figure 1.3) (40). Translation of several other agr-regulated proteins was 
subsequently found activated or inhibited by RNAIII employing similar mechanisms (41, 
42). Among them is the repressor of toxins (Rot), a transcription repressor targeting 
genes of a series of secreted toxins and proteases (Figure 1.3) (43). Hence, there are at 
least three known mechanisms by which RNAIII exercises control over agr effector 
protein production: (i) acting as the coding mRNA (ii) blocking translation and/or 
promoting degradation of the effector mRNA and (iii) indirectly influencing effector 
transcription by down-regulation of rot.  
 
Within the past decade, nucleic-acid array analysis extended our scope of agr-
autoinduction effectors beyond those under RNAIII regulation (44, 45). Employing a 
DNA-array strategy, Shu et al. identified, in addition to P2 and P3, three operons 
containing AgrA-binding elements in their promoter regions (Figure 1.3) (45). Two of 
these three encode phenol-soluble modulins (PSMs) whose leukocidal activities are 
essential for the bacterium’s immune evasion. In contrast to the DNA-array approach for 
AgrA binding, hundreds of S. aureus genes were found influenced by agr autoinduction 
in a comparative transcriptomic study (44). While this study provides no information on 
the mechanism by which individual genes are affected, it assisted the identification of a 
few genes carrying agr-related functions. As a notable example, PmtABCD, the only 
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ABC transporter up-regulated upon induction of the agr system, was later shown to 
involve the exportation of PSMs (46).  
 
1.1.4 Interspecies variation of agr 
One of the most intriguing features of the agr locus is its polymorphism within single 
species. Within five years of the first agr locus being cloned, four allelic variants of this 
locus were reported (20, 47). The variable region spans half the length of the P2 operon, 
covering the main body of AgrB, the entire AgrD and the N-terminal half of AgrC ORFs. 
This setting allows each agr variant to specifically produce, and mediate autoinduction in 
response to, its own AIP (Figure 1.4a). In S. aureus strains carrying different agr 
variants, the vast majority of conserved, structural genes (excluding mobile genetic 
elements) are predominantly identical, suggesting that the variation occurs at a sub-
species level. Strains harboring each agr allele are therefore classified as a pherotype or a 
specificity subgroup.  
 
While S. aureus from all four groups are capable of qualitatively similar autoinduction 
when cultured alone, the effect of AIPs on the induction of a heterologous agr system is, 
in most cases, strongly inhibitory (Figure 1.4a) (48). The only exception lies between the 
two most closely related groups, I and IV—AIPs from these groups share 7 identical 
residues out of 8 positions. Despite this level of similarity, AIP-I activates the induction 
of group-IV strain three orders of magnitude less potently than AIP-IV. By contrast, the 
thiolactone-forming cysteine is the only identical residue shared between AIP-I and AIP-
II. Clinical isolates of S. aureus from one infection site rarely exhibit variegation in the 
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agr locus, primarily because an agr-heterologous cell population cannot achieve 
cooperative autoinduction to support the fitness of all participant subgroups (49).  
 
A long-standing puzzle of agr polymorphism concerns the evolutionary advantage 
offered by individual agr alleles. Indeed, a correlation has been observed between agr 
variants and infection types (49). For instance, group-III strains are overrepresented in 
menstrual toxic shock syndromes, while the exfoliatin-producing strains causing scalded  
                          
Figure 1.4 Allelic variation of agr among four S. aureus subgroups 
(a) Structure and efficacy of AIPs from all four subgroups. (b) Effect of agr variants on 
the autoinduction timing when introduced to an isogenic, agr-null background. The 
background strain carrying the indicated agr allele and a P3-driven β-lactamase reporter 
was assayed for the β-lactamase activity in the medium supernatant at indicated time 
points. Plot shows a time courses of the β-lactamase activity (closed symbols) and a 
growth curve (open, gray symbols) for each agr allele tested. The figure was adapted 
from citation (48).  
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skin syndrome are predominantly group-IV. In a seminal study performed by Geisinger et 
al., all four agr alleles were introduced, one at a time, into an agr-null background strain 
through chromosomal insertion at an identical attachment site (50). Side-by-side 
comparison of these alleles on an isogenic background revealed major differences in the 
temporal control of autoinduction: induction was achieved earliest with group-I and 
group-IV and latest with group-III alleles. This observation argues for a model in which 
agr variants act as alarm clocks for the onset of autoinduction, and their correlation to 
infection types originated from the infection site’s selection for the most favorable 
induction timing. The mechanism underlying the differential autoinduction timing and 
dynamics mediated by different agr variants, however, requires further investigation.  
 
1.2 Biochemistry of the agr autoinduction 
As was alluded to in section 1.1.3, central to agr autoinduction is a positive feedback 
circuit consisting of two mutually enhancing pathways, namely the production and 
sensing of AIP. AIP production begins from the translation of RNAII into four Agr 
proteins. AgrD, the precursor of AIP, is first proteolytically processed by AgrB, a 
membrane-integrated peptidase to generate a thiolactone intermediate. This intermediate 
is then exported across the membrane and is subject to a second proteolysis step to 
release the mature AIP pheromones into the extracellular space. This AIP-production 
pathway enhances the sensing pathway by contributing the activation signal. AIP sensing 
is achieved through its detection by the membrane-bound receptor histidine kinase 
(RHK), AgrC. This interaction activates a phospho-relay cascade that leads to the 
phosphorylation of the cognate response regulator (RR), AgrA. Upon phosphorylation, 
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AgrA binds to the P2 promoter and up-regulates the transcription of RNAII, which 
encodes all four Agr proteins. This enhances the synthesis of AgrB and AgrD proteins 
and confers positive feedback to the AIP synthesis pathway.  
 
This dissertation will primarily focus on the biochemical and biophysical characterization 
of protein components involved in the above feedback loop. Thus, an in-depth, stepwise 
review from biochemical perspectives will be provided in this section, covering works 
published before and during my matriculation at the Rockefeller University, with the 
exception of my own work, which will be presented in Chapters 2 through 5.  
 
1.2.1 Translation of Agr proteins 
Although the coding sequence of all four Agr proteins are co-transcribed in the 
polycistronic RNAII, this transcript is exquisitely designed to finely coordinate their 
translation. Discernible ribosomal binding sequences (RBS) are found immediately 
upstream to each ORF (Figure 1.5a) (38). The RBS preceding the coding sequence of 
AgrD and AgrA closely matches the consensus sequence, suggesting highly efficient 
translation initiation (51). Furthermore, the AgrB and AgrD ORFs are concatenated in 
such a way that the RBS of AgrD locates upstream to the AgrB stop codon. This design 
harnesses the translation activity within the AgrB ORF to prevent secondary structure 
formation that might otherwise occlude the translation initiation at the AgrD RBS, further 
increasing the production efficiency of AgrD (52). By contrast, the ORFs of AgrB and 
AgrC are expected to be less active due to (i) the less favorable RBS and (ii) the sub-
optimal initiating codons, i.e., UUG for AgrB and GUG for AgrC. These features are 
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expected to result in the enzymatic substrates, AgrD and AgrA, being produced in excess 
to their respective enzymes, AgrB and AgrC. Moreover, two out of four proteins encoded 
by RNAII are integral membrane proteins. Since membrane insertion occurs co-
translationally, the polysome complex of RNAII, which also translates AgrD, must 
localize in the proximity of the cell membrane (Figure 1.5b) (53). Because the 46-aa 
 
Figure 1.5 Architecture of RNAII and the possible implication on the translation of 
Agr proteins. 
(a) The coding-strand DNA sequence of the polycistronic RNAII: four RBSs are 
indicated with red boxes. ORFs are indicated with arrows following the color code in 
Figure 1.2, accompanied with the translated sequence. Due to the space limit, only the 
coding region of the first and last five amino acids is shown for each ORF. (b) Diagram 
showing the putative membrane localization of the RNAII polysome as a consequence of 
membrane-protein translocation.  
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AgrD is highly hydrophobic and likely unstructured unless associated with the lipid 
bilayer (vide infra, section 1.2.2), it might be an important protective measure to 
synthesize AgrD in proximity to the cell membrane to prevent its aggregation or 
degradation.  
 
1.2.2 Formation of the AIP thiolactone 
One of the most fascinating features of the agr system is the thiolactone structure of the 
AIP. In reality, however, this thiolactone motif is generated by a single proteolysis 
reaction involving AgrB and AgrD (54, 55). The substrate of this proteolysis, AgrD, 
contains the mature AIP sequence sandwiched by an N-terminal leader peptide and a C-
terminal recognition sequence (Figure 1.6a). The AgrB-catalyzed proteolysis clips off the 
recognition sequence as a linear peptide and concomitantly installs the thiolactone to the 
N-fragment, herein referred to as the thiolactone intermediate. The N-terminal 20 
residues of the leader form an amphipathic helix and anchors AgrD to the cell membrane 
putatively by lateral association (56). This positioning is required for AgrD processing, as 
the substitution of its N-terminal region with an artificial amphipathic helical sequence, 
but not a hydrophobic trans-membrane domain, is tolerated. In all staphylococcal AgrDs, 
the amphipathic sequence is followed by an “IG” motif that might act as a helicity 
breaker to facilitate the proteolytic release of mature AIP from the thiolactone 
intermediate (57). The recognition sequence, on the other hand, is enriched in acidic 
residues and highly conserved in staphylococcal AgrDs. The hydrophilicity of this region 
has been thought to prevent full-length AgrD from premature exportation (Jeffery G. 
Johnson, unpublished work). The significance of the sequence conservation is not yet 
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fully understood despite some evidence showing a couple of positions are essential for 
competent AIP production (Figure 1.6a) (55, 58).  
 
Figure 1.6 Formation of the AIP thiolactone 
(a and b) Sequence alignment of the four (a) AgrD and (b) AgrB variants from S. aureus: 
acidic and basic residues are highlighted in red and blue, respectively. Residues playing 
explicit roles in AgrD processing are highlighted with red boxes. In (a), the orange 
cylinder and red stars indicate the amphipathic α-helical sequence and the positions on 
which alanine mutagenesis abolishes AIP production. In (b), the topology of AgrB 
predicted in silico by TMHMM 2.0 (TMHMM) or determined employing PhoA-fusion 
(PhoA) or SCAM (SCAM) strategy is displayed above the alignment. I, O, H and R 
denote an aligned position to reside intracellularly, extracellularly, within a TM helix or 
within a re-entry loop, respectively. (c) The proposed mechanism of the thiolactone 
formation exemplified by the cleavage of group-I AgrD. 
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AgrB, the peptidase catalyzing the proteolysis of AgrD, is a multi-pass membrane 
protein. The topology of AgrB has been experimentally determined twice, each time 
yielding a model different from the computationally predicted one (Figure 1.6b) (58, 59). 
Interestingly, while the experimental studies might be expected to be more credible, the 
topology they determined does not conform to the generally accepted features of α-
helical membrane proteins. The six-transmembrane (TM) model generated from a 
phosphatase-fusion strategy, for instance, contained two 12-aa TM domains that are 
obviously too short to span a typical bacterial cell membrane when adopting the α-helical 
conformation (60). The substituted cysteine accessibility method (SCAM), on the other 
hand, gave rise to a four-TM model in which most basic residues flanking the TM 
domains localizes to the extracellular side. This configuration contradicts the “positive-
inside” rule, which states that membrane-proximal basic residues prefer intracellular 
localization due to the direction of the physiological electrochemical potential across the 
cell membrane (61). Due to these controversies, cartoon presentation of AgrB in this 
dissertation will avoid elaborating on its topology. Ultimately, this controversy may not 
be addressed without a high-resolution structure of this protein.  
 
The AgrB-catalyzed proteolysis of AgrD has been studied extensively employing both 
genetic and biochemical approaches. Two residues invariable in all known AgrB 
homologs, one cysteine and the other histidine, have been identified as the catalytic diad 
(Figure 1.6b) (54). Interestingly, all three topology models agreed with each other 
regarding to the intracellular localization of this catalytic diad, which ensures its 
accessibility to the AgrD substrate. An elegant peptidyl-transfer mechanism has been 
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proposed for this reaction (55), in which AgrB attacks the scissile bond by its active-site 
cysteine to form an acyl-enzyme thioester intermediate with the concomintant release of 
the linear AgrD C-fragment (Figure 1.6c). The intermediate is then resolved by 
transferring the peptidyl group of the AgrD N-fragment to the side-chain thiol group of 
its internal cysteine residue (C28). This releases the N-fragment as a thiolactone and 
recycles the free enzyme. While this mechanism is attractive, direct characterization of 
the thiolactone motif in the AgrD N-fragment has never been achieved. Despite this 
ambiguity, two lines of evidence strongly support that AgrB is sufficient for the 
production of the thiolactone intermediate (55). Firstly, co-expression of AgrB with the 
AgrD C28A mutant, rather than the wild-type AgrD, resulted in the detection of the acyl-
enzyme intermediate on non-reducing SDS-PAGE, suggesting that this cysteine is indeed 
the acceptor of peptidyl transfer. Secondly, AIP-related activity was found in the growth 
medium of Escherichia coli co-expressing AgrB and AgrD. This observation also argues 
for the role of AgrB in the cyclization in that the thiolactone macrocycle is required for 
the autoinduction activity of AIP, while an AgrD cyclase is not likely to exist in the 
distantly related in E. coli. 
 
Besides the catalytic diad, other regions and positions required for this activity have been 
revealed in both AgrB and AgrD employing mutagenesis strategies (58). Important 
findings include: (i) the cleavage site on AgrD is defined by residues on the -3, -1 and +2 
positions, which are likely involved in enzyme-substrate recognition (Figure 1.6a); (ii) 
truncating the leader peptide from the N-terminus or the recognition sequence from the 
C-terminus impedes proteolysis and (iii) the conserved, soluble N-terminus of AgrB (aa 
	   19	  
1-42) is required for the proteolytic activity. With respect to group specificity, 
heterologous AgrB-AgrD pairs involving AgrB-II or AgrD-II are inactive (62). This is 
not surprising because at the -3 position relative to the cleavage site, AgrD-II has a serine 
while the rest three have a phenylalanine. Determinants of group specificity in AgrB-II 
have been determined through sequence shuffling (62). Collectively, these efforts shed 
light on the AgrB-AgrD recognition despite the absence of a high-resolution structural 
model.  
 
1.2.3 Translocation and maturation of AIP 
After being processed by AgrB, the thiolactone intermediate awaits another proteolysis 
event to release the freely diffusive AIP pheromone from the membrane-anchoring N-
terminal leader peptide. Moreover, an active or facilitated translocation event is also 
required for the successful secretion of AIP due to its presumed lack of membrane 
permeability. Intriguingly, the agr locus does not encode designated proteins to account 
for these steps. While the AIP-sensing function of AgrC and AgrA could be confidently 
predicted from sequence analysis, AgrB, a peptidase from a less studied protein family, 
had been surmised to also export and/or cleave the thiolactone intermediate (59). While 
the second cleavage activity turned out to be absent as was shown in biochemical studies 
(54), the possibility of its involvement in AgrD translocation has not been formally ruled 
out.  
 
In principle, the translocation could occur either before or after the second proteolysis, 
albeit the former scenario is favored by a few lines of evidence. In 2007, Kavanaugh and 
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coworkers showed that the general signal peptidase, SpsB, cleaves a heptapeptide 
mimicking the leader peptide-AIP junction of AgrD-I at the expected releasing site (57). 
Because the catalytic domain of SpsB localizes in the extracelluar space, the authors 
argued in favor of the translocation-first model. It should be noted that this study 
provided no solid evidence on the cleavage of the native thiolactone intermediate by 
SpsB, nor did it test the activity of SpsB on the releasing-site sequence from other S. 
aureus subgroups. More recently, large quantities of the AgrD leader peptide have been 
detected in the S. aureus extracellular matrix (63, 64). This result also corroborates the 
translocation-first model, as the alternative, proteolysis-first model entails separate 
translocation of both leader and AIP fragments, which would be substantially less 
economical. The transporter responsible for AIP production, regardless of the substrate 
being exported, is yet to be identified.  
 
The second proteolysis of AgrD is fascinating in that it affords the tail-length variation 
among AIPs. Because the C-terminal carboxylate of AIP participates the thiolactone 
macrocycle, residues N-terminal to the conserved, thiolactone-forming cysteine are 
collected referred to as the exocyclic tail. The tail length is 2 residues for AIP-III, 3 for 
AIP-I and IV, and 4 for AIP-II (See Figure 1.4). The sequence contexts of the scissile 
bonds are so diverged among groups-I, -II and –III that a single protease is not likely to 
cleave all three with appropriate efficiency and specificity. In line with this notion, SpsB 
failed to cleave group-II thiolactone intermediate under all conditions tested (Jeffery G. 
Johnson, unpublished data).  
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Although the exact identity of the transporter and AIP-releasing protease are unknown, 
educated predictions can be made on the properties of these proteins. Due to the 
autoinductory nature and the non-essential role of the agr system, they are expected to be 
either housekeeping proteins (e.g., SpsB) highly efficient in their respective agr-related 
function or agr-inducible proteins that carry out specific functions.  
 
1.2.4 AIP-AgrC interaction 
In S. aureus, AgrC is the only known receptor of the AIP. This 430-aa protein adopts the 
modular architecture commonly seen for RHKs, consisting of an N-terminal, membrane-
integrated sensor module that detects AIP and a C-terminal histidine kinase (HK) module 
that carries out enzymatic functions (65). Topology analyses of the AgrC sensor module 
have generated less controversy compared to that of AgrB (65-67). All experimental and 
computational models agree on the intracellular localization of the HK domain as well as 
the positioning of the last four TM domains between residue 78 and 204, while the major 
debate lies on the number of TM domains within the N-terminal 77 residues. An earlier 
phosphatase-fusion strategy and a set of topology-prediction programs argued for two 
TM domains in this region (65), whereas a recent SCAM analysis and a different set of in 
silico programs suggested three (66). It is worth mentioning that both experimental 
studies were performed in E. coli, whose inner membrane may not support the exact fold 
of AgrC in S. aureus due to the drastically different lipid composition (68). In this 
dissertation, AgrC will be drawn following the former, 6-TM model that the Muir Lab 
has accepted for a long period of time (Figure 1.7a). However, readers should bear in 
mind that AgrC might adopt a 7-TM topology.  
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The sensor domain is connected to the HK domain via a short interdomain linker. As in 
most class-I RHKs, the AgrC HK domain contains two subdomains (Figure 1.7a) (69). 
The subdomain proximal to the sensor is the dimerization and histidine phosphorylation 
(DHp) subdomain, which folds into an α-helical hairpin and dimerizes through the  
 
 
Figure 1.7 The AgrC-AIP interactions. 
(a) Domain architecture of AgrC-I. The protein is shown as a homodimer with the 
integral membrane sensor domain and cytoplasmic DHp and CA subdomains colored in 
blue, brown and green, respectively. The interdomain linker and the DHp-CA linker 
region are depicted as red and purple dashed lines. (b) The design of reporter-strain 
assays: diagram shows the strategy to test the activating or inhibitory effect of a certain 
compound. The reporter protein is a β-lactamase, and nitrocephin is a β-lactam that 
displays a red color upon its hydrolysis. (c) A summary of the consensus conclusions 
drawn from the SAR studies of S. aureus AIPs. (d) Diagram showing the two sets of 
counteracting activities of a typical class-I RHK, with the kinase and phosphatase 
activities shown in solid and dash arrows, respectively.  
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formation of a four-helix bundle. Consequently, AgrC, as do most RHKs known to date, 
forms obligatory dimers. The distal, C-terminal subdomain is the so called catalytic and 
ATP-binding (CA) subdomain, which adopts the common fold of the GHKL (DNA 
gyrase, Hsp90, histidine kinase and MutL) superfamily (70). The CA subdomain binds to 
the triphosphate nucleotide and catalyzes the phosphorylation at a conserved histidine 
residue on the DHp subdomain. Auto-phosphorylation of the AgrC homodimer occurs in 
trans, i.e., the CA subdomain of one subunit catalyzes the phosphorylation of the DHp 
subdomain of the other subunit (Figure 1.7a). This was concluded from the observation 
that the agr- phenotype conferred by mutating the phospho-accepting histidine in agrC 
could be complemented by another copy of agrC gene encoding a RHK deficient of 
ATP-binding (71). The crystal structure of a nucleotide-free AgrC CA domain has been 
available since 2014 (72).  
 
The AIP binding site has been mapped using domain-swapping approaches. The variable 
region of the P2 operon includes the coding sequence of the sensor but not HK domain. 
Swapping the sensor and HK domains among subgroups demonstrated that the AgrC 
sensor dictates the AIP-sensing specificity (73). Further swapping of the distal (C-
terminal 4 TM domains) and the proximal (N-terminal 2 or 3 TM domains) sequences 
leads to the conclusion that AIP binding, regardless of the efficacy, relies on the distal 
part of the AgrC sensor (74). Taking advantage of the strong similarity between AgrC-I 
and AgrC-IV, engineering also revealed that exchanging the second extracellular loop 
(ECL2) completely switches their group specificity. Since AIP sequence of group-I and –
IV differs only at position 4, this residue likely interacts with the ECL2 on AgrC (75).  
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To pinpoint the structural elements of AIPs required for AgrC binding and/or activation, 
extensive structure-activity relationship (SAR) studies have been performed. Most of 
these studies rely on agr reporter strains for readout. These agr-null strains harbor a 
plasmid-born agr locus devoid of agrBD, with the P3 operon fused to a reporter gene, in 
most cases the β-lactamase (blaZ) or green fluorescent protein (gfp) gene (Figure 1.7b) 
(76, 77). Such designs render these strains deficient in AIP production but capable of 
transducing extracellular AIP signals following the specificity dictated by the agrAC. The 
activity of the reporter protein directly reflects the signaling outcome, i.e., the 
transcription activity of P3. SAR studies on S. aureus AIPs published to date have 
reached consensus on several important conclusions. First of all, the 5-aa, 16-membered 
ring structure is of utmost importance for binding (Figure 1.7c) (25, 78). To date, no 
linear peptide has ever shown any activity on a native AgrC. Alternating the ring size by 
more than one atom has also never been tolerated, although recently the Muir Lab 
showed that mutating the Asp5 in AIP-I to homo-β-Asp retains activation despite a loss 
of potency (79). Notably, changing the thiolactone linkage to a lactam or oxolactone, a 
modification that maintains the ring size, also abolishes the activation while retains the 
cross-group inhibition activities (Figure 1.7c) (25, 78). Other modifications to the 
macrocycle backbone, including methylation of amide bonds and substitution of single 
residue with the corresponding peptoid mimic, showed heterogeneous effects depending 
on the subject AIP and the modification site (80-82). Secondly, two positions at the C-
terminal end of all known AIPs (not limited to S. aureus) are conserved for hydrophobic 
amino acids (74). Their hydrophobicity is required for the tight binding to AgrC, as 
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alanine mutation at either position abolishes both cognate-group activation and cross-
group inhibition (Figure 1.7c) (25, 78, 83). Last, but not least, the cognate-activation 
activity of AIP is highly sensitive to structural modification. Modification of the 
exocyclic tail or mutation of the second ring-participating residue has converted native 
AIPs into cognate-group inhibitors (Figure 1.7c). Prominent examples include the 
appendage of a tyrosine residue to the N-terminus of AIP-III, as well as the D5A 
mutation in AIP-I and D4A in AIP-III (48, 78, 83). In all, these SAR studies provided 
precious insights on the design principles of AIPs, which have guided the design of many 
useful reagents including AIPs tagged with affinity epitopes or photocrosslinkers (Aishan 
Zhao, unpublished work), as well as QS inhibitors of all S. aureus subgroups (48, 77).  
 
By sequence homology, AgrC and AgrA forms a two-component signaling system 
(TCS). Such systems exist in all three domains of life and are particularly prevalent in 
bacteria (84). In a TCS, the RHK component usually processes two counteracting sets of 
activities (Figure 1.7d): the auto- and trans-kinase activity that installs phosphorylation to 
its cognate response regulator (RR); and the phosphatase activity that removes the 
phosphorylation (69). In response to its cognate signal, RHK adjusts the balance between 
its two sets of activities and thereby modulates the RR phosphorylation level. Signal 
transduction employing TCSs is common among QS systems, however the effect of AI 
binding on RHK’s kinase-phosphatase balance diverges (26). Importantly, using crude 
membrane vesicles from E. coli over-expressing AgrC, Lina et al. have shown that the 
presence of the cognate AIP activates the auto-kinase (65). Furthermore, Geisinger et al. 
showed that the cognate AIP binding at one sensor domain within a dimer affords 
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qualitatively similar activation to the phosphorylation of both subunits (71). Despite these 
efforts, a detailed understanding of the biochemistry and the signaling mechanism of the 
AgrC-AgrA TCS would entail high-resolution structural information as well as 
quantitative biochemical/biophysical characterization.  
 
1.2.5 AgrA phosphorylation and transcription activation 
Acting as the phospho-receiver in the TCS as well as a transcription activator, AgrA 
consists of two domains, each assuming one of its two functions. The N-terminal receiver 
domain is shared across all RR proteins and dimerizes upon phosphorylation at its 
conserved Asp residue (69). The C-terminal DNA binding domain belongs to the LytTR 
protein family and binds to the consensus DNA elements located in the P2 and P3 
promoter region (85). The crystal structure of the AgrA DNA binding domain in complex 
with a cognate 16-nt DNA fragment has been solved (Figure 1.8a) (86). In stark contrast 
to most known transcription factors that bind DNA using α–helices, AgrA LytTR domain 
is enriched in β-strands and harnesses residues on its inter-strand loops for the interaction 
with DNA. This unique binding pattern causes bending of the DNA double-helix by 38o 
upon the interaction (Figure 1.8a). Amino acid residues required for the stability, DNA-
binding and/or transcriptional activation have been identified employing structure-guided 
or alanine-scan mutagenesis approaches (86, 87). Intriguingly, an AgrA mutant, 
AgrAY229A, is deficient in activating transcription from the P3 promoter even through it 
binds and bends the DNA element indistinguishably from the wild type. This finding 
suggested that the surface patch surrounding Y229 might be specialized for transcription 
regulation through an unknown mechanism.  
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Figure 1.8 The crystal structure of AgrA and the regulatory elements of P2 and P3 
transcription. 
(a) Ribbon diagram of AgrA in complex with a 16-bp double-strand DNA containing its 
cognate binding sequence. AgrA is shown in green, with the sulfur atoms in Cys199 and 
Cys228 capable of disulfide formation under oxidative stress highlighted with yellow 
spheres. A 38o arc next to the DNA strands illustrates the magnitude of DNA bending as 
a consequence of AgrA binding. (b) Double-strand DNA sequence of the intergenic 
region within the agr locus. The -10 and -35 elements with respect to the transcription-
starting site (TSS) are marked with orange arrows and the AgrA-binding elements with 
red arrows. Red boxes denote the binding elements for SarA. 
 
Autoinduction of agr presupposes a different temporal pattern of P2 and P3 transcription. 
Prior to autoinduction, a tight repression of the P3 operon is preferred to avoid 
unnecessary RNAIII-mediated mRNA degradation, while a reasonable expression level 
of P2 genes is required to set the stage of the autoinduction circuit. In agreement with this 
idea, experiments have confirmed that the baseline transcription level of P2 is higher, 
while its activation is less dramatic, compared to that of P3 (88). How could the same 
pool of AgrA possibly exercise differential regulation over two operons? The answer lies 
within their promoter sequences. Both P2 and P3 promoter regions contain, in the 
orientation of transcription, two AgrA-binding elements followed by the -35 and -10 
boxes required for RNA polymerase (RNAP) recognition (Figure 1.8b). In spite of the 
similar architecture, AgrA-recognition sequences in P2 provide stronger affinity to AgrA 
than that in P3 (89). Thus, the promoter occupancy of P2 would be higher than that of P3 
given limited availability of phosphorylated AgrA. Moreover, the spacer between the -35 
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and -10 boxes measures 18 nts in the P2 promoter and 20 nts in P3, both deviating from 
the optimal, 17-nt length (Figure 1.8b) (88, 90). Strikingly, shortening the spacer of P3 to 
the optimal length dramatically enhances the baseline transcription activity both in vitro 
and in vivo (88, 91). In light of this observation, the DNA-bending effect of AgrA 
binding as well as the dimerization induced by AgrA phosphorylation, has been surmised 
to rearrange the -35 and -10 boxes back to the optimal conformation to facilitate the 
binding of RNAP. Having been supported by in vitro transcription data, this theory 
provides a solid explanation for the more substantial up-regulation of P3-gene production 
during autoinduction. 
 
The agr locus is a hot spot of signal integration due to its central role in direct regulation 
of dozens of effector genes. AgrA, for instance, can be inactivated by oxidative stress 
through the formation of a disulfide bond between two cysteine residues at positions 199 
and 228 (Figure 1.8a) (92). Apart from AgrA, at least two transcription factors, SarA and 
SarR, are known to bind directly within the intergenic sequence between P2 and P3 
(Figure 1.8b) (93, 94). Production of both SarA and SarR is growth-phase dependent, 
with their protein levels peaking during late-exponential and stationary phases, 
respectively (95, 96). While SarA enhances AgrA-dependent P2 transcription, SarR 
exhibits a repressive effect. Thus, their coordinated expression is thought to play a role in 
the down-regulation of agr activity in the stationary phase. In contrast to these direct agr-
binding factors, more factors/pathways are known to regulate agr effectors in an agr-
independent manner. At least two TCSs, SaeSR and SrrAB, control the virulence gene 
expression at the transcriptional level in response to stress conditions (97). Notably, a 
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global metabolic regulator, CodY, has recently been found to influence agr gene 
expression (98). The Bacillus homolog of this protein is known to respond to the 
secondary messenger, guanosine tetraphosphate (ppGpp) (99). In S. aureus, however, the 
codY deletion causes substantial over-expression of both P2 and P3 genes and hence a 
premature-autoinduction phenotype (100). Unexpectedly, CodY has barely detectable 
affinity to agr promoters, and the connection between CodY and agr gene products is 
still unclear.  
 
1.3 Reagent development for the manipulation of agr 
S. aureus requires agr not for survival but virulence. Interfering with the autoinduction, 
or QQ, should therefore be effective in combating the infection caused by this bacterium. 
Meanwhile, the likelihood of resistance development against agr-targeting reagents is 
expected to be lower since they impose milder selection pressure versus classic, 
bactericidal or bacteristatic antibiotics (101). These potential properties qualify agr-
targeting reagents as attractive candidates for the treatment of staphylococcal infection. 
The cross-group inhibitory property of AIPs provides the first view of the effectiveness 
of QQ (25). AIP inhibitors have been shown to attenuate the spread of S. aureus 
infections in mice, phenocopying the use of agr-null S. aureus strains as infective agents 
(25). Remarkably, administering the antagonistic AIP during the beginning 3 hours of 
infection is sufficient for its attenuation effect despite the short lifetime of this peptide in 
vivo (30).  
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Although effective in containing new colonization by S. aureus, the effect of QQ reagents 
on existing infections has not been reported. It is noteworthy that silencing of the agr 
system is known to strengthen S. aureus biofilm and potentially benefits the maintenance 
of chronic infection (102). Conversely, activation of the agr system might represent a 
more attractive strategy in tackling S. aureus infection—not only does it disperse the 
biofilm, the constant induction of the agr-regulated genes also takes tolls on the fitness of 
the bacterium, rendering them more susceptible to classic antibiotics (103). Practical 
application of this strategy would entail a global activator that simultaneously activates 
the autoinduction of all four S. aureus subgroups. This reagent could potentially be a 
cocktail of a series of “clean” activators that each activates one or more agr variants 
without substantially affecting the rest. Unfortunately, the outcome of agr activators in 
animal models has not been tested to date, nor has any clean agr activator ever been 
developed. Because of the strong bias against agr activators in this field, the rest of this 
section will be dedicated to the discovery of QQ reagents. 
 
1.3.1 AIP scavenging in host defense 
Even in the absence of exogenous drugs, the mammalian host is able to scavenge AIPs 
and hence block autoinduction (Figure 1.9). Consequently, the lifetime of AIPs in vivo is 
on the order of a couple of hours (104). There are two major mechanisms by which AIPs 
are scavenged in the host serum. Firstly, AIP-I and AIP-IV contain, at their C-terminal 
position, a methionine residue essential for their receptor binding. As a consequence, 
oxidation of the thioether group on the methionine side chain by reactive oxygen species 
(ROS) into a sulfoxide leads to complete inactivation of these two AIPs (Figure 1.9) (78). 
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It was found thereafter that this oxidation also occurs in mice, and NADP oxidase-
knockout animals are more susceptible to group-I S. aureus infection due to their 
deficiency in ROS production induced by immune response (104). In addition to 
oxidation, a more general neutralization strategy employing low-density and very-low-
density lipoproteins (LDL and VLDL) is capable of removing AIPs free from oxidation-
sensitive residues (e.g., AIP-III) (105, 106). Upon sequestration into lipoprotein particles, 
AIPs are then internalized by macrophages through receptor-mediated endocytosis and 
subject to lysosomal degradation. Notably, pre-oxidation of LDL by the ROS generated 
during the immune response significantly enhances its AIP-binding affinity, suggesting a  
 
 
Figure 1.9 Mechanisms of AIP scavenging by mammalian hosts. 
Diagram depicts two major mechanisms known to date, namely, lipoprotein sequestration 
and direct oxidation, that allows mammalian hosts to inactivate S. aureus AIPs. 
Inactivated AIPs upon oxidation are shown in gray, with X denoting the methionine 
sulfoxide generated by oxidation.  
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causal relationship between infection and the implication of AIP clearance machineries 
(Figure 1.9) (106). While this arrangement has its physiological merit, the lack of 
protection during the beginning few hours following invasion provides the pathogen 
opportunities to expand and establish its colonization.  
 
1.3.2 AgrC-targeting reagents 
In principle, chemicals blocking any step within the autoinduction loop should effectively 
accomplish quorum quenching. Unfortunately, out of five potential protein targets, i.e., 
AgrA, AgrB, AgrC, the AIP-releasing protease and the transporter, only the AgrA LytTR 
domain and the AgrC CA subdomain have had their crystal structures solved, while the 
last two proteins have not yet been unambiguously identified (72, 86). Consequently, 
target-specific drug design is predominantly limited to chemical engineering based on the 
AIP scaffold. Native AIPs provide a rich source of information for the design of QQ 
reagents due to their cross-group inhibitory properties. As opposed to native AIPs, 
however, QQ reagents are expected to inhibit the autoinduction of all four groups. 
Guided by the structure-activity relationship of AIPs (vide supra, section 1.2.4), AIP-I, -
II and -III have all been successfully modified into global QQs of S. aureus (Figure 
1.10a) (48, 77, 83). Despite this success, the AIP backbone is peptidic in nature and 
hence suffers such drawbacks as high immunogenicity and lack of stability in vivo. In a 
prominent attempt to address this problem, modification of single residues in AIP-III 
through peptoid-mimic substitution or N-methylation has generated a few global QQs 
(82). Full peptomer mimic possessing global QQ activities, however, has not yet been 
identified.  
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Aside from synthetic peptides derived from the native AIP scaffold, reported inhibitors of 
S. aureus autoinduction are predominantly secondary metabolites from other microbes. It 
should be pointed out that most these compounds have not been shown to directly interact 
with AgrC, nor have their activities been tested against all four subgroups of S. aureus. 
Nonetheless, some of these inhibitors share astonishing similarity to native AIP despite 
their disparate origin. For instance, solonamides, a series of tetrapeptides produced by 
marine bacteria from the genus Photobacterium, possess a 16-membered macrocycle 
containing four one β-hydroxy-acid and four α-amino-acid building blocks (Figure 
1.10b) (107). Thus, solonamides and a few other agr-repressing natural products  
 
 
Figure 1.10 Synthetic molecules or natural products that targets agr. 
(a) Global AgrC inhibitors derived from native AIPs. Groups that differ from the wild-
type AIP are highlighted in red. (b) Putative AIP-mimic natural products. (c) The 
Pseudomona autoinducer 3-oxo-C12-HSL and secondary metabolite HQNO. (d) The 
AgrA-targeting lead compound, savarin.  
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containing AIP-like macrocycles, including avellanin and cochinmicin (Figure 1.10b) 
(108, 109), are believed to function through competitive inhibition of AgrC. Two other 
natural products, 3-oxo-C12-HSL and 4-hydroxy-2-heptylquinoline N-oxide (HQNO) 
originated from Pseudomonas aeruginosa, are capable of quenching S. aureus 
autoinduction with a low-micromolar IC50 (Figure 1.10c) (110). Interestingly, both P. 
aeruginosa and S. aureus are known to colonize the airways of cystic fibrosis patients, 
and these two compounds might play a role in the inter-species competition (111). In 
particular, the HSL compound has bactericidal activity at high-micromolar concentrations 
and may act as an allosteric inhibitor of AgrC at lower concentrations as was inferred 
from its interaction with AIPs in cell-based assays (112). Given the similar, amphiphilic 
structure of these two compounds, it is tempting to surmise that they function through 
interacting with the cell membrane.  
 
1.3.3 AgrA-targeting reagents 
In contrast to AgrC, which has four variants in S. aureus, targeting AgrA could be 
simpler due to its uniform sequence in all four subgroups. On the other hand, because 
AgrA localizes in the cytoplasm, membrane permeability would be required for effective 
AgrA inhibition in living organisms. As opposed to the SAR-guided design of AIP 
analogs into desired AgrC inhibitors, development of AgrA-targeting QQ reagents 
predominantly relied on the library screening approach employing cell-based readouts. 
AgrA was identified as the target in the validation process.  
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According to the crystal structure of AgrA LytTR domain in the absence of bound DNA, 
binding of a small organic compound to a hydrophobic cleft might disrupt the AgrA-
DNA interaction (113). As a proof of principle, Leonard et al. screened over a 500-
member library and identified a few AgrA-targeting hits with low-milimolar affinity 
(113). Screening of a much larger library led to the discovery of Staphylcoccus aureus 
virulence inhibitor (savirin), which optimally blocks S. aureus autoinduction at 13.5µM 
through the same mechanism (Figure 1.10d) (114). This drug robustly inhibits 
autoinduction phenotypes of S. aureus and attenuates the lesion size in the classic murine 
abscess model. Importantly, resistance did not emerge upon extensive passage of S. 
aureus in the presence of savirin. Because of its optimal physicochemical properties and 
biological activities, savirin is viewed as a promising lead compound awaiting further 
SAR studies. 
 
1.3.4 AIP-sequestration reagents 
The last class of QQ reagent developed works through sequestration of AIPs from their 
interaction with AgrC. Employing a stable, oxo-ester variant of AIP-IV as the antigen, a 
set of AIP-IV specific, mouse monoclonal antibodies was developed (115). The 
antibodies showed excellent QQ activity in vitro, and protected mice from the 
development of skin-infection symptoms upon inoculation with a group-IV strain. 
Nonetheless, the prohibitive cost of the development and production of antibody drugs 
might present a formidable barrier for the application of QQ antibodies in practical anti-
staphylococci therapies.  
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1.4 Summary: specific aims and significance 
Elucidation of QS-dependent exo-protein regulation represents a major advance in the 
understanding of S. aureus physiology and pathology. Key to this achievement is the 
discovery and characterization of the agr locus, which can be divided into two phases 
demarcated by the sequencing of agr allelic variants and the isolation of the AIP. Dr. 
Richard P. Novick, a professor at New York University Medical Center and a close 
collaborator of the Muir Group, has made leading contributions throughout the first 
phase, primarily involving the isolation, cloning and sequencing of the agr locus. 
Thereafter, the Muir Group joined the campaign since 1997 and the two groups 
collectively initiated the second phase featuring the molecular and mechanistic 
characterization of agr. In the following years up until the beginning of my dissertation, 
the Novick-Muir collaboration has primarily focused on (i) the validation of the agr 
autoinduction circuit as a potential drug target and (ii) the dissection of molecular 
determinants in AIP and AgrC that define the affinity and signaling efficacy of their 
interaction. Meanwhile, other research groups around the world have attempted to 
understand the mechanisms of action for every single agr gene product, predominantly 
employing cell-based genetic/biochemical approaches and qualitative detection methods. 
Many fundamental biochemical questions, in particular with respect to integral 
membrane proteins AgrB and AgrC, were therefore left open. During the same period of 
time, geneticists have outlined the signaling network surrounding the autoinduction 
circuit, but little effort has gone to identifying missing components of the autoinduction 
circuit itself, namely the transporter and the AIP-releasing enzyme. In a quest to fill up 
the knowledge gaps listed above, I decided to investigate individual biochemical events 
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in the autoinduction circuit primarily through in vitro reconstitution using highly purified 
synthetic or recombinant components. Importantly, this strategy conforms to the pure-
chemistry spirit and chemical biology strength of the Muir Group.  
 
The overall aim of this dissertation is to perform comprehensive biophysical, biochemical 
and bioinformatic characterizations of AgrB and AgrC and thereby provide mechanistic 
insights to the institution and regulation of their enzymatic activities. Specific aims are 
addressed in each chapter. A comprehensive database search for homologs of AgrC 
proteins is included in Chapter 2, accompanied by inferences from the perspective of 
systematic evolution. To enable quantitative enzymology study on AgrC in various ligand 
states, the receptor was reconstituted to the nanometer scale lipid-bilayer discs, or 
nanodiscs, which contain a topologically open membrane. The reconstitution, the 
recapitulation of ligand responses of AgrC, and the determination of parameters 
describing its ligand binding and kinase activities are presented in Chapter 3. AgrC is 
also unique for having a number of activity states depending on the ligands bound. In 
Chapter 4, a conformation-activity landscape is charted and ligand-induced molecular 
motions detected for AgrC to shed light on its signaling flexibility. Chapter 5 is dedicated 
to the reconstitution of AgrB-catalyzed proteolysis of AgrD, focusing on identifying the 
driving forces that power the formation of the high-energy AgrD thiolactone intermediate 
without free-energy input from ATP.  
 
QS-mediated behaviors are widely present in pathogenic bacteria. Gram-positive 
pathogens including Listeria monocytogenes, Enterococcus faecalis and Clostridium 
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perfringens all possess autoinduction systems sharing striking homology to the S. aureus 
agr system in both protein sequences and regulatory architectures (116-119). This 
dissertation establishes a solid body of knowledge concerning the biochemical principles 
of the agr system, which may provide guidance for understanding of virulence-protein 
regulation in many other clinically significant organisms. Moreover, the profound impact 
of agr on protein production and energy expense can be harnessed to modulate the 
microbe’s fitness under certain selective conditions. Although the effectiveness of agr-
targeting reagents as the standalone drug is still under debate, they still hold considerable 
potential as components of therapeutic cocktails against S. aureus infection. The in vitro 
reconstitution system of AgrB and AgrC may enable target-specific library screening 
employing the affinity-selection mass spectrometry (ASMS) strategy, which offers much 
larger throughput compared to cell-based screening assays and should expand the chance 
of discovering useful reagents in future anti-staphylococcal practices (120).  
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Chapter Two: Bioinformatic Analysis of the S. aureus AgrC 
To confer the enzymatic as well as the regulatory functions, most class-I RHKs share five 
sequence motifs that enable them to bind the nucleotide/metal cofactor and, depending 
upon the signaling state of the sensor domain(s), adopt the active or inactive 
conformation through an appropriate DHp-CA interaction. In each motif, one or several 
position(s) are highly conserved for certain amino acids. Therefore, these motifs are 
named “homology boxes”, denoted by the amino acid on their respective most conserved 
positions (69). The H-box, for instance, features the phospho-acceptor His residue, and is 
involved in the kinase-competent DHp-CA interaction as well as the DHp-RR interaction 
that supports the trans-kinase or phosphatase activity (Figure 2.1a) (121, 122). All other 
four homology boxes reside in the CA subdomain. Among them, the F-box is unique for 
its involvement in the kinase-inactive conformation: the conserved Phe associates to a 
hydrophobic patch on the DHp subdomain and thus holds back the CA from approaching 
the phospho-acceptor His (Figure 2.1b) (123). The remaining three motifs, namely the N-
, G1- and G2- boxes, interact with the divalent metal, the adenine base and the 
triphosphate anion of the ATP-metal cofactor, respectively (Figure 2.1c-e) (124). 
Because of their high levels of conservation, database search for RHK sequences depends 
predominantly upon the detection of these homology boxes.  
 
It has long been noticed that S. aureus AgrC protein possesses unusual sequence features 
in several of its homology boxes. In a seminal study carried out by Grebe and Stock 
(125), 384 RHK sequences known as of 1999 were classified into a series of subfamilies 
based on sequence homology in their HK domains. Together with 14 close homologs all 
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governing peptide-mediated intercellular communication, AgrC falls in the HPK10 
subfamily, which was denoted to “show very distinct characteristics that clearly 
distinguish them from other histidine kinases” (125). These characteristics include: (i) a 
distinct H-box sequence pattern, F[RK]HDYxN; (ii) the absence of the first Asn residue 
in the N-box motif, NxxxN; and (iii) the lack of any detectable G1-box motif, DxGxG.  
 
 
Figure 2.1 Primary functions of HK homology boxes captured in crystal structures. 
In all panels, the HK domain is shown in green ribbon diagram. Homology-box residues 
participating interactions and adenosine nucleotide (if present) are highlighted with stick 
model. Carbon atoms of the namesake residue and the adenosine nucleotide are colored 
in magenta and cyan, respectively. Red dashes denotes important hydrogen/coordination 
bonds. (a) The H-box of the E. coli stress sensor, CpxA docked to the surface of a CA 
subdomain in an auto-kinase-competent conformation. PDBID: 4biv. (b) The F-box of 
the Thermotoga maritima HK853 docked to a hydrophobic patch on the DHp subdomain 
to enforce the inactive conformation. PDBID: 2c2a. (c) The N-box of the E. coli 
chemoreceptor kinase, CheA in complex with ADPCP and Mn2+. The metal cation is 
shown as a purple sphere. PDBID: 1i5a. (d) The G1-box of the M. maritima HK853 in 
complex with ADP. Red spheres are the oxygen atoms of two water molecules. PDBID: 
2c2a (e) The G2-box of the CheA kinase in complex with ADPCP and Mn2+. PDBID: 
1i5a. In (d) and (e), structural elements sheltering the homolog boxes are removed for 
clarity.  
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Recently, computational analysis identified strong sequence co-variation between the N- 
and H-box motifs, suggesting that they likely interact at the DHp-CA interface required 
for auto-phosphorylation (126). While a double-mutant cycle might account for the 
deviation of AgrC N- and H-boxes from canonical sequences, the AgrC sequence at the 
G1 region provides no hint on how this RHK harnesses ATP (or any triphosphate 
nucleotide) for auto-phosphorylation. In this chapter, we first seek to identify, from the 
genomic databases, more RHK sequences sharing the distinct features of the HPK10 
subfamily. Sequence analysis was then performed, leading to a few hypotheses on the 
biochemical properties of AgrC and the evolution trajectory of the agr system.  
 
2.1 Identification of close AgrC homologs from genomic databases 
Two rounds of database search were performed (Figure 2.2). In the first round, the 
intracellular sequence of the group-I S. aureus AgrC (residues 205-430) was used as the  
 
 
Figure 2.2 Flow chart of the database search for AgrC homologs. See text for details.  
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query to search the reference-sequence protein database (Refseq_protein) with Pattern 
Hit Initiated BLAST (PHI-BLAST) (127). The initial pattern was 
[FILV][RK]H[DE][YF]. In order to preserve the initial pattern, no subsequent PSI-
BLAST was performed. Hits with E-values below 0.05 were pooled. To reduce the 
redundancy of the hit pool, the CD-HIT program was used to cluster near-identical 
sequences with an identity threshold of 80% (128). One representative sequence from 
each cluster was included in the non-redundant sequence collection, which was aligned 
using the COBALT program for the detection of the CA domain (129). False (non-RHK) 
hits lacking a G2-box were removed manually. Out of 183 sequences obtained in the first 
round, 12 most distantly related to AgrC-I were chosen as queries for a second round of 
database search with similar strategies (see Appendix Table 1). Hit sequences obtained 
from both rounds were pooled and, upon removal of redundant and false hits, returned 
330 non-redundant RHK sequences (Appendix Table 1). 
 
To understand the G1-box configuration in AgrC, we generated a sequence profile of the 
330-sequence collection using HMMER (130), and aligned it to an RHK with a canonical 
G1-box, the osmotic sensor EnvZ from E. coli. Strikingly, aligned to the first position of 
the EnvZ G1 motif, “DxGxG”, is an Asn conserved in 326 out of 330 sequences, to 
which we refer as the ‘G1-box Asn’ (Figure 2.3). Notably, the frequency of Asn at this 
position is 9% in contrast to 85% for Asp in the GHKL super-family to which all CA 
subdomains belong (70). In contrast, amino acids aligned to either EnvZ G1-box glycines 
are not conserved among these 330 sequences. This result strongly suggests that AgrC, 
one of the 326 possessing the G1-box Asn, employs this residue to interact with the 
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nucleotide cofactor. Furthermore, since we did not assign any sequence pattern when 
performing the PHI-BLAST, this unique G1-box feature must have co-evolved, directly 
or indirectly, with the input H-box sequence pattern. 
  
Further analysis revealed another common feature of these 326 sequences: although 
covering 194 species from 22 taxonomic families, they all come from low-GC gram-
positive bacteria in line with 15 founding members of the HPK10 subfamily (Table 2.1). 
Interestingly, the four sequence hits that did not conform to these two criteria contain 
both a canonical G1-box and originate from Gram-negative bacteria or archaea. These 
two features suggested that this 326-sequence collection represents a self-consistent 
expansion of the original RHK10 subfamily. It is noteworthy that the lack of first Asn in 
the NxxxN N-box motif [characteristic (ii)] no longer holds true within this expanded 
RHK10 subfamily.  
 
2.2 Sequence analysis of the HPK10 subfamily 
Among the 326 sequences, 318 were predicted to span the membrane at least once and 
286 to span five times or more, according to the TMHMM program (Figure 2.4a) (131).  
                           
Figure 2.3 Alignment of the E. coli EnvZ protein to HPK10 subfamily members at 
the G1 box. The G1-box Asn and the conserved residues in canonical G1 boxes are 
highlighted in orange and blue, respectively.  
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Interestingly, with only one exception, none of these multi-span HPK10 sequences is 
predicted to contain an extracellular sensor domain, suggesting that most HPK10 
 
Table 2.1 Taxonomic coverage of the HPK10 subfamily  
Phylum Class Order Family 
Negativicutes Selenomonadales Veillonellaceae 
Mollicutes Acholeplasmatales Acholeplasmataceae 




























Figure 2.4 Statistics of the expanded HPK10 subfamily. 
(a) Number of TM domains predicted for the 326-sequence collection by the software 
package, TMHMM 2.0. (b) Predicted length of the interdomain linker (in residues) in the 
multiple sequence alignment of the 285 sequences. 
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subfamily members likely sense extracellular or intra-membrane signals with membrane-
embedded sensors (132). To better delineate the boundaries of the AgrC-I intracellular 
modules, we generate a new hidden Markov model (HMM) using the alignment of these 
286 multi-span sequences, and harnessed it to analyze a sub-alignment of 18 sequences, 
each representing a taxonomic family (Figure 2.5a). These analyses revealed a less 
conserved, short linker between the well-aligned last TMH and the DHp subdomain in all 
sequences (Figures 2.4b and 2.5b). Specifically in AgrC-I, the conserved DHp subdomain 
that aligns to the HMM with high confidence begins at residue 222 rather than at residue 
200 immediately after the last TMH (Figure 2.5b). We therefore refer to AgrC-I1-200 as 




Figure 2.5 Identification of a less conserved interdomain linker within AgrC 
(a) Posterior probabilities of the 18-sequence sub-alignment according to the profile 
HMM: positions in the HMM are displayed with numbering corresponding to residues in 
AgrC-I; predicted domains of AgrC-I are shown above. (b) HPK10 subfamily alignment 
from the last TMH to the first DHp helix: highly conserved residues and the phospho-
acceptor histidine are highlighted in orange and blue, respectively.  
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2.3 Summary and discussions 
The taxonomic restriction of the HPK10 subfamily revealed in this chapter provides 
intriguing insights on the evolution trajectory of the AgrCA TCS as well as the agr QS 
circuit. First of all, that all subfamily members come from the phylum Firmicutes 
strongly supports the theory that the ancestral HK domain carrying all HPK10-specific 
features emerged after the branching of this phylum from the tree of life. A subphylum-
specific emergence is also possible, as the distribution of HPK10 members across the 
phylum is highly uneven, with more than 95% sequence found in orders Bacillales, 
Lactobacillales and Clostridales. 
 
Despite the rapid expansion of the sequence database, our knowledge on the function of 
HPK10 subfamily members has not progressed as much. Founding members of the 
subfamily were discovered about two decades ago for their involvement in the 
autoinduction circuits encoded by homologs of the S. aureus agr locus and the 
Streptococcus pneumoniae com locus—and this remains the only known function of this 
RHK subfamily to date (125). In our database search, a number of HPK10 genes were 
found without an agrB or a comAB homolog (see below) in their genomic context, and 
their functions are so far intractable. The AI of the prototypical streptococcal com system 
is a linear peptide named the CSP (for competence-stimulating peptide), which is sensed 
by the ComDE TCS, a close homolog of AgrCA (Figure 2.6) (133). Notwithstanding the 
homology of the AI-sensing module, the ComAB machinery that both processes and 
secretes the CSP is completely unrelated to AgrB—rather it shares close homology with 
the plasmid-borne E. coli hemolysin transporter, HlyBD (Figure 2.6) (134, 135). 
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Interestingly, the AgrBD homologs were also found to exist in a broader spectrum of 
Firmicutes than the intact agr system (136). These findings raised the possibility that 
both systems emerged through the co-regulation of pre-existing AI production and 
sensing genes, which were subsequently grouped into a single operon. Given the 
prevalence of agr homologs in Bacillales and Clostridales and com homologs in 
Lactobacillales, these two systems likely emerged independently and gained their 
autoinductory function thereafter through convergent evolution. A comparative analysis 
of the phylogeny of the HPK10 subfamily to that of AgrB and ComAB would test this 
hypothesis more rigorously. 
 
The bioinformatic analysis described in this chapter was directed to address two 
questions, namely, what aspects of AgrC biochemical properties we should focus in the 
subsequent in vitro reconstitution study and how to interpret the results from an 
evolutionary perspective. While the classic theme of phospho-relay has been well  
 
 
Figure 2.6 Comparison between the prototypic com and agr loci 
Gene-products encoded by the (a) com and (b) agr loci are shown in arrows indicating 
their direction of transcription. Coding region of the HPK10-subfamily RHK and the 
LytTR-family RR are colored in green and blue, respectively.  
 
	   48	  
established for TCSs, the sequence peculiarity in the H- and G1-boxes of the HPK10 
subfamily foreshadows some intriguing subfamily-specific behaviors related to these two 
homology boxes. Specifically, the unique H-box sequence may enable a distinct 
regulatory pattern of the AgrC auto-kinase, trans-kinase and phosphatase activities 
following signal input. We will therefore investigate all three above activities of AgrC 
under resting, activated or inhibited ligand states. Furthermore, as the only conserved 
residue that putatively interacts with the nucleobase, the G1-box Asn must either harness 
a different triphosphate nucleotide as the phosphoryl donor, or bind to the ATP adenine at 
an altered affinity. Consequently, the nucleotide specificity and the affinity to the favorite 
nucleotide will be another focus of our biochemical studies. Data that distinguish AgrC 
from the majority of RHKs are expected, and will be interpreted within the boundary of 
the HPK10 subfamily and the extracellular peptide sensing in Firmicutes.  
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Chapter Three: Reconstitution of Biochemical Events Related to AgrC 
Quantitative information on how AgrC works as a kinase and how its activity is regulated 
by native AIP ligands is critical to the understanding of the regulatory architecture of S. 
aureus autoinduction. Unfortunately, such information is in a short supply, however, 
primarily due to the limitations of cell-based reporter assays. The complicated whole-cell 
system occludes specific detection of individual proteins, while the reporter-protein 
readout cannot faithfully reflect the rate of a single biochemical event involved in two-
component signaling cascade. To circumvent these drawbacks and provide quantitative 
insights into the activity and regulation of this pivotal receptor histidine kinase (RHK), an 
in vitro reconstitution system involving highly purified components must be 
implemented. In this chapter, we describe the reconstitution of AgrC homologs to an 
artificial membrane system that restores their expected biochemical activity and ligand 
response. During the course of our reconstitution attempts, a polyclonal, pan-specific 
antibody for phosphohistidine (pHis) detection was developed in the Muir Lab, enabling 
highly efficient, quantitative detection of AgrC phosphorylation (137). Taking advantage 
of this new reagent as well as our reconstitution system, we determined physicochemical 
parameters for the interaction between AgrC-I and native AIPs, as well as kinetic 
parameters of the RHK’s auto-kinase and phospho-relay activities in the apo- and 
activator-bound states.  
 
3.1 Functional reconstitution of AgrC to nanodiscs 
We elected to use nanometer-scale lipid-bilayer discs (nanodiscs) as the model membrane 
for the incorporation of AgrC (Figure 3.1a) (138). Nanodiscs are a supramolecular mimic 
	   50	  
of high-density lipoproteins consisting of a discoidal lipid bilayer surrounded and 
stabilized by two copies of a membrane scaffold protein (MSP). Importantly, the 
topologically open nanodiscs, as opposed to membrane vesicles, enables AgrC, when 
incorporated, to simultaneously access its AIP ligands and enzymatic substrates in the 
bulk solution because both sets of reagents are membrane-impermeable. 
 
 
Figure 3.1 Reconstitution of AgrC-I to nanodiscs composed of DMPC and DMPG 
(a) Schematic showing the workflow used for reconstituting AgrC-I dimers into 
nanodiscs. (b and c) Purification of (b) AgrC-I from E. coli membrane extract and (c) 
AgrA from E. coli total soluble lysate as analyzed by SDS-PAGE with CBB-stain. Bands 
corresponding to the target proteins are indicated. Asterisk indicates a 100-kDa protein 
co-purified with AgrC-I. (d) Purification of reconstituted AgrC-I discs by Ni-NTA 
affinity chromatography as analyzed by SDS-PAGE with Coomassie-brilliant blue (CBB) 
staining; bands corresponding to AgrC-I and the scaffold protein (MSP) are indicated. (e) 
AgrC-I discs analyzed by size exclusion chromatography (SEC). Fractions collected 
between the dashed lines were further analyzed by SDS-PAGE with CBB staining 
(bottom). (f) SEC-MALS analysis of empty and purified AgrC-I discs. Moverall 
corresponds to the average molecular weight (MW) of the peak calculated from the UV, 
light-scattering, and differential refractive-index readouts. Mprotein corresponds to the 
measured MW of the proteins in each case; AgrC-I = 51 kDa, MSP = 29 kDa. (g) 
Stoichiometry of AgrC-I discs as analyzed by SDS-PAGE: AgrC-I discs (left lane) and 
an equimolar mixture of purified AgrC-I and MSP (right lane) were resolved and 
visualized with CBB staining.  
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Among four AgrC homologs in S. aureus, the group-I variant was the first to be 
successfully over-expressed in E. coli and hence employed in nanodisc-reconstitution 
trials. Both AgrC-I and AgrA were purified as His6-tagged recombinant proteins (Figure 
3.1b and c). The detergent-solubilized AgrC-I did not have any auto-kinase activity 
regardless of the presence of AIP (data not shown). We then set out to prepare 
homogeneous nanodiscs containing one copy of the AgrC-I dimer per disc. To this end, 
purified AgrC-I was added to mixed micelles containing excess MSP and lipids [1,2-
dimyristoyl-sn-3-glycero-phosphocholine (DMPC) and 1,2-dimyristoyl-sn-3-glycero-
phosphochglycerol (DMPG), molar ratio 1:3, see below], lowering the chance of 
incorporating more than one copy of AgrC-I dimer in each nanodisc (Figure 3.1a) (139). 
Detergent was then removed to drive self-assembly, and nanodiscs containing AgrC-I 
(AgrC-I discs) were separated from empty discs using Ni-NTA affinity purification 
(Figure 3.1a and d). Purified AgrC-I discs gave a single, symmetric peak on size-
exclusion chromatography (SEC) from which the peak fractions were pooled for further 
studies (Figure 3.1e). The product has a narrow molecular weight distribution analyzed 
by size-exclusion chromatography in tandem with multi-angle light scattering (SEC-
MALS, Figure 3.1f) (140). The expected stoichiometry of one copy of AgrC-I dimer per 
disc was also confirmed in the SEC-MALS experiment, as well as using SDS-PAGE 
employing ratiometric standards (Figure 3.1g).  
 
In preliminary trials of AgrC-I reconstitution, a series of phosphatidylcholines (PC) were 
tested for their ability to mediate nanodisc assembly (139). DMPC was selected because 
of the relative ease in obtaining a monodisperse population of AgrC-I discs (data not 
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shown). Notwithstanding this favorable behavior, AgrC-I embedded in DMPC nanodiscs, 
although possessing a basal level of auto-kinase activity, failed to activate upon binding 
to AIP-I, its cognate activator peptide (Figure 3.2a, lanes 1 and 2). Because the major 
phospholipid in S. aureus cell membrane is the anionic phosphatidylglycerol (PG), we 
adjusted the nanodisc lipid to a mixture of DMPC and DMPG at a molar ratio of 1:3 and 
successfully restored the AIP-I dependent auto-kinase activation of AgrC-I (Figure 3.2a, 
lanes 3 and 4) (68). Surprisingly, co-migration assays showed that AgrC-I embedded in 
nanodiscs with either lipid composition binds to the activator AIP with equal capacity,  
 
 
Figure 3.2 Dependence of AgrC-I activation on lipid composition 
(a) AgrC-I auto-kinase activation: AgrC-I discs reconstituted with different lipid mixtures 
were phosphorylated with 1 mM ATP at 37 oC for 3 minutes. The cognate AIP-I was 
included as indicated. pHis levels in AgrC-I were analyzed by anti-pHis western blotting 
(upper). The blot was CBB stained thereafter as a loading control (lower). (b) Co-
migration assay of a fluorescein-labeled AIP-I, FAM-AIP-I (refer to Figure 3.7a) with 
selected nanodisc samples: AgrC-I or empty discs assembled with DMPC only or a 
DMPC-DMPG mixture were incubated with excess FAM-AIP-I and analyzed by SEC. 
UV and fluorescence detection of the chromatograms are overlaid. (c) AgrC-I discs 
reconstituted with DMPC and DMPG at a series of ratios were tested for auto-kinase 
activation as in (a). 
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suggesting that the zwitterionic DMPC membrane disrupts the translation of signal 
binding into enzymatic response (Figure 3.2b). Lipid environments enriched for anionic 
DMPS largely restored the responsiveness of the receptor to AIP (Figure 3.2a, lanes 5 
and 6). To further dissect the role of zwitterionic and anionic lipids in AgrC-I activation, 
we reconstituted the receptor into nanodiscs consisting of DMPC and/or DMPG at seven 
different ratios. The magnitude of AIP-I-dependent activation increased gradually as the 
DMPG content increased, reaching a maximal at a DMPG content of 75% (Figure 3.2c). 
These data suggested that a reasonably high negative-charge density, rather than the 
presence or absence of any specific lipid per se, is required for the full activation of the 
AgrC-I auto-kinase. Thus, all AgrC-I discs in this dissertation, unless noted otherwise, 
were assembled from this activation-optimal lipid mixture containing DMPC and DMPG 
at a molar ratio of 1:3. 
 
Subsequent success in the expression and purification of AgrC-II and AgrC-III allowed 
us to reconstitute these two receptors for comparative studies versus AgrC-I (Figure 
3.3a). Unexpectedly, neither AgrC-II nor AgrC-III was activated by the cognate AIP 
when embedded in nanodiscs composed of the PG-rich, 1,2-dimyristoyl (DM) 
phospholipid mixture (Figure 3.3b, lanes 7 and 8; 19 and 20). In search of a membrane 
environment that bolsters their activation, we further varied the fatty-acyl groups of the 
lipids participating the reconstitution. Gratifyingly, a mixture of 1-palmitoyl-2-oleyl-sn-
glycero-phosphocholine (POPC) and 1-palmitoyl-2-oleyl-sn-glycero-phosphoglycerol 
(POPG) at 1:3 molar ratio supports robust activation to both receptors (Figure 3.3b, lanes 
11 and 12; 23 and 24). As a result, auto-kinase assays involving the comparison among 
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three AgrC variants were performed on nanodiscs assembled with this lipid mixture. It is 
noteworthy, however, that the AgrC nanodiscs prepared using 1-palmitoyl-2-oleyl (PO) 
phospholipids did not exhibit solution behaviors as homogenous as those made of DM 
phospholipids. The heterogeneity of the former was reflected by the SEC elution profile, 
in which a shoulder eluted earlier than the major peak indicated the presence of 
abnormally large particles (Figure 3.3c). As a result, only nanodiscs from the major-peak 
 
 
Figure 3.3 Nanodisc reconstitution of AgrC-II and -III using POPC and POPG 
(a) Purification of AgrC-II and AgrC-III from E. coli membrane extracts as analyzed by 
SDS-PAGE with CBB-stain. The position of target-protein bands is indicated by “AgrC”. 
Bands indicated by asterisks likely correspond the soluble HK domain generated from the 
proteolysis of the full-length protein by host proteases. (b) Lipid-composition screen for 
AgrC-II and AgrC-III activation: 3 µM AgrC dimer, 12 µM MSP and appropriate amount 
of the indicated phospholipid stock were mixed and subject to detergent removal. The 
post-assembly mixtures, without further purification, were treated with 20 µM [γ-32P] 
ATP, 5 mM MgCl2 and the activator AIP (if indicated) at 37 oC for 40 minutes. pHis 
levels were analyzed by autoradiography. (c) SEC traces of post-assembly mixtures 
exemplified by AgrC-III discs. Fractions collected between the wider dashed lines were 
further analyzed by SDS-PAGE with CBB staining (bottom). Shadow indicates the 
segment of elution from which AgrC-III discs with expected sizes were pooled for further 
use. (d) SEC-MALS analysis of empty and purified AgrC-III discs. As in Figure 3.1f, 
Moverall and Mprotein of the peak were shown in each case; AgrC-III = 52 kDa, MSP = 29 
kDa.  
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fractions (Figure 3.3c, shadowed area) were collected for biochemical studies. The 
expected, one-dimer-per-disc stoichiometry of this nanodisc sample was confirmed 
employing SEC-MALS (Figure 3.3d).  
 
3.2 Recapitulation of AIP-dependent regulation of AgrC kinase activity 
Both AIP and AgrC from S. aureus subgroup-I have been extensively investigated for 
their structure-activity relationships (48, 74, 75, 78). These studies provided access to 
potent synthetic AIP agonists and antagonists of this system as well as a body of genetic 
data on the cognate RHK, AgrC-I, including the availability of constitutive mutants of the 
receptor. Next, we attempted to recapitulate major findings from these studies employing 
our in vitro system. Auto-kinase assays revealed a baseline level of activity in AgrC-I 
dimers embedded in nanodiscs composed of DMPC-DMPG mixture (Figure 3.4a, lane 5). 
Native AIPs from all four S. aureus agr variants also behaved in line with what has been 
observed previously in cell-based studies: AIP-I, the cognate AIP, strongly stimulated the 
auto-kinase activity of AgrC-I; AIP-II suppressed AgrC-I activity below the basal level 
and so acted as an inverse agonist, AIP-III behaved as a neutral antagonist and so did not 
effect the basal activity, and AIP-IV was an agonistic ligand with similar efficacy to AIP-
I (Figure 3.4a, lanes 1-4 and Figure 3.4b) (48). Interestingly, a truncated AIP-I analog, tr-
AIP-I, behaved as a partial agonist of AgrC-I when added at saturating concentrations 
(Figure 3.4a, lane 6, Figure 3.4b and c) (48). Importantly, AgrC-I discs were pHis-free 
prior to treatment with ATP, and the phosphorylation of AgrC-I survived treatment with a 
few common buffer molecules at high concentrations, but was labile to hydroxylamine 
treatment, a signature of pHis-containing proteins (Figure 3.4d and e) (141). The 
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phosphorylation level also decreased upon incubation with ADP, which is indicative of 
the reverse auto-kinase reaction seen in other systems (Figure 3.4d) (142). As expected, 
auto-kinase activity was abolished when we reconstituted AgrC-I carrying inactivating  
 
 
Figure 3.4 Auto-kinase activity and AIP-dependent regulation of AgrC-I  
(a and b) Auto-kinase assays with AgrC-I variants or AIP analogs: 1.4 µM nanodiscs 
containing AgrC-I wild-type (WT), constitutive mutant R238H (Con), DHp-inactive 
mutant H239Q (His) or CA-inactive mutant G394A/G396A (Kin) were phosphorylated 
with 20 µM [γ-32P] ATP at 37 oC for 40 minutes. WT-AgrC-I was treated with indicated 
AIP peptides; truncated AIP-I is referred to as tr-I or tr-AIP-I. pHis levels were analyzed 
by autoradiography in (a) or quantified using scintillation counting in (b). Bar-graph 
shows CPM values normalized to the AIP-free reaction. Error bars = SD (n = 3). (c) 
Saturation of tr-AIP-I binding to AgrC-I. 1.4µM AgrC-I discs were treated with tr-AIP-I 
at indicated concentrations and then incubated with 20 µM [γ-32P] ATP at 37 oC for 40 
minutes. Plot shows pHis levels normalized to the peptide-free reaction versus tr-AIP-I 
concentration, fit to a saturation-binding model. Error bars = S.D. (n = 3). (d) Stability 
test of phosphorylation on AgrC-I. Pre-phosphorylated AgrC-I discs (refer to Figure 
3.10c) were treated with indicated reagent at 37 oC for 20 min in a buffer containing 50 
mM Tris, pH = 8.0, 100 mM NaCl, 5 mM MgCl2. pHis levels of AgrC-I were analyzed 
by anti-pHis immuno-blotting (upper). The blot was CBB-stained thereafter as a loading 
control (lower). (e) Hydroxylamine (HA) treatment of phosphorylated AgrC-I. AgrC-I 
discs were phosphorylated with ATP (lanes 1 and 2) as described in Figure 3A or mock-
treated  (lanes 3 and 4) and then incubated with either buffer (lanes 1 and 3) or 500 mM 
HA (lanes 2 and 4) at 37oC for 5 min. pHis levels of AgrC-I were then analyzed by 
western blotting.  
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mutations in either the CA or DHp subdomains (Figure 3.4a, lanes 8 and 9) (71). 
Conversely, incorporation of a constitutively active AgrC-I mutant into nanodiscs led to 
significantly elevated levels of baseline activity (Figure 3.4a, lane 7) (143), providing 
further evidence that this in vitro reconstitution system replicates the cellular behavior of 
this RHK.  
 
Quorum sensing is mutually inhibitory among S. aureus subgroups-I, -II and –III. 
Because the effects of AIP-II and AIP-III on AgrC-I auto-kinase activity are qualitatively 
different, it would be interesting to also distinguish inverse agonism versus neutral 
antagonism on kinase activities conferred by other non-cognate AIP-AgrC pairs. To this 
end, auto-kinase assays were performed on three AgrC homologs incorporated to POPC-
POPG nanodiscs (Figure 3.5a and b). In this membrane environment, AgrC-I exhibited 
similar responses to AIP-I and –II, although a slight but significant activation was 
observed in the presence of AIP-III. The efficacy of non-cognate AIP binding is 
reciprocal between every two groups: AIP-I confers weak activation to AgrC-III, while 
all combinations involving AIP or AgrC from the more distantly related group-II causes 
repression of the kinase activity. Intriguingly, with the presence of excess cognate AIPs, 
AgrC-II and AgrC-III exhibited 70% and 40% the activity of their group-I homolog 
(Figure 3.5a and b). The activity ranking of these AgrC homologs in their activated states 
is consistent with the order of autoinduction timing of their respective subgroups: the 
most active AgrC-I mediates the earliest induction in group-I cells, while group-III cells 
harboring the least active AgrC-III induce at highest cell densities (50). Thus, the uneven 
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kinase activity in AgrC homologs may act as the intrinsic timer for S. aureus 
autoinduction.  
 
3.3 The AgrC-I-AgrA phospho-relay and AgrA dephosphorylation 
Phospho-relay from AgrC-I to AgrA was reconstituted by adding the purified full-length 
RR to AgrC-I discs that had been pre-phosphorylated with [γ-32P]-ATP and then 
exchanged into an ATP-free buffer. Time courses revealed efficient phosphoryl group 
transfer between the RHK and RR, with a t1/2 of 66 seconds (Figure 3.6a, lanes 2-8 and 
Figure 3.6b). The inclusion of AIP-1 in the mix had little effect on the rate of transfer  
 
 
Figure 3.5 Comparison of the auto-kinase activity and regulation among S. aureus 
subgroups-I, -II and -III 
Auto-kinase assays of three AgrC homologs: 1.4 µM POPC-POPG nanodiscs containing 
wild-type AgrC-I, AgrC-II or AgrC-III were pre-incubated with the indicated AIP peptide 
or vehicle and then treated with 20 µM [γ-32P] ATP and 5 mM MgCl2 at 37 oC for 40 
minutes. pHis levels were analyzed by autoradiography in (a) or quantified using 
scintillation counting in (b). In (b), bar graph shows CPM values grouped according to 
AgrC homologs, with bars colored for different ligand states. Error bar = S.D. (n = 3).  




Figure 3.6 Phospho-relay and phosphatase assays of AgrC-I and AgrA 
(a) Phospho-relay from AgrC-I to AgrA: AgrA was incubated with AgrC-I discs labeled 
with [γ-32P]-ATP and indicated AIPs. Aliquots removed at various time-points were 
analyzed by SDS-PAGE followed by autoradiography. (b) Quantification of the 
autoradiograms in panel (a) showing decay of pHis levels in AgrC-I (normalized to t = 0) 
as a function of time. Error bars = range (n = 2). (c and d) Dephosphorylation of AgrA: 
AgrA (2 µM) was phosphorylated by incubation with the constitutively active chimera 
protein GC214 (0.1 µM dimer – see text for details) labeled with a [32P]-phosphoryl 
group. This reaction was then supplemented with 2 µM AgrC-I discs and 10 µM AIP-I or 
AIP-II as indicated. Progress of the reaction was (c) analyzed by autoradiography and (d) 
plotted showing time courses of phosphorylation levels of GC214 (closed circles and 
dashed lines) and AgrA (open squares and solid lines). In (d), time courses are colored 
according to the presence of AgrC-I and/or indicated AIP. Error bars = S.D. (n = 2). (e) 
Kinetics of AgrA chemical dephosphorylation: the AgrC-I-free reaction in (c) was 
repeated and samples were withdrawn at more time points for analysis. Phosphorylation 
levels of GC214 and AgrA-I were plotted as mean ± S.D. (n = 4). Data symbols and 
connecting lines are same as in (d). 
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(Figure 3.6a, lanes 10-16 and Figure 3.6b, t1/2 = 52 sec), indicating that the agonist AIP 
acts solely at the level of AgrC phosphorylation. Surprisingly, we observed that the 
presence of the inhibitor AIP-II slowed down the rate of transfer (Figure 3.6a, lanes 18-
24 and Figure 3.6b, t1/2 = 140 sec). Thus, this inverse-agonistic AIP can inhibit the TCS 
both at the level of HK auto-phosphorylation and phospho-relay to the RR. Whether 
similar inhibition of phospho-relay occurs in other inverse-agonistic AIP-AgrC 
interactions is currently under investigation.  
 
Next we asked if AgrC possesses any phosphatase activity against phosphorylated AgrA, 
an activity common among RHKs (69). Since AgrA forms precipitate quickly following 
acetyl-phosphate treatment (data not shown), we employed an enzymatic approach to 
phosphorylate AgrA in situ using a soluble, highly active AgrC variant (GC214, see 
Chapter 4) as the phospho-donor. We then monitored the decay of [32P]-phosphorylated 
AgrA in the presence or absence of AgrC-I disks. Surprisingly, we found no acceleration 
of AgrA dephosphorylation in the presence of AgrC-I disks at 20-fold excess to the 
GC214 phospho-donor (Figure 3.6c, compare lanes 1-6 to 7-12, and Figure 3.6d). 
Inclusion of either AIP-I or AIP-II along with AgrC-I discs also had no effect (Figure 
3.6c, lanes 13-18, 19-24 and Figure 3.6d). Consequently, the decrease in AgrA 
phosphorylation levels is due to the self-catalyzed dephosphorylation of the RR, with a 
t1/2 of 3.9 minutes (Figures 3.6c and e). We therefore conclude that AIP signals do not 
regulate agr signaling at the level of RR dephosphorylation.   
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3.4 Physicochemical parameters of the AIP-I-AgrC-I interaction 
All S. aureus AIPs feature a 5-residue macrocycle closed by a thiolactone bond formed 
by condensation of the sulfhydryl group of a conserved cysteine and the peptide C-
terminus (Figure 3.7a). It has been speculated that the intrinsic chemical reactivity of this 
thiolactone could lead to a covalent interaction, either irreversible or transient, with AgrC  
 
Figure 3.7 Ring-opening of the thiolactone is involved in AIP-AgrC interactions 
(a) Schematic presentation of AIP-I and FAM-AIP-I. (b) Diagram showing the AgrC-
mediated ring-opening hypothesis (see text for details) and the rationale to capture the 
covalent adduct employing iodoacetamide. (c) Stability test of AIPs in the presence of 
AgrC-I discs: AIP-I or AIP-II (2 nmol) were incubated in the presence or absence of 
AgrC-I discs (0.2 nmol) at 37oC. Percentage of intact AIP that remained after each 
treatment was quantified using HPLC and plotted as mean ± SD (n = 3). (d) AgrC-I discs 
were phosphorylated as described in Figure 3.2a with the indicated peptides (10 µM) for 
3 minutes. The reactions were then analyzed by western blotting. (e) Attempt to capture 
the putative covalent adduct between FAM-AIP-I and AgrC-I: AgrC-I discs (2 µM) were 
incubated with vehicle (DMSO) or FAM-AIP-I (5 µM) at 37oC for 30min followed by 
treatment with vehicle (buffer) or 50 mM iodoacetamide at 37oC for 30min. The reaction 
mixture was analyzed by non-reducing SDS-PAGE and visualized by fluorescence (top 
and middle panels). The gel was then stained with CBB for loading control (bottom 
panel). 
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(see Figure 3.7b) (25). This was readily tested using our in vitro system. The free levels 
of intact AIP-I or AIP-II did not change after treatment with AgrC-I nanodiscs, indicating 
that receptor engagement does not lead to an irreversible adduct or to release of 
hydrolyzed peptide (Figure 3.7c). Conceivably, the covalent adduct could be transient 
and chemically reversible. To explore this, we exploited a fluorescein-labeled AIP-I 
analog (FAM-AIP-I) that has AgrC-I agonist activity indistinguishable from that of the 
native AIP-I (Figure 3.7a and d) (48). Incubation of FAM-AIP-I and AgrC-I nanodiscs in 
the presence of excess iodoacetamide, which would alkylate the newly generated cysteine 
within the linearized AIP and hence trap the putative adduct, failed to produce any 
fluorescently labeled AgrC-I as indicated by non-reducing SDS-PAGE (Figure 3.7b and 
e). We therefore conclude that the AIP-AgrC complex does not rely on the chemical 
reactivity of the thiolactone bond. 
 
We next turned to the stoichiometry of the AIP-AgrC binding interaction. For this we 
titrated AIP into AgrC-I nanodiscs fixed at a concentration of 1.25 µM, about two orders 
of magnitude higher than the EC50 value for AIP-I (25, 48). Assuming that the EC50 value 
is a reasonable estimate of the KD value (vide infra), the AIP-I added to the system should 
bind to AgrC-I in a linear fashion until saturation of binding sites is achieved. The auto-
kinase activity of AgrC-I was used as a measure of the level of AIP-I binding. As 
predicted, the initial auto-kinase velocity of the system first increased linearly and then 
reached a plateau after the AIP-I concentration reached ~2 equivalents with respect to 
AgrC-I nanodiscs (Figure 3.8a). These observations strongly suggest that each AgrC-I 
dimer possesses two binding sites for AIP-I, and more intriguingly, that AIP-I binding at 
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one site causes the same level of auto-kinase activation regardless of the occupancy of the 
other site – i.e., there is no evidence of cooperatives binding between the two subunits. 
 
Figure 3.8 The stoichiometry and dissociation constants of the interaction between 
AgrC-I and AIPs 
(a) Stoichiometry of the AgrC-I/AIP-I interaction. AgrC-I discs were incubated with 20 
µM [γ-32P]-ATP along with AIP-I at different concentrations and in each case the initial 
auto-kinase velocity (vi) was determined by monitoring build-up of radio-labeled AgrC-I 
over time using autoradiography. Plot shows vi (normalized to the AIP-free reaction) 
versus [AIP-I]/[AgrC-I disc] ratio. Error bars = SD (n = 3). (b) Equilibrium binding of 
FAM-AIP-I to AgrC-I discs. Corrected steady-state anisotropy change (ΔSSAc, see 
Section 7.4.3) of FAM-AIP-I fluorescence was plotted as a function of added wild-type 
(open circle and solid line) or mutant (S109VS116I, closed circles and dashed line) 
AgrC-I discs and fit to a Hill equation. One representative titration of 4 is shown. Error 
bars (technical) = SEM (n = 6). (c) Auto-kinase activation of AgrC-IS109VS116I dimers: 
0.25 µM nanodiscs containing wild-type AgrC-I dimers (left four lanes) or AgrC-
IS109VS116I mutant dimers (right four lanes) were incubated with 1 mM ATP, 5 mM MgCl2 
and AIP-I at indicated concentrations at 37oC for 3min. The reactions were then analyzed 
by anti-pHis western-blotting (top) and Coomassie blue staining (bottom). (d) 
Equilibrium binding of native AIPs to AgrC-I discs based on competitive displacement of 
FAM-AIP-I from AgrC-I. ΔSSA of FAM-AIP-I is plotted as a function of added AIP-I 
(open squares and the dashed curve) or AIP-II (closed triangles and the solid curve). The 
data are fit to a competitive binding model (see Section 7.4.3). One representative 
titration of 3 is shown. Error bars (technical) = SEM (n = 6). 
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FAM-AIP-I also provided us with an opportunity to measure the equilibrium binding 
affinity of the AIP-AgrC interaction using a fluorescence-based assay. The fluorescence 
anisotropy of FAM-AIP-I was monitored as a function of added AgrC-I nanodiscs and 
the data fit to a transformed Hill equation (Figure 3.8b). The binding isotherm yielded a 
KD for FAM-AIP-I binding to AgrC-I of 122 ± 26 nM (n = 4), with a Hill coefficient of 
0.97 ± 0.20. Importantly, we observed no change in anisotropy when AIP-I was titrated 
with nanodiscs containing an AgrC-IS109VS116I mutant that is defective in AIP-I-dependent 
activation  (Figure 3.8b and c) (75). The lack of cooperation in the interaction between 
AIP-I and AgrC-I correlates well with the independent, but additive, role of the two 
binding sites in the auto-kinase activation of AgrC-I. The KD for native AIP-I and AIP-II 
were 63 ± 13nM (n = 3) and 160 ± 20nM (n = 3), respectively, obtained from competitive 
titrations of a pre-formed complex between FAM-AIP-I and AgrC-I (Figure 3.8d). The 
KD for AIP-I was 2.2-fold greater than its EC50 (28nM) obtained from reporter-gene 
assays, likely due to amplification effects in AgrC-mediated two-component signaling, 
which have been seen in other types of signal transduction pathways (48).  
 
3.5 Nucleotide specificity and kinetics of AgrC-I auto-phosphorylation 
Atomic-resolution structures of CA subdomains in complex with adenosine nucleotides 
reveal a role for the conserved ‘G1 box’ residues in nucleotide binding: the amine group 
of the adenine ring hydrogen bonds to the Asp residue, while the negative charge on the 
Asp is stabilized by interactions with the backbone amides of the two glycine residues 
(Figure 3.9a) (123). Sequence analysis described in Chapter 2 suggested that AgrC-I 
lacks these key residues and, therefore, the interaction between CA subdomain and ATP 
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might be altered (Figure 3.9b). Notably, the Asn residue aligned to the position of the 
conserved Asp is reminiscent of a GTP-dependent RHK, BA2291 from Bacillus 
anthracis (144). This notwithstanding, AgrC-I apparently favors ATP over GTP, as no 
substantial phosphorylation was observed upon incubation with the latter (Figure 3.9c). 
 
To further investigate the influence of this non-canonical G1 motif on nucleotide binding, 
we determined the apparent Km values for the cofactor in the presence or absence of AIP-
I using dot-blot-based kinetic assays (Figure 3.10a). The first-order kinetic constant (k1) 
for AgrC-I auto-phosphorylation was determined at a series of ATP concentrations and fit  
 
Figure 3-9 Nucleotide specificity of AgrC-I 
(a) Diagram depicting the adenine binding by conserved G1-box residues in the crystal 
structure of HK853 from Thermotoga maritime (PDB ID: 2c2a). The CA subdomain of 
HK853 is shown as ribbon diagram in green, with ADP and the conserved Asp411, 
Gly413 and Gly415 of HK853 highlighted by stick models. Two water molecules are 
shown in red spheres, and hydrogen bonds in black dashed lines. An α-helix stacking 
against the ADP nucleotide is omitted for clarity. (b) Sequence alignment showing the 
G1 box in S. aureus AgrC and B. anthracis BA2291 versus three RHKs carrying 
canonical G1-box sequences. Conserved Asp and Gly in canonical G1-boxes, Asn 
residues aligned to the conserved Asp and a hydrophobic position well-aligned in all 
sequences are highlighted in blue, green and red, respectively. (c) Nucleotide specificity 
of AgrC-I: AgrC-I discs were incubated with 1 mM ATP or GTP, 5 mM MgCl2 and 
excess AIP-I peptide at 37oC. Aliquots were removed from each reaction at indicated 
time points, spotted in a row on the blotting membrane and analyzed for pHis levels 
through immuno-blotting. (d) Comparison of the Km for ATP among RHKs. All shown 
RHKs except AgrC possess canonical G1-box sequences.  
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to the Michaelis-Menten kinetic model (Figure 3.10b). As expected, the presence of AIP-
I stimulated receptor auto-phosphorylation, reflected in an ~8-fold increase in the  
 
 
Figure 3.10 Kinetics of the forward and reverse auto-kinase reactions in AgrC-I 
(a and b) Kinetics of the auto-kinase reaction: AgrC-I discs were incubated at 37 oC with 
ATP (at indicated concentration) and 5 mM MgCl2 in the presence or absence of 10 µM 
AIP-I peptide. Aliquots were removed from each reaction at indicated time points and 
spotted in a row on the blotting membrane. pHis levels of AgrC-I in each reaction were 
(a) analyzed by anti-pHis immuno-blotting and (b) converted into first-order kinetic 
constants and plotted as a function of ATP concentration for reactions in the presence 
(open square, dashed curve) or absence (closed circles, solid curve) of 10 µM AIP-I. 
Error bar = SD (n = 3). In (b), one representative membrane of three is shown. (c) Pre-
phosphorylated AgrC-I discs analyzed by size-exclusion chromatography. Fractions 
collected between the dashed lines were further analyzed by western blotting with anti-
pHis antibody (inset). (d-f) Kinetics of the reverse reaction: pre-phosphorylated AgrC-I 
discs were incubated at 37 oC with ADP (at indicated concentration) and 5 mM MgCl2 in 
the presence or absence of 10 µM AIP-I peptide. Reactions were analyzed as in (a) and 
Michaelis-Menten plotting was performed as in (b). 
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Table 3.1 Kinetic parameters of AgrC-I forward and reverse auto-kinase activities 
Reactions AIP-I (µM) KM (mM) kmax(min
-1
)a 
Forward 10 1.5 ± 0.5 3.0 ± 0.5 
Forward 0 2.8 ± 0.4 0.33 ± 0.03 
Reverse 10 0.17 ± 0.06 6.9 ± 0.6 
Reverse 0 0.26 ± 0.07 7.2 ± 0.5 
a: kmax, the maximal first-order kinetic constant. 
 
maximum first-order rate constant, kmax, compared to the apo receptor (Table 3.1). The 
apparent Km for ATP was 2.8 mM for apo-AgrC-I and 1.5 mM for AIP-I-bound AgrC-I, 
both at least an order of magnitude larger than a few well-characterized RHKs with 
normal G1 boxes (Figure 3.9d) (142, 145, 146). Therefore, sequence variation in the G1-
box weakened the affinity between ATP and AgrC-I presumably due in part to the 
substitution of a neutral Asn residue for a stronger hydrogen-bond acceptor, Asp. 
Intriguingly, mutation of the G1-Asn back to Asp in AgrC-I abolished the auto-kinase 
activity (data not shown), suggesting that the AgrC ATP-binding pocket has co-evolved 
with this conserved Asn and is no longer able to adapt to its replacement by Asp.  
 
A similar kinetic characterization was performed for the reverse auto-kinase reaction, in 
which phosphorylated receptor transfers the phosphoryl group back to ADP. AgrC-I discs 
were first phosphorylated in the absence of AIP and then separated from nucleotides 
using size-exclusion chromatography (Figure 3.10c). Using this protocol, 52.5% of the 
histidine sites were phosphorylated in the product. Kinetic constants for the reverse 
reaction were determined at a series of ADP concentrations in the presence or absence of 
AIP-I (Figures 3.10d and 3.10e). The reverse reaction was significantly more efficient: 
the Km for ADP was lower while the kmax was higher than the forward reaction (Figure 
3.10f and Table 3.1). This observation is consistent with the more favorable free energy 
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of hydrolysis of phosphohistidine compared to ATP (-13 kcal/mol vs. -7.3 kcal/mol) 
(141). More surprisingly, and in stark contrast to the forward reaction, the presence of 
AIP-I had no significant effect on the efficiency of the reverse reaction. Thus, AIP-I 
binding to AgrC-I shifts the equilibrium in the favor of the forward reaction. 
 
3.6 Summary and discussions 
In this Chapter, we have presented a comprehensive biochemical characterization of the 
AgrCA TCS. We found that AgrC-I dimers reconstituted into lipid nanodiscs possess a 
substantial level of basal activity. The cognate autoinducer non-cooperatively binds to 
AgrC-I in a 2:2 stoichiometry with nanomolar affinity, with individual binding events 
adding equally to stimulate the auto-kinase activity of the RHK. The pHis moiety on 
auto-phosphorylated AgrC-I is stable under physiological conditions, but rapidly transfers 
the phosphoryl group to AgrA. Remarkably, AgrC homologs from three S. aureus 
subgroups exhibit uneven auto-kinase activities in the activator-bound state. Meanwhile, 
AgrC lacks any detectable phosphatase activity, leaving self-catalyzed AgrA 
dephosphorylation the only reaction that counteracts the phospho-relay cascade. These 
biochemical properties are likely to play essential roles in controlling the onset of 
virulence in S. aureus. At low cell density, for instance, the basal auto-kinase activity of 
AgrC maintains a low level of phosphorylated AgrA that, due to its differential affinity to 
the regulatory elements in the P2 and P3 promoter regions, enables baseline transcription 
of the P2 operon rather than P3 (88). AIP, produced as a consequence, would accumulate 
to levels that significantly activate the AgrCA TCS during log-phase bacterial growth. 
The strong affinity of AIP for AgrC, the lack of phosphatase activity in AgrC, and the 
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positive feedback of the autoinduction loop collectively leads to a burst of RNAIII 
production and thereby an abrupt switch into a high-density, virulent mode of life. Since 
AgrA, and hence the kinetics of AgrA chemical dephosphorylation is conserved, the 
kinase activity conferred by the activated RHK is therefore most likely responsible for 
the difference in autoinduction timing among S. aureus subgroups (50). Finally, the t1/2 of 
phosphorylated AgrA is a mere 3.9 minutes at 37oC, shorter than most characterized 
transcription-factor RRs including the E. coli osmolarity RR, OmpR (t1/2 ~ 70min), the E. 
coli cation-homeostasis RR, PhoB (t1/2 ~ 15min) and the B. subtilis sporulation regulator 
Spo0A (t1/2 ~ 7 min) (147). This enables agr-activated cells to rapidly turn off virulon 
expression and revert to vegetative growth if separated from the quorum.   
 
AgrC-I is also distinguished from most other characterized RHKs by its dramatically 
lowered affinity for adenosine nucleotides, likely due to substitutions in the G1-box. We 
reason that this atypically low affinity might allow AgrC to sense cellular ATP levels, 
which vary significantly between optimal and stress conditions. Indeed, down regulation 
of accessory gene expression in times of nutrient or oxygen deprivation had been 
reported (29). Since the cellular ATP concentration data is not available for S. aureus, the 
values for E. coli must be used as a reference (148). With abundant carbon source, E. coli 
contains approximately 3.5 mM cellular ATP, which decreases to sub-milimolar levels at 
stationary phase, or after switching to a weaker electron acceptor for respiration. 
Assuming similar variations in S. aureus, a drastic decrease in the auto-kinase activity 
would be expected for AgrC (apparent Km for AgrC-I ~2 mM) under nutrient-limiting or 
anaerobic conditions. Thus, we propose that inactivation of the virulon under stress 
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conditions is at least partly a consequence of the acute sensitivity of AgrC to falling ATP 
levels, ultimately leading to a down-regulation of the agr response. This sensitivity may 
extend to processes mediated by other receptors of the HPK10 subfamily given the 
conserved nature of the altered G1-box. 
 
During the course of our reconstitution studies, a remarkable dependence on anionic 
bilayer environment was found for AgrC-I activation. The exact basis of this lipid-
sensitivity in AgrC-I activation remains unclear. We did, however, rule out the possibility 
of global misfolding for AgrC-I embedded in 100% DMPC nanodiscs in that it forms 
dimers that bind to a fluorescent AIP-I analog, albeit without any resulting auto-kinase 
stimulation (Figure 3.2a and c). Given the highly basic amino acid sequence of the AgrC-
I sensor domain (theoretical pI = 9.3), we speculate that anionic lipids enable competent 
conformational coupling between the AIP-binding site and AgrC-IHK by neutralizing 
excessive positive charges in the sensor domain. Intriguingly, the strongly anionic cell 
membrane found in S. aureus is shared among other species from the low-GC Gram-
positive phylum (Firmicutes), and distinguishes them from those representing major 
Gram-negative phyla (149). In addition, our bioinformatic analysis revealed a striking 
restriction of the HPK10 subfamily, to which AgrC belongs, to the phylum Firmicutes. 
All characterized RHKs from this subfamily are receptors of peptidic pheromones, and, 
perhaps not coincidentally, peptide-mediated QS is not known in any Gram negative 
species. A plausible explanation for this taxonomic boundary is that HPK10 subfamily 
receptors are all evolved in, and presumably well adapted to, the anionic lipid 
environment. Such adaptation, if generally present, would create a considerable barrier to 
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horizontal gene transfer of HPK10 homologs into Gram-negative species, which have 
PE-rich inner membranes. Biochemical studies into additional HPK10 homologs, perhaps 
using the nanodisc technology employed herein, might lend further support to the idea 
that peptide-responsive RHKs are restricted to Gram-negative bacteria because of the 
lipid composition of their membranes. 
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Chapter Four: Mechanisms by which AgrC-I Responds to Signals 
Quorum-sensing machineries in bacterial pathogens have been long regarded as potential 
therapeutic targets and, consequently, previous drug-development campaigns provide a 
broad spectrum of small-molecule ligands for several QS-mediating RHKs including 
AgrC-I (27). Among all these RHKs, S. aureus AgrC-I stands out for its versatility in 
ligand response (48). In line with the observations made from reporter strains, using the 
in vitro reconstitution system described in Chapter 3, distinct levels of kinase activity 
have been observed for AgrC-I in at least four ligand states (Figure 3.4a), contradicting 
the common on/off switch view for RHKs (150). To understand this signaling flexibility 
of AgrC, two pieces of information are needed, namely (i) the conformational change of 
the AgrC-I HK domain induced by AIP binding and (ii) the response of the AgrC-I HK 
activities to diverse conformational changes. Importantly, ligand-induced molecular 
motions have never been detected for any membrane-bound RHKs prior to our study. In 
this chapter, we first systematically perturb the conformation of the AgrC-I HK domain, 
employing a protein-chimera strategy, in order to chart a conformation-activity landscape 
of this module. The nanodisc reconstitution system was then harnessed for the detection 
of molecular motions triggered by AIP binding.  
 
Constitutive mutants of AgrC-I have been identified previously employing a library-
screening approach (143). These mutants, although all capable of activating P3-driven 
gene expression in reporter strains in the absence of AIP-I, vary dramatically with their 
signaling behavior. Some mutants, for instance, do not respond to any AIP added, while 
others are often revertible by AIP-II but not AIP-III. Interestingly, mutants in the first 
	   73	  
category all bear mutations in the HK domain, while those in the second may carry 
mutations in either the sensor or the HK domain. In this chapter, we sought to understand 
(i) how a constitutive mutation in the HK domain, R238H, alters the conformation-
activity landscape and (ii) why AIP-II is able to revert constitutive activity of a subset of 
mutants. Besides explaining some interesting in vivo phenotypes, the diverse in vitro 
behaviors of these mutants revealed in this work expand our view on the evolvability of 
the signal-response properties of AgrC-I.  
 
4.1 Perturbing the conformation of the AgrC-I HK domain 
Structural and functional studies on isolated HK domains have given rise to models of 
receptor activation involving rotation of helices that comprise the DHp subdomain  
(Figure 4.1a) (123, 150). These helical movements are thought to modify packing of the 
DHp leading to a repositioning of the CA subdomain such that phosphorylation of the His 
is, or is not, permitted on the basis of spatial proximity (123). This “helix-rotation” model 
entails a relatively rigid linkage between the DHp subdomain and the preceding sensor or 
transmission domains to enable effective propagation of conformational changes 
generated by the sensor. Interestingly, in crystal structures obtained for dimeric RHKs, 
the linkers between the DHp subdomain and the preceding module predominantly form a 
pair of α-helices, extending the first α-helix of each DHp subdomain (DHp-α1) (123, 
151-153). The possibility of the AgrC-I interdomain linker (residues 201-221) being 
helical is particularly attractive because it would allow the formation of a contiguous 
helix spanning the last TM domain, the linker and the DHp-α1, providing a ready conduit 
for the conformational change in the sensor being transmitted to the HK domain (Figure 
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4.1b). This idea is supported by or analysis of the amino-acid composition of the 
interdomain linker sequence across the HPK10 subfamily (Figure 4.1c). Helical-breaking 
residues, namely glycine and proline, are strongly underrepresented in this region 




Figure 4.1 An α-helical linker connecting the AgrC-I sensor and HK domains.  
(a) Structural alignment of the DHp subdomain in the T. maritima RHK, HK853, 
captured at the resting (green) and phosphatase-active (blue) states. Cβ atoms on residues 
249 and 253 in the DHp-α1 are highlighted with spheres to help visualize the structural 
rearrangement of the four-helix bundle. (b) Cartoon of full-length AgrC-I showing α-
helical interdomain linkers (in red). Helical nucleation that would stabilize the linker 
helix is highlighted with arrows. (c) Amino acid frequency in the interdomain linkers 
within HPK10 sequences. Frequency of each amino acid is normalized to its overall 
composition in proteins. Under-represented amino acids are indicated with arrows. (d) 
Sequence of the wild-type linker peptide (upper) and the L205PM208P mutant peptide 
(lower). Mutated residues are highlighted in red. (e) Helical content of linker peptides: 
plot shows calculated helical content as a function of % TFE for the wild-type (black) 
and L205P/M208P mutant (red) peptides. CD spectroscopy was performed at 20oC. The 
15-µM peptide samples were prepared in buffers containing 10 mM phosphate, pH = 7.0 
and 50 mM NaF and the indicated percentage of TFE (v/v). (f) Auto-kinase activation of 
AgrC-IL205P/M208P mutant: nanodiscs containing wild-type (WT) or mutant AgrC-I dimers 
were phosphorylated with [γ-32P]-ATP and analyzed by autoradiography. CBB indicates 
the Coomassie-stained loading control.  
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α-helix formation in this region (Figure 4.1c). Furthermore, we synthesized two peptides 
corresponding to the AgrC-I linker, one with the wild-type sequence and the other with 
two residues, Leu 205 and Met 208, mutated to Pro (Figure 4.1d). Analysis of these 
peptides by circular dichroism (CD) spectroscopy revealed, in the presence of 20% (v/v) 
2,2,2-trifluroethanol (TFE), high helical propensity in the wild-type peptide, which is 
greatly attenuated in the case of the mutant (Figure 4.1e). No helicity was found in the 
complete absence of TFE, suggesting that packing between two (or more) linkers is not 
strong enough to stabilize the helical conformation as in classical coiled coil peptides. 
Notably, this finding does not conflict with the linkers being helical in full-length AgrC-I 
in which its helicity could be further promoted by the presence of flanking helical 
elements through helical propagation (155). The L205P/M208P mutations that 
diminished helicity of the linker peptide abolished the AIP-I-dependent kinase activation 
in full-length AgrC-I, further underscoring the importance of the helical continuity in this 
region (Figure 4.1f).  
 
Given the dimeric configuration of the AgrC-I HK domain and the helical propensity of 
the interdomain linker, we hypothesized that fusing the linker to a GCN4 peptide, which 
adopts a dimeric, parallel coiled-coil conformation, would lend control to the rotational 
conformation of the interdomain linker pair (Figure 4.2a). The GCN4 dimer is extremely 
stable (KD = 0.28 nM) (156), which we expected to provide the rigid body needed to 
impose twisting force on the appended linker region, presumably driving the 
conformation away from the resting state. We prepared 15 chimera proteins, each 
comprising an N-terminal GCN4 coiled-coil sequence and a C-terminal AgrC-I HK 
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domain separated by an intervening interdomain linker segment of variable length. These 
protein chimeras were termed GC205 to GC219 after GCN4-AgrC-I and the position of 
the first AgrC-I residue fused to GCN4, to which we refer as the junction residue. Since 
the C-terminal residue of the GCN4 portion registers at the ‘d’ position in the classic 
 
Figure 4.2 Design principles of the GCN4-AgrC-I chimera series 
(a) Cartoon of a GCN4-AgrC-I chimera with the interface between the GCN4 (in cyan) 
and the interdomain linker (in red) indicated by a blue plane. The DHp and CA 
subdomains are colored brown and green, respectively. Right panel, coiled-coil helical 
wheel representation of the interface highlighting the register of the last residue of GCN4 
(‘d’, in blue) and the junction residue (‘e’, in red). (b) Design of GCN4-AgrC-I chimera 
proteins. The 25-aa GCN4 coiled-coil was sequentially fused to residues in the 
interdomain linker. GCN4 residues registering at coiled-coil position ‘d’ are noted 
underneath the sequence in blue. (c) Limited trypsinolysis of AgrC-I205-430 and three 
chimera proteins: substrate proteins (4 mg/mL) were incubated with trypsin (60 µg/mL) 
in ice for 20min. The reactions were stopped using protease inhibitors and resolved on 
SDS-PAGE. Tryptic fragments either including the peptide bond next to Arg212 or 
generated from the cleavage at this site are identified employing HPLC-MS (now shown). 
Corresponding gel bands of these fragments are recognized based on their molecular 
weight and abundance, and highlighted with cartoons and arrows.  
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 coiled-coil helical wheel, we inferred that the junction residue in each chimera should be 
moved to the ‘e’ position (Figure 4-2b). Because the resting register of the linker residues 
in full-length AgrC-I follows the α-helical periodicity, the magnitude that these chimeras 
twist the linkers away from their resting conformation should exhibit the same periodicity 
with respect to the linker length between the GCN4 coiled coil and the AgrC-I HK 
domain. 
 
Structural integrity of the interdomain-linker in these chimera proteins was preliminarily 
investigated employing limited trypsinolysis. The peptide bond next to Arg212 in the 
linker is highly susceptible to trypsin cleavage in an intracellular AgrC-I construct, AgrC-
I205-430 (Figure 4-2c). This result is reminiscent of the lack of helicity in the standalone 
linker peptide, as was revealed in the CD-spectrometry experiment in the absence of 
TFE. This peptide bond gains resistance against trypsin cleavage, however, in GC205, 
GC206 and GC207 (Figure 4-2c), suggesting a more defined linker structure in these 
chimera proteins.  It is therefore highly probable that the interdomain linker adopts stable 
helical conformations only when sandwiched by two other helical elements: this 
requirement is fulfilled in both full-length AgrC and GCN4-AgrC-I chimeras, but not in 
AgrC-I205-430. 
 
4.2 Conformation-activity landscape of the AgrC-I HK domain and the molecular 
motion induced in full-length AgrC-I by AIP-I or AIP-II binding 
All 15 GCN4-AgrC-I chimeras were expressed in E. coli and purified for auto-kinase 
assays. Strikingly, the phosphorylation levels of these GCN4-AgrC-I fusion proteins 
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fluctuated periodically with the length of the linker (Figure 4.3a). The periodicity, 
obtained from fitting the data to a sine wave function, was 3.6, constituting one turn of an 
α-helix (Figure 4.3b). Because the magnitude of twisting applied to the linkers is also 
expected to follow the same periodicity, this result directly correlates the auto-kinase  
 
Figure 4.3 Twisting of the interdomain linkers exercises rheostat-like control over 
the auto-kinase activity of the AgrC-I HK domain.  
(a) Auto-kinase activities of GCN4-AgrC-I chimeras: dimeric chimeras and AgrC-I discs 
(with or without added AIP as indicated) were treated with [γ-32P]-ATP and analyzed by 
autoradiography as in Figure 4.1f. Linker length (in residues) is indicated underneath the 
loading control. (b) Quantification of the data in panel (a). Plot shows normalized 
phosphorylation levels of the chimeras (normalized to that of the apo-AgrC-I discs) as a 
function of the linker length. Curve is a sinusoidal function fit to the data. Error bars = 
SD (n = 3). (c) Classical helical wheel showing the angle (θ) by which each position on 
the linker helix deviates from position 209. Since the linker conformation in GC209 
resembles that of AgrC-I in the resting state (refer to Figure 4.4d and e), the putative 
twisting angle imposed to the linker helices in each GCN4-AgrC-I chimera should be the 
inverse number of θ for its junction residue position. (d) The conformation-activity 
landscape of the AgrC-I HK domain: Plot shows activity of all 15 GCN4-AgrC-I 
chimeras versus the putative twisting angle. Error bar = S.D. (n = 3).  
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activity to the twisting movement of the linkers. Consequently, a conformation-activity 
landscape is obtained from plotting the auto-kinase activity of each chimera with the 
putative twisting angle of the linkers away from their resting conformation represented by 
that in GC209 (Figure 4.3c and d, see below for the reason why GC209 is the reference). 
This landscape is remarkably smooth, allowing the rheostat-like control of the kinase 
activity by gradually twisting the linker helices. Chimeras with activity equivalent to that 
of AgrC-I in all three ligand states were found (Figure 4.3a), suggesting that the ligand-
dependent differential activities of the full-length receptor might also be achieved 
through adjusting the linker conformation. 
 
A Cys crosslinking strategy was used to study the conformational changes in the linker 
region of full-length AgrC-I that accompany AIP binding. Based on the helical twisting 
model that emerged from the GCN4 chimera data, we hypothesized that, depending on 
the location of the Cys and the ligand state of the receptor, inter-subunit disulfide bonds 
would be more or less likely to form under oxidizing conditions. The absence of native 
Cys residues in the linker region facilitated this approach (Figure 4.1d). Five AgrC-I 
mutants with Cys replacements at residues 205-209 were expressed, purified and 
incorporated into nanodiscs. The mutants behaved similarly to wild-type AgrC-I in terms 
of their auto-kinase response to agonist and antagonist AIPs (Figure 4.4a). Non-reducing 
SDS-PAGE analysis of the mutants following oxidation with glutathione revealed a 
marked difference in the amount of covalent dimer formed depending on the mutant and 
the presence or absence of AIP (Figure 4.4b). The yield of covalent dimer from each 
sample was normalized for loading, and grouped according to three activity states (apo,  
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Figure 4.4. AIP binding induces rotational movement of the AgrC-I linker helices 
(a) Auto-kinase activities of AgrC-I single-point Cys mutants. Nanodiscs containing 
wild-type or Cys-mutant AgrC-I dimers were incubated with 20 µM [γ-32P]-ATP, 5 mM 
MgCl2 and excess AIP peptide (as indicated) at 37oC for 40min. 32P-labeled AgrC-I in 
each reaction was quantified through scintillation counting. Error bar = SD (n = 3). (b 
and c) inter-subunit crosslinking of AgrC-I single-point Cys mutants: nanodiscs 
incorporated with wild-type or mutant AgrC-I dimers were mock-treated or incubated 
with 10 mM oxidized glutathione (GSSG) along with indicated AIPs. (b) Formation of 
covalent dimers as analyzed by SDS-PAGE with Coomassie stain. MSP, membrane 
scaffold protein. (c) Quantification of the crosslinking results. Plot shows levels of 
disulfide-linked dimer formation normalized to loading, grouped according to the three 
ligand states. Error bars = SD (n = 3). (d) Rotation of the interdomain linker helices in 
AgrC-I induced by AIP binding. Top: Cartoons of AgrC-I dimer in the apo- (middle), 
AIP-I-bound (left) and AIP-II-bound (right) states. Bottom: The corresponding 
conformation of the linker helices is depicted with helical wheels showing the positions 
205-209 according to the Cys crosslinking results. Ligand binding and the consequent 
rotation of linker helices are highlighted between panels. (e) Auto-kinase activities of 
chimera proteins in which interdomain linker conformation mimics that of AgrC-I in 
three ligand states: plot shows normalized phosphorylation levels of GC205 through 
GC212 as a function of junction residue positions (with AgrC-I numbering). Linker-
conformation surrogate of each AgrC-I activity state is marked with an arrow. 
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AIP-I-bound or AIP-II-bound) as in Figure 4.4c. This revealed a periodicity within each 
state that, analogous to the GCN4 chimera data, could be interpreted by assigning 
parallel, juxtaposed helical structure to the linkers (Figure 4.4d). When analyzed in this 
way, the linker helices within the apo-AgrC-I dimer are oriented such that positions 205, 
208 and 209 are juxtaposed and able to form crosslinks when Cys residues are placed at 
these sites. Binding of the AIP-I activator leads to a ~80° counter-clockwise rotation of 
the two linker helices in the dimer such that residues 206 and 209 are now in optimal 
position to form crosslinks. Conversely, binding of the AIP-II inhibitor leads to a ~30° 
clockwise rotation of the helices from the resting state resulting in residue 208 being 
optimal for crosslinking.  
 
This interpretation of the crosslinking data was used to further analyze the differential 
activity associated with GCN4-chimeras. As noted above, the junction residue in each 
chimera can be assigned to the ‘e’ position of the coiled-coil helical wheel. Based on this 
logic, we predict that GC209, GC210 and GC205 should be conformational surrogates of 
the apo-, AIP-I- and AIP-II-bound forms of AgrC-I, respectively (Figure 4.4d, refer to 
Figure 4.3b for the register of position ‘e’). Remarkably, these chimeras accurately 
phenocopy the three activity states of AgrC-I: compared to GC209, GC210 had much 
higher auto-kinase activity while GC205 was not as active (Figure 4.4e). We therefore 
conclude that ligand binding regulates the auto-kinase activity of AgrC-I by inducing 
symmetric rotation in the helical TMH-DHp linker region.   
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4.3 A constitutive mutation, R238H, modifies the conformation-activity landscape. 
AgrC-IR238H is the most prominent and robust constitutive mutant among all such mutants 
identified for AgrC-I. It conveys full activation to the P3-driven gene expression in the 
absence of any ligand and, therefore, has been employed in a few studies as a surrogate of 
wild-type AgrC-I in the AIP-I-bound state. The R238H mutation, however, occurs within 
the DHp subdomain, suggesting a modulation of the input-response property of the HK 
domain rather than the conformational states of the sensor. Perhaps as a consequence, the 
activity of P3-driven reporter genes in S. aureus expressing this mutant is unaffected by 
the presence of AIP-I or AIP-II. Being aware of the non-linearity of the reporter-gene 
readout, we decided to further investigate the effect of both AIPs on the kinase activity of 
nanodisc-embedded AgrC-IR238H.  
 
AgrC-IR238H was expressed and purified from E. coli and reconstituted to nanodiscs in 
which the lipid bilayer consists of POPC and POPG at a molar ratio of 1:3. Wild-type 
AgrC-I discs of the same lipid composition were used for back-to-back comparison in the 
auto-kinase assay. AgrC-IR238H had a strong baseline activity, which elevated only 
moderately when the RHK binds to the activator AIP-I (Figures 4.5a and b). By contrast, 
the wild-type RHK, although exhibiting a much lower baseline activity in the apo state, 
was turned on by AIP-I-binding so potently that its activity surpassed that of the mutant 
in the activated state (Figures 4.5a and b). This mutation also diminished the inhibitory 
effect of AIP-II on the auto-kinase activity (Figures 4.5a and b). Consistent with the 
unchanged sensor domain in this mutant, binding affinities of AIP peptides are largely 
unaffected. The fluorophore-tagged AIP, for instance, binds to AgrC-IR238H discs with 
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slightly stronger affinity than to the wild-type (51 vs 122 nM), as was determined in the 
titration experiment employing a fluorescent-anisotropy readout (Figure 4.5c). The 
presence of excess AIP-I or AIP-II effectively displaces FAM-AIP-I from its binding site 
on the mutant (Figure 4.5d). We surmise, based on these observations, that this mutation 
renders the AgrC-I HK domain less sensitive to the conformational input from the sensor 
domains, rather than elevating its kinase activity at all conformational states.  
 
Figure 4.5 Auto-kinase activity and ligand responses of AgrC-IR238H 
(a and b) Auto-kinase assays comparing the R238H mutant to the wild type: the 
nanodisc-incorporated receptors were pre-incubated with indicated AIP-peptides or the 
vehicle (DMSO), and then phosphorylated with 20 µM [γ-32P] ATP at 37 oC for 40 
minutes. pHis levels were analyzed by autoradiography in (a) or quantified using 
scintillation counting in (b). In (b), the count per minute (CPM) values were normalized 
to that of the wild-type AgrC-I in the absence of AIP. Error bars = S.D. (n = 3) (c) 
Equilibrium binding of FAM-AIP-I to AgrC-IR238H discs. As in Figure 3.8b, corrected 
steady-state anisotropy change (ΔSSAc, see Section 7.4.3) of FAM-AIP-I fluorescence 
was plotted as a function of added AgrC-IR238H discs and fit to a Hill equation. One 
representative titration of 3 is shown. Error bars (technical) = SEM (n = 6). (d) 
Dissociation of FAM-AIP-I from AgrC-IR238H discs as a result of competition with native 
AIPs: bar graph shows the ΔSSA of 20 nM FAM-AIP-I upon forming complex with 150 
nM AgrC-IR238H discs alone (open bars) or in the presence of 10 µM indicated AIP 
competitors (closed bars). Errors bars = S.D. (n = 3). 
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To further substantiate this idea, we employed the chimera protein strategy introduced in 
section 4.2 to chart the conformation-activity landscape for this mutant HK domain. 
Eleven GCN4-AgrC-IR238H chimeras were prepared and their auto-kinase activities were 
compared to the corresponding GCN4-AgrC-I constructs (Figure 4.6a-d). Remarkably, 
activities of the mutant chimera series also changed periodically with the length of the 
interdomain linker (Figure 4.6a and b). Fitting the activity-linker length relationship to a 
sine wave function revealed that the fluctuation amplitude in the mutant chimera series is 
less than 30% of that observed in the wild-type series (compare Figure 4.6b to d), 
confirming the notion that the mutant HK domain is less responsive to conformational 
perturbations. Other parameters of the two waves are strikingly similar: both followed the 
α-helical “wavelength” of 3.6 residues, while no phase shift was observed between them. 
The “baseline” of the two waves, defined as the mean of the maxima and minima of the 
fluctuation, is also comparable between the two series. Previous experiments on the 
GCN4-AgrC-I chimera series identified GC205, GC209 and GC210 as the 
conformational surrogate of the AIP-II-bound, apo and AIP-I-bound AgrC-I and 
phenocopy their activity levels (Figure 4.6e). These relationships hold true in the mutant 
chimera series, as GC205R238H, GC209R238H and GC210R238H accurately recapitulated the 
strong activity of AgrC-IR238H in the apo state and the weak effect that AIP-I and AIP-II 
have on this system (Figure 4.6e). Plotting the auto-kinase activity of each GCN4-AgrC-
IR238H chimera as in Figure 4.3d revealed the conformation-activity landscape for the 
mutant HK domain (Figure 4.6f). Notably, the activity minimum of this landscape is 
much higher than that of the wild-type series, and this level of kinase activity probably 
affords full activation of the P3 promoter in the reporter-strain settings.   
	   85	  
 
Figure 4.6 The R238H mutation renders the AgrC-I HK domain less responsive to 
the twisting movement of linker helices. 
 (a and b) Auto-kinase assay of 11 GCN4-AgrC-I chimeras bearing the mutant AgrC-I 
HK domain. An autoradiogram with the corresponding Coomassie-stained loading 
control (a) and an activity-linker length plot (b) are shown. In (b), curve shows the 
sinusoidal function fit to the data. (c and d) Auto-kinase assay data and the quantification 
result for the chimera series carrying the wild-type AgrC-I HK domain. Note that the 
panels in (a) and (c) were scanned from the same film (for autoradiograms) or stained in 
the same gel (for loading controls). In (b) and (d), intensity of each band on the 
autoradiogram was normalized to that of GC209. (e) Auto-kinase activity of the linker-
conformation surrogates (refer to Figure 4.4 d and e) versus the full-length receptors. (f) 
Comparison of the conformation-activity landscape between the wild-type and mutant 
AgrC-I HK domains. Putative twisting angles are calculated according to Figures 4.4e. 
Normalized auto-kinase activity of the chimera series bearing wild-type (gray bars) and 
R238H mutant (black bars) HK domains are plotted. Fitting to a sinusoidal function 
returns smoothened landscapes for the wild-type (dashed curve) and R238H (solid curve) 
HK domain. For clarity, the wild-type data (gray bars) were shifted to the right by 10o 
along the horizontal axis. In panels (a), (c) and (e), auto-phosphorylation was performed 
employing [γ-32P] ATP and pHis levels analyzed by autoradiography. 
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We next asked whether an intracellular construct, AgrC-I205-430 bearing the R238H 
mutation would convey the high level of auto-kinase activity expected for the full-length 
mutant. To our surprise, this construct gains very little activity upon the R238H mutation 
(Figure 4.7a). Suspecting that the sensor domain might be necessary for the auto-kinase 
activation by this mutation, we truncated AgrC-I to leave the C-terminal four, two or one 
TM domain(s). All truncated AgrC-I mutants, after nanodisc reconstitution, exhibited 
activities as strong as the full-length mutant (Figure 4.7a), suggesting the intact sensor 
domains and the inter-subunit interaction mediated thereby are not required for the gain 
of activity conferred by this mutation. Apart from bridging specific interactions, other 
possible roles of TM domains in organizing the nanodisc-incorporated histidine kinase 
include (i) anchoring the soluble portion of AgrC-I in proximity to the lipid bilayer and 
(ii) propagating helicity to the interdomain linker to which it directly connects. The later 
role is analogous to the GCN4-dependent stabilization of the linker helices in the chimera 
proteins (see Figure 4.4e). To dissect between these two roles, we installed a pair of 
phospholipid anchors to a dimeric AgrC-I soluble-domain (AgrC-I208-430) at the N-
terminus of both subunits (Figure 4.7b and c). Reconstitution of this protein-lipid 
conjugate to nanodiscs successfully attached the soluble AgrC-I construct to the lipid 
bilayer (Figure 4.7d). Unexpectedly, this attachment via lipid moieties, as opposed to 
TM-domain anchors, was detrimental to the auto-kinase activity of both the wild-type 
and mutant AgrC-I208-430 (Figure 4.7e). On the other hand, kinase activation by the 
R238H mutation is tolerant to the substitution of the TM sequence in the single-TM 
AgrC-I construct with an unrelated TM domain from an E. coli protein (LepB) or the 
insertion of a two-aa spacer to this LepB-AgrC-I chimera between the TM domain and 
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Figure 4.7 Auto-kinase activation by the R238H mutation requires the attachment 
of the AgrC-I construct to nanodiscs by a TM domain 
(a) The effect of the R238H mutation on the auto-kinase activity of various truncated or 
chimera AgrC-I constructs. All constructs except AgrC-I205-430 were first reconstituted to 
nanodiscs prior to activity analysis. A domain diagram is displayed for each construct 
next to the corresponding autoradiogram panel, with AgrC-I sensor domain shown in 
blue, the E. coli LepB TM domain in ocher, the interdomain in red, the DHp subdomain 
in salmon, and the CA subdomain in green. (b) The chemical structure and a cartoon 
presentation of the phospholipid-maleimide derivative, 16:0 PE MCC. (c) Diagram 
showing the putative configuration of the lipidated AgrC-I208-430 construct upon nanodisc 
reconstitution. Intersection of the nanodisc membrane is shown in gray. (d) SEC analysis 
of nanodiscs carrying the lipidated AgrC-I208-430. Fractions between the dotted lines were 
analyzed by SDS-PAGE with Coomassie staining. MSP, membrane scaffold protein. (e) 
Auto-kinase analysis of AgrC-I208-430 constructs with or without the R238H mutation. 
Reaction contains the unmodified AgrC-I208-430 (condition 1), the unmodified AgrC-I208-
430 with empty nanodiscs added in trans (condition 2), or the nanodisc-reconstituted, 
lipidated AgrC-I208-430 (condition 3). In panels (a) and (e), Auto-phosphorylation was 
performed employing [γ-32P] ATP and pHis levels analyzed by autoradiography. 
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the interdomain linker (Figure 4.7a). Therefore, the helicity, and perhaps the orientation 
of the TM-domain anchors, rather than the HK domain’s proximity to the lipid bilayer, 
plays a crucial role in supporting the strong kinase activity of the mutant HK domain.   
 
4.4 Reconstitution of the AIP-II-revertible constitutive mutants 
By contrast to what was observed for AgrC-IR238H, the activation of P3-driven gene 
transcription caused by a subset of AgrC-I constitutive mutants is revertible by their 
binding to AIP-II—the peptide was therefore identified as an inverse agonist of AgrC-I 
(143). However, it is unclear how the baseline auto-kinase activity of AgrC-I and its 
response to AIP binding change in these mutants. Constitutive point mutations causing 
AIP-II revertible phenotypes were identified in all modules of AgrC-I. We picked four 
representative mutants bearing mutation in the sensor (AgrC-IS183F), the interdomain 
linker (AgrC-IL205R), the DHp subdomain (AgrC-IR238K) or the CA subdomain (AgrC-
IE306Q) for auto-kinase assays employing the nanodisc-reconstitution system.   
 
The above four mutants were purified from recombinant expression in E. coli and 
incorporated to nanodiscs (Figure 4.8a). The phospholipid stock used for nanodisc 
assembly consisted of POPC and POPG at a molar ratio of 1:3. Auto-phosphorylation of 
the wild-type and mutant AgrC-I discs with [γ-32P]-ATP and MgCl2 revealed mild 
elevation of the baseline kinase activity in all four mutants (Figure 4.8b). In contrast to 
the R238H mutant, however, AgrC-IR238K and AgrC-IE306Q carrying HK-domain 
mutations maintained the sensitivity to AIP-I: their activities in the AIP-I-bound state 
were indistinguishable from the wild type. AgrC-IS183F and AgrC-IL205R bearing 
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mutations preceding the HK domain, on the other hand, were only moderately activated 
by AIP-I. Surprisingly, all four mutants exhibited reduced sensitivity to the inverse 
agonist, AIP-II. As a consequence, AgrC-IL205R and AgrC-IR238K exhibited, when bound 




Figure 4.8 Ligand responses of the AIP-II-revertible constitutive mutants 
(a) Affinity purification of AgrC-I mutants: fractions from the Ni-NTA purification of 
indicated AgrC-I mutants were resolved on SDS-PAGE and proteins visualized by 
Coomassie staining. The expected position for full-length AgrC-I is indicated next to the 
gel. (c) Auto-kinase analysis of AIP-II-revertible AgrC-I mutants: wild-type or mutant 
AgrC-I discs (0.7 µM) were incubated with 20 µM [γ-32P] ATP, 5 mM MgCl2 and 10 µM 
AIP if indicated, and the pHis levels were analyzed with autoradiography.  
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 the wild type (Figure 4.8b, compare lanes 9 and 12 to lane 1). It is therefore unlikely that 
AIP-II reverts the constitutive phenotype of these mutants solely by suppressing their 
auto-kinase activities. We speculate that the newly discovered activity of AIP-II, i.e., 
retarding the AgrC-I-AgrA phospho-relay, might play the critical role in reverting the 
constitutive phenotype of these mutants. This possibility will be investigated in the near 
future.  
 
4.5 Summary and discussions 
4.5.1 Auto-kinase regulation of AgrC-I 
In this chapter, we have combined the strength of the nanodisc-reconstitution system and 
an artificial protein-chimera approach to investigate the signaling mechanism of AgrC-I. 
Our studies indicate that the interdomain linker assumes a helical conformation whose 
structural properties are intimately tied to the activity state of the receptor. Cys 
crosslinking studies in the context of full-length AgrC-I revealed distinct crosslinking 
patterns for the resting, activated and inhibited states, indicating a substantial 
reorganization of the structure in the linker in response to binding of both activator and 
inhibitor AIPs. Interestingly, the first of these patterns (resting state) is not a simple 
weighted average of the latter two, which is inconsistent with a model wherein the 
interdomain linkers are in equilibrium between ‘on’ and ‘off’ conformations with ligand 
binding altering the equilibrium position of the system (Figure 4.9). Rather, this 
crosslinking data is more consistent with discrete linker conformations for AgrC in all 
three states.  
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Figure 4.9 An alternative model of the linker conformation in three ligand states 
In this model, the linkers are in an equilibrium between an ‘on’ state associated with high 
auto-kinase activity and an ‘off’ state with low activity. Binding of activator or inhibitor 
AIPs shifts the equilibrium position. See text for details.  
 
Our analysis of a series of GCN4-AgrC-I chimeras provided further insight on the signal-
response behavior of AgrC-IHK. Assuming that the interdomain linker adopts a parallel 
helical conformation, that the GCN4 coiled coil maintains itself as a rigid body in all 
chimeras and that α-helicity continues at the GCN4-AgrC-I junction, then the activity of 
AgrC-I HK domain is seen to change gradually as a function of the twisting angle away 
from the resting state (Figure 4.3d). Intriguingly, the auto-kinase activity of full-length 
AgrC-I in the activator-bound state is significant weaker than the maximum activity of 
AgrC-I HK domain exhibited in chimeras GC207 and GC214 (Figure 4.4a), suggesting 
that the “working range” of the native RHK might be tailored by natural selection to meet 
the demand of optimal autoinduction timing.  
 
Our chimera approach has some interesting parallels with the work of Moffat and 
coworkers on FixL from Bradyrhizobium japonicum (157). Similar to AgrC, the linker 
region in FixL connecting the sensor and HK domains is proposed to be helical. 
Chimeras between the FixL HK domain and a LOV light sensor domain from a 
heterologous protein (YtvA from B. subtilis) are active only when the FixL residue at the 
junction occupies two periodically equivalent positions (‘i’ and ‘i + 4’) in each haptad 
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repeat of the putative linker coiled-coil. Maintaining the appropriate periodicity of the 
helical linker is therefore thought to be critical to the construction of functional RHKs via 
shuffling between sensor and HK domains, including such events as they occur during 
evolution (158). In stark contrast to the YtvA-FixL chimeras, our GCN4-AgrC-I 
constructs exhibited many intermediate activities between the two extremes: the system is 
remarkably plastic. Shuffling between the AgrC-IHK (or other HK domains with similar 
behaviors) and heterologous sensory modules could therefore result in new RHKs 
exhibiting variable degrees of basal kinase activity and possibly dynamic range, 
depending on the fusion junction and the structural rearrangement of the sensor between 
signaling states. Conceivably, such functional plasticity would be beneficial during RHK 
evolution by increasing the chance of generating competent chimera receptors that could 
serve as starting points for further selection for an optimal working range for the new 
sensory function.  
 
Following the publication of our work discussed above (159), three papers came out each 
describing a crystal structure in which HK domain dimers were captured in the catalytic-
active state (122, 153, 160). As opposed to the symmetric, inactive HKs (Figure 4.10a), 
the active HK dimers are strikingly asymmetric: while one CA subdomain binds to the 
phospho-acceptor His in a catalysis-competent conformation, the other still adopts the 
inactive conformation as if in an inactive dimer (Figure 4.10b). Key to this asymmetry is 
the extra bending of the DHp-α1 colored in yellow in Figures 4.10a and b (Figure 4.10a, 
red arrow), which disrupts a hydrophobic patch that would otherwise sequester the 
catalysis-competent CA subdomain (Figure 4.10a and b, compare the electrostatic surface 
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in the dashed circle). In compliance with these structural evidences, helical “tilting” or 
“scissoring” of the linkers preceding the DHp subdomains has been observed in a few 
full-length RHKs as a consequence of signaling input (152, 161, 162). Rotational 




Figure 4.10 New structural evidence on the molecular movement related to RHK 
activation 
(a and b) Comparison between crystal structures of two HK-domain dimers, one captured 
in the inactive state (PDBID: 2c2a, panel a) and the other in the active state (PDBID: 4i5s, 
panel b). In each dimer, one inactive CA subdomain is hidden for clarity. The remaining 
CA subdomain is colored green, adopting the inactive conformation in (a) and the kinase-
competent conformation in (b). The DHp-α1 helix that experiences bending movement is 
colored in yellow and the rest of the DHp four-helix bundle is shown in ocher. The 
phospho-acceptor His that would react with the displayed CA is highlighted in magenta. 
A transparent electrostatic surface is also displayed for the DHp subdomain. In (a), the F-
box Phe residue (black spheres) binds to a hydrophobic patch (dashed circle) in the DHp 
four-helix bundle and holds the CA from approaching the phospho-acceptor His. A red 
arrow indicates the bending motion of the yellow helical segment that would activate the 
displayed CA subdomain. In (b), the dashed circle indicates the disruption of the 
hydrophobic patch as a consequence of the bending motion, and the CA subdomain 
relocated to bind the His in a catalysis-competent conformation. (c) The intracellular 
domains of the E. coli stress sensor CpxA (PDBID: 4biv). The highly symmetric HAMP 
domain is colored in blue, and the helical elements in the DHp subdomain are colored 
sequentially in cyan, green and light green. Arrows highlight the differential helical 
bending between the HAMP and DHp in two subunits that breaks the symmetry of the 
dimer.  
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component of the overall linker movement in conjunction with tilting or scissoring (152, 
162). Notably, however, the local, symmetric helical rotation found in the AgrC-I 
interdomain linkers in our study needs not contradict with the asymmetry in the HK 
module necessary for kinase activation. This notion is supported by the perfect symmetry 
of HAMP transmission modules in an overall asymmetric structure of the intracellular 
portion of the E. coli stress sensor RHK, CpxA in its active conformation (Figure 4.10c) 
(122). Specifically, the interdomain linkers connecting the HAMP and DHp modules are 
bent at different magnitudes to adapt to the conformational mismatch between their 
flanking modules (Figure 4.10c, black arrows). In our inter-subunit crosslinking analysis 
of AgrC-I, the linker segment (residues 205-209) in which we performed Cys substitution 
is very close to the sensor domain and perhaps upstream to the putative kink site. 
Assuming this arrangement to be true, this segment of the linker pair may retain a two-
fold symmetry in full-length AgrC-I at different ligand states.  
 
The success of the protein-chimera strategy also strictly relies on the capability of α-
helices to bend and/or unwind in order to relieve conformational stress. According to the 
designing principle, the junction residues would be rotated from its resting register by 
about 180 degree in some chimeras. This movement, if faithfully propagated to the DHp 
subdomain, would displace the hydrophobic residues out of the four-helix bundle core 
and thereby dismantle the HK dimer. The interdomain linkers in these chimeras, 
therefore, must modulate the severe rotational input into a combination of milder rotation 
and tilting output discernible for the HK domain. Conceivably, this modulation is not 
possible when the linker is too short and perhaps as a consequence, almost no 
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intermediate level of auto-kinase activities was observed in chimeras with linker length 
shorter than 7 residues (Figure 4.3a). It is currently unclear how this modulation enables 
the continuous correlation between the rotational conformation input and the auto-kinase 
activity. A multi-facet strategy involving high-resolution structural characterization and 
single-molecule fluorescence measurement is proposed in section 6.1.3 to address this 
fascinating puzzle.  
 
4.5.2 Trans-kinase regulation of AgrC-I 
Upon auto-phosphorylation, the RHK component relies on its trans-kinase activity to 
relay the phosphoryl group to its cognate RR. Despite the essential role of this activity in 
the TCS signaling, its regulation has been overlooked in most biochemical studies of 
other TCS systems. Two reasons might account for the lack of quantitative kinetic studies 
on phospho-relay reactions: (1) that these reactions are too fast to be accurately 
quantified (t1/2 on the order of a few seconds, see Figure 3.6e); and (ii) that the 
phosphatase activity of the RHK, which is also variable among signaling states, interferes 
with the phospho-relay kinetics. In our in vitro reconstitution studies on the wild-type 
AgrC-I, AIP-II was found to significantly inhibit the phospho-relay from the receptor to 
its cognate RR, AgrA (Figure 3.6a and b). In fact, the cognate AIP-I slightly accelerates 
this process (Figure 3.6a, compare lanes 11 and 12 to 3 and 4). Key to these findings is 
the complete lack of phosphatase activity in AgrC-I (Figure 3.6c and d), a rare property 
among RHKs that may facilitate further investigations into the conformation-activity 
relationship of the AgrC-I HK domain with respect to the trans-kinase activity. To realize 
quantitative measurement of the trans-kinase activity in the GCN4-AgrC-I chimera 
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series, an assay based on a three-component phospho-equilibration system is designed in 
section 6.1.2. 
 
4.5.3 Mechanisms of constitutive activity 
Novel TCSs emerge in two ways: lineage-specific expansion (LSE), in which the HK 
domain of the ancestral RHK recombines with a new set of sensor domain(s) to carry out 
a new sensory function in the same organism, or horizontal gene transfer (HGT), in 
which the ancestral TCS is introduced to, and performs its original function in, a distantly 
related organism (163). In both scenarios, however, successful establishment of a sensory 
pathway entails adaptation of the nascent TCS to the signaling demand of the host 
organism, which would depend primarily on natural selection on beneficial mutations that 
occur randomly (158). Central to this adaptation is the adjustment of the threshold level 
of the signal as well the sensitivity of the response to signals above the threshold. At the 
molecular level, these properties of a TCS depend in part on the conformation-activity 
landscape of the RHK component, which dictates its resting and activated kinase 
activities. Therefore, how this landscape changes following point mutations would be 
indicative to the evolutionary trajectory of RHKs. In this Chapter, we examined the 
conformation-activity landscapes of an AgrC-I HK domain bearing a point mutation, 
R238H. We found that the auto-kinase activity of this mutant is less sensitive to 
rotational motions compared to the wild type: that it fluctuates so mildly around a 
relatively high level, enables the corresponding full-length RHK, regardless of the ligand 
state, to activate P3-driven reporter genes. This result exemplifies the profound impact 
that a point mutation might have on the conformation-activity landscape of an HK 
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domain, and should inspire a more comprehensive effort to understand the “evolvability” 
of this landscape, perhaps employing a saturation mutagenesis approach (164).  
 
In contrast to the HK-domain constitutive mutations (R238H, R238K and E306Q), those 
occurring in or proximal to the sensor domain (S183F and L205R) apparently do not alter 
the conformation-activity landscapes of the HK domain and, therefore, the mechanism of 
action for these mutations is less tractable. In the previous report in which these mutants 
were identified, the authors suggested that both mutants tend to shift the last TM domain 
towards the cytoplasm and thereby mimic the activated conformation even in the absence 
of AIP-I (143). Such “piston-like” movements have been ruled out for the mechanism of 
type-I RHK activation (165, 166). Nonetheless, the multi-span sensor domain in AgrC-I 
may allow this TM domain to, after the piston-like shift, rotate or tilt in order to optimize 
its packing with the rest of the sensor domain and thereby confer auto-kinase activation. 
This model needs to be tested experimentally in the future, primarily through assessing 
the solvent accessibility of certain membrane-proximal residues and mapping the 
mutation-induced conformational change of the interdomain linkers.  
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Chapter Five: The Key Driving Forces That Power AIP Thiolactone Formation 
As was described in section 1.2.3, the AIP contains a thiolactone ring formed by 
condensation of the C-terminal carboxyl group and the sulfhydryl group of an internal 
cysteine. This macrocyclic structure is absolutely necessary for binding of the peptide to 
its receptor, AgrC. AIP biosynthesis is of particular interest to us because the high-energy 
thiolactone linkage forms directly from the AgrB-catalyzed proteolysis of AgrD without 
free-energy input from ATP hydrolysis (Figure 5.1a) (55). Notably, the reaction occurs at 
the inner leaflet of the cytosolic membrane and the N-cleavage fragment, herein referred 
to as AgrD(1-32)-thiolactone, is then translocated to the extracellular leaflet of the cell 




Figure 5.1 The AIP biosynthesis pathway and the model for free-energy change 
estimation for the thiolactone formation.  
(a) The AIP production pathway in S. aureus cells as exemplified by processing of AgrD-
I. (b) A two-step model that recapitulates the thiolactone formation from a linear peptide. 
Estimated values of free-energy change and/or equilibrium constant are shown for each 
step. See text for details.   
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challenge to maintain, on the cytoplasmic side of the cell membrane, an abundant pool of 
the AgrD(1-32)-thiolactone to support its rapid translocation required for punctual agr 
autoinduction. In this chapter, we both estimated the ∆G for the thiolactone-formation 
reaction based on existing data and determined it experimentally. To account for the 
discrepancy between the estimation and the experimental results, the stability of the 
thiolactone macrocycle was also probed under various conditions employing a ring-
opening equilibrium approach. Our data show that efficient thiolactone production is 
driven by two unanticipated features of the system; (i) membrane-association of the 
thiolactone-containing intermediate which stabilizes the macrocycle and (ii) rapid 
degradation of the C-terminal proteolysis fragment, AgrDC, which affects the reaction 
equilibrium position.  
 
5.1 Estimation of the free energy cost associated with thiolactone formation  
To get a better picture for the thermodynamic challenge associated with conversion of 
AgrD into a thiolactone, we first estimated the ∆G for the reaction based on existing data 
on analogous model reactions. A two-step process would recapitulate such a reaction: the 
scissile peptide bond first undergoes thiolysis with a coenzyme A mimic, N-
acetylcysteamine (NAC), to give an N-terminal thioester fragment and an unmodified C-
fragment (Figure 5.1b) and the N-terminal fragment subsequently cyclizes into a 
thiolactone to release NAC (Figure 5.1b). In the following discussion, ∆Go’ is defined as 
the free energy change of a chemical process at 37oC, 100kPa and pH = 7.0 with all 
reactants involved present at standard activities.  
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The first step can be accomplished through first the hydrolysis of the scissile peptide 
bond and the subsequent thioesterification of the N-fragment by NAC. For the hydrolysis 
process we referred to the hydrolysis of a Gly-Gly bond, ∆G0’ = 2.2kcal/mol (167). For 
the thioesterification process, the ∆G0’ for the condensation between acetic acid and 
coenzyme A (CoA), i.e., 7.5 kcal/mol (168), needs to be adjusted for the difference in 
acidity between the C-terminal carboxylic group of a generic peptide (pKa = 3.3) and 
acetic acid (pKa = 4.8) (169). pKa value of acids have been found to linearly correlate 
with the pKeq (negative logarithm of the equilibrium constant) of the hydrolysis of their 
methyl esters into their deprotonated anions and methanol (170). The slope is 1.02. 
Assuming this linear relationship holds for thioesters, thioesterification of a C-terminal 
carboxylate on a peptide should be 2.1 kcal/mol less favorable than that of acetate (169). 
Therefore, the estimated overall ∆G10’ for the thiolysis of a generic peptide bond should 
be: 
∆G10’ = -2.2 + 7.5 + 2.1 = 7.4 kcal/mol                   equation 5.1 
With respect to the second, ring closure step, the ∆G0’ is strongly dependent on the ring 
being formed. As a moderate estimation, we assume that the ring formed upon trans-
thioesterification to be a typical large ring such that it is neither strongly stabilized, like a 
five- or six-membered ring, nor destabilized like those in mid-sized rings. We also 
assume that the trans-thioesterification is isoenthalpic, primarily because the pKa of the 
thiol group in a cysteine side chain is close to that in NAC.  
 
We calculate the ∆G20’ of the cyclization from an estimated equilibrium constant Keq, 
which equals the apparent first-order kinetic constant of the forward reaction divided by 
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the apparent second-order kinetic constant of the reverse (thiolysis) reaction. The 
denominator should be equivalent to the secondary kinetic constant of a thiol-exchange 
process involving a linear peptidyl-NAC thioester, in that the rotational movements 
around the bonds adjacent to the thioester motif are not restrained in the large ring. The 
equilibrium constant therefore equals to the ratio between the first-order kinetic constant 
of the intramolecular (cyclization) reaction and the second kinetic constant of an 
analogous intermolecular (thiol-exchange) reaction between a thioester and a thiol group. 
This ratio, by definition, represents the effective molarity (EM) of the cyclization. 
Empirically, the EM of large, unstrained ring formation from bifunctional chain 
molecules falls predominantly within the range 0.01M - 0.05M independent of the 
functional groups involved, as was summarized by Illuminati and Mandonlini (171). This 
range corresponds to a ∆G20’ value ranging from 1.8 to 2.8 kcal/mol. We hence used 
∆G20’ = 2.3 kcal/mol to calculate the ∆G0’overall and the Keq, overall for the strain-free 
thiolactone formation from a generic peptide (equations 5.2 and 5.3). 
∆G0’overall = ∆G10’ + ∆G20’ = 9.7 kcal/mol            equation 5.2; 
Keq, overall = exp (-∆G0’overall / RT) = 1.4 × 10-7       equation 5.3. 
 
The estimated Keq, overall, if applied to the AgrD(1-32)-thiolactone formation from AgrD, 
would restrict the intracellular abundance of the former to a level incompatible with the 
AIP production rate required for agr autoinduction (see Discussion). Therefore, assuming 
the thiolactone intermediate to be the direct product of AgrB-mediated proteolysis in 
vivo, some mechanism must exist to render the reaction more permissible. 
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5.2 Expression and purification of recombinant AgrB and AgrD constructs 
We elected to study AgrB and AgrD from S. aureus group-I and -II for our reconstitution 
studies. The current model of AIP biosynthesis has been developed primarily using 
group-I Agr proteins, which are significantly diverged from their group-II counterparts: 
AgrB-II and AgrD-II share 61% and 48% sequence identity with AgrB-I and AgrD-I, 
respectively. Importantly, genetic studies show that heterologous processing of AgrD is 
forbidden between these two groups (62).  
 
Wild-type AgrD-I and AgrD-II, as well as N-terminally FlagHis6-tagged versions thereof, 
were generated using a recombinant fusion protein strategy (Figures 5.2a and 7.1, 
Appendix Figure 1 and Appendix Table 2). AgrB-I and AgrB-II were over-expressed in 
E. coli as His6-tagged recombinant proteins and purified (Figure 5.2b). Surprisingly, 
AgrB-I showed multiple bands when analyzed by SDS-PAGE, while AgrB-II migrated 
primarily as a single species of the expected molecular weight with a small amount of an 
apparent dimer. Western blot analysis revealed the presence of the His6-tag in all of these 
high molecular weight species, indicating that they relate to AgrB-I and AgrB-II (Figure 
5.2b). That these high molecular weight species might result from covalent oligomers, 
was ruled out by matrix-assisted laser desorption ionization mass spectrometry (MALDI-
MS) (Figure 5.2c).  
 
The unusual electrophoretic behavior of AgrB-I, and to a lesser extent AgrB-II, could be 
a consequence of heterologous oligomerization induced by SDS micelles. However, 
native inter-subunit interactions within membrane protein complexes are often resistant to 
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SDS (172), leading us to wonder whether AgrB might oligomerize under more native 
conditions. This idea was supported by a crosslinking experiment on AgrB-II solubilized 
with a zwitterionic detergent, fos-choline-12, in which specific dimer formation was 
observed upon short glutaraldehyde treatment (Figure 5.3a). Since detergent-solubilized 
AgrB-II is not active (data not shown), we asked whether the dimerization persists upon 
incorporation to nanometer-scale lipid bilayer discs, or nanodiscs (see chapter 3) (138). 
Boldog and coworkers have employed a clever nanodisc based strategy to show that the 
bacterial chemoreceptor, Tar, forms stable dimers (173). We adapted this strategy to  
 
Figure 5.2 Preparation of recombinant AgrB and AgrD  
(a and b) SDS-PAGE analysis of all four AgrD constructs prepared herein (panel a) and 
samples from the affinity purification of AgrB proteins (panel b). L: bacterial membrane 
extract; FT: flow through; E: elution. An anti-His6 western blot of purified AgrB proteins 
is shown to the right. (c) MALDI mass spectrum of AgrB-I (calculated molecular weight 
= 22.7 kDa) showing the absence of covalent dimer. Bovine cytochrome C (molecular 
weight = 12,384 Da, showed up at m/z = 12,407 Da) was used as an internal standard for 
m/z calibration. The monovalent and divalent ions of the AgrB-I peak at m/z = 23006 Da 
and 11513 Da, respectively. 
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study the oligomerization behavior of AgrB in a bilayer (Figure 5.3b). Accordingly, 
nanodiscs were assembled in the presence of different amounts AgrB-II, such that the 
amount of the protein varied from being sub-stoichiometric relative to the number of 
discs to being in large excess. AgrB-II-incorporated nanodiscs from each assembly were 
isolated through Ni-NTA purification followed by size-exclusion chromatography (SEC), 
and the averaged protein molecular weight in each particle was analyzed using SEC in 
tandem with a multi-angle light scattering detector (SEC-MALS, Figure 5.3c). The 




Figure 5.3. Dimerization of AgrB under native conditions.  
(a) SDS-PAGE analysis of detergent-solubilized AgrB-II before or after glutaraldehyde 
treatment. (b) Theoretical distribution of AgrB structural units in nanodiscs: diagram 
showing the scenarios of reconstituting AgrB into excess nanodiscs assuming AgrB 
preferably forms monomers or dimers. (c and d) Protein content per disc (c) and AgrB 
copy number per disc (d) of affinity-purified AgrB-II nanodiscs as a function of pre-
assembly AgrB-to-nanodisc ratio. (e) Proteolysis of FlagHis6-AgrD-II after treatment 
with AgrB-II nanodiscs: reactions were analyzed by SDS-PAGE. Average AgrB-II copy 
number per disc is indicated. The products, AgrD-II-(1-32) fragments (linear and/or 
thiolactone) are collectively indicated as AgrD-IIN. MSP, membrane scaffold protein. 
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copies of MSP (30 kDa each) per particle, a known feature of this system (Figures 5.3c 
and d) (173). In line with our finding using detergent-solubilized protein, AgrB-II was 
incorporated as dimers when deposited at a monomer-to-disc ratio of 0.5:1 or 1:1. It is 
noteworthy that the monomer-to-disc ratio of the purified AgrB-II discs levels out at 4, 
suggesting that the 12.8 nm-diameter nanodisc is capable of accommodating two AgrB-II 
dimers. The proteolytic activity of these nanodiscs was tested using the FlagHis6-tagged 
AgrD-II substrate (Figure 5.3e). Interestingly, nanodiscs containing a single copy of the 
AgrB-II dimer were more active than those containing two copies of the dimer (Figure 
5.3e, compare lanes 2 and 3 to lanes 6 and 7). This is possibly due to the better 
availability of membrane surface necessary for substrate docking in nanodiscs containing 
single copy of AgrB-II dimer (56). The key result, however, is that AgrB appears to form 
stable dimers in a biologically active state. 
 
5.3 AgrD(1-32)-thiolactone is the major product of the AgrB-catalyzed proteolysis of 
AgrD 
We next set out to characterize the products of AgrB-mediated proteolysis of AgrD. To 
this end, AgrB and AgrD (from agr-I or -II) were co-reconstituted into liposomes 
composed of POPC and POPG at a ratio of 3:1. This lipid composition was selected 
based on preliminary proteolysis assays employing AgrB embedded in liposomes 
comprising POPC-POPG mixtures at different ratios (Figures 5.4a and b). Tris-Tricine 
SDS-PAGE revealed efficient proteolysis occurring between cognate AgrB-AgrD pairs 
but not heterologous ones (Figure 5.4c). Further characterization of the proteolysis 
products of non-tagged AgrD-I and AgrD-II was achieved using reverse-phase (RP) 
	   106	  
HPLC and mass-spectrometry (MS) (Figure 5.5a). For each reaction, RP-HPLC/MS 
identified three products in additional to the starting material, namely; AgrDC, AgrD(1-
32)-thiolactone and linear-AgrD(1-32) (Figures 5.5b-d and Appendix Figure 2). 
Importantly, consistent with the AIP biosynthesis model depicted in Figure 5.1a, the 
thiolactone is the major AgrD(1-32) fragment in both reactions (Figures 5.5.b and d, 
green arrows). We therefore refer to the AgrB-catalyzed processing of AgrD as the 
‘proteolytic cyclization’. 
 
Figure 5.4 Lipid-composition dependence and subgroup specificity of the AgrB-
catalyzed proteolysis of AgrD.  
(a and b) Lipid-composition dependence of AgrB-I activity. FlagHis6-AgrD-I was treated 
with AgrB-I proteoliposomes consisting of phospholipids at indicated compositions. 
Samples were withdrawn at indicated time points for SDS-PAGE analysis. (a) SDS-
PAGE analysis of one representative time course and (b) kinetic plot of AgrD-I 
consumption from densitometric quantification of the gel are shown. Error bars = range 
(n = 2). (c) Proteolysis specificity between AgrB-AgrD pairs from agr-I and agr-II 
alleles. FlagHis6-tagged AgrDs were treated with indicated liposomal reagents at 37oC for 
6hrs. The reactions were resolved on Tris-Tricine SDS-PAGE and proteins visualized 
with SYPRO-Ruby staining (Invitrogen). In panels (a) and (c), the AgrD(1-32) fragments 
(linear and/or thiolactone) are collectively indicated as AgrD-IN or AgrD-IIN. 
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5.4 AgrD processing by AgrB is a reversible process 
In our initial reconstitution trials, complete consumption of AgrD was never observed, 
despite significant production of AgrD(1-32)-thiolactone. To account for this, we 
speculated that the proteolytic cyclization might have reached a balanced equilibrium 
under our reaction conditions. To test this idea, we treated AgrD-I (the FlagHis6-tagged 
version, 20 µM) with proteoliposomes containing 1 µM AgrB-I and analyzed the reaction  
 
 
Figure 5.5 AgrD(1-32)-thiolactone is the major product of the AgrB-catalyzed 
proteolysis of AgrD.  
(a) Schematic representation of the proteolysis reaction. (b and c) C4 RP-HPLC 
chromatograms of the proteolysis reactions of (b) AgrD-I and (c) AgrD-II. Product peaks 
are indicated with arrows. (d and e) Deconvoluted MS highlighting the isotopic profile of 
the AgrD(1-32)-thiolactone species (green arrows) generated from (d) AgrD-I and (e) 
AgrD-II.   
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mixture by RP-HPLC at a series of time points (Figure 5.6a). We observed time-
dependent consumption of the starting material, as well as the production of three new 
species identified by MS as the AgrDC cleavage fragment, and the thiolactone- and linear 
AgrD(1-32) fragment. The amount of starting material and products were quantified 
based on integration of the RP-HPLC traces and the molarity of each species was 
normalized to the starting molarity of AgrD (Figure 5.6b). During the initial stage of the 
reaction (t < 10 minutes), the full-length precursor AgrD was efficiently cyclized to 
AgrD(1-32)-thiolactone (with the concomitant release of the AgrDC fragment), while 
only small amounts of linear AgrD(1-32) were generated. The cyclization then gradually 
slowed down, reaching a maximum by about 30 minutes, which is likely due to the 
dynamic equilibrium being reached (vide infra). In contrast to this equilibration behavior, 
the linear AgrD(1-32) was produced irreversibly at a slow but constant rate throughout 
the time course (Figure 5.6b). Intriguingly, its production after t = 30 minutes was 
coupled to a concerted decrease in the molar fraction of AgrD and AgrD(1-32)-
thiolactone (Figure 5.6b). This kinetic observation can be understood in terms of a pre-
equilibrium model, in which the proteolytic cyclization is a reversible process occurring 
much faster than the irreversible production of linear AgrD(1-32). In this model, the fast 
reaction reaches a quasi-equilibrium state that approximates the real thermodynamic 
equilibrium.  
 
To further explore the apparent reversibility of the proteolytic cyclization, we synthesized 
an AgrD-IC peptide with a C-terminal carboxyamide (AgrD-IC-NH2) and attempted to 
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Figure 5.6 AgrD processing by AgrB is a reversible process.  
(a and b) Time course of the proteolytic cyclization: a representative set of RP-HPLC 
curves (a) and a kinetic plot of indicated species generated from integrated peak areas 
thereof (b) are shown. In (b), all molarity was normalized to the amount of full-length 
AgrD at t = 0. Error bars = SD (n = 3). (c and d) Time course of the ligation reaction: 
samples were resolved on RP-HPLC and amount of full-length AgrD and both AgrD(1-
32) fragments was quantified using MS employing standards. A representative set of 
deconvoluted MS spectra (c) and a kinetic plot of indicated species (d) are shown. Error 
bars = SD (n = 3). (e) Scheme showing the mechanism of AgrB-catalyzed proteolysis of 
AgrD. (f) Ligation reactions starting at a series of AgrDC concentrations: reactions were 
analyzed at t = 120 min and deconvoluted mass spectra are shown as in panel (c). (g) Plot 
showing the equilibrium molar ratio between AgrD and AgrD(1-32)-thiolactone as a 
function of the molarity of AgrDC in the ligation (black circles) and proteolysis (red 
circles) systems. Error bars = SD (n = 3). 
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ligate it to a recombinantly prepared, FlagHis6-tagged AgrD-I(1-32)-thiolactone (Figure 
7.1 and Appendix Figure 1) in the presence of AgrB-I proteoliposomes, thereby 
generating the corresponding full-length AgrD-I construct (Appendix Figure 2). Since 
this ligation product co-eluted with the AgrD(1-32)-thiolactone starting material on RP-
HPLC, quantification of these two species relied on MS analysis employing ratiometric 
standards (Figures 5.6c and d). The ligation reaction occurred rapidly and a quasi-
equilibrium state was achieved within 40 minutes. Importantly, the post-equilibration 
behavior of the ligation system (after t = 40 minutes) showed a marked similarity to that 
observed with the proteolysis reaction (compare Figures 5.6d to b): the molar fraction of 
both AgrD and AgrD(1-32)-thiolactone dropped in a concerted fashion, while the ratio 
between them stayed roughly constant. This result unambiguously demonstrated a 
balanced, dynamic equilibrium of AgrD proteolysis under our reaction conditions. 
 
It has been proposed that the active-site cysteine within AgrB (Cys84) attacks the scissile 
peptide bond in AgrD to form an acyl-enzyme intermediate that subsequently undergoes 
an intramolecular trans-thioesterification to give the AgrD(1-32)-thiolactone (Figure 
5.6e) (55). Hydrolytic resolution of this acyl-enzyme intermediate could potentially yield 
the linear AgrD(1-32) peptide. In accordance with this model, the inactive AgrBC84A 
mutant is unable to ligate the AgrDC peptide to AgrD(1-32)-thiolactone or to hydrolyze 
the thiolactone (Figure 5.6c, top spectrum and Figures 5.7a and b). Therefore, we 
conclude that the catalytic activity of AgrB supports the proteolysis/ligation equilibrium 
and the irreversible production of AgrD(1-32) (Figure 5.6e).  
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We next set out to determine the equilibrium constant of the proteolytic cyclization 
reaction. To this end, the pre-equilibrium positions in the presence of different 
concentrations of AgrDC were monitored and plotted (Figures 5.6f and g, black data 
points). As expected, the pre-equilibrium position shifted towards the formation of full-
length AgrD at higher AgrDC concentrations. Linear regression of the plot in Figure 5.6g 
returned an equilibrium constant for the proteolytic cyclization, Keq = 1.0x10-5, or if one 
treats AgrDC as a reversible ligand for the thiolactone, a dissociation constant (KD) of 10 
µM. This corresponds to a ∆G0’ of 7.1 kcal/mol, which is 2.6 kcal/mol more favorable 
than expected based on our initial estimate from model reactions. Gratifyingly, the pre-
equilibrium state obtained using AgrD as the starting material (Figure 5.6b) conformed 
well to this equilibrium constant derived form the linear regression (Figure 5.6g, the red 
data point).  
 
 
Figure 5.7. Generation of AgrD(1-32) is dependent upon AgrB catalysis. 
The AgrD(1-32)-thiolactone was treated with indicated liposomal reagent at 37 oC for 1hr 
and then Sep-Pak processed and resolved on RP-HPLC. A representative set of 
chromatograms (a) and a bar graph showing the percentage of hydrolysis (corrected for 
SPE recovery) (b) are shown. Error bars = range (n = 2). 
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5.5 AgrD(1-32)-thiolactone is stabilized by phospholipids 
Our experimentally measured equilibrium constant for proteolytic cyclization indicates 
the reaction is about 70-fold more favorable than might be expected based on model 
reactions (Keq = 1.0 x 10-5 vs. 1.4 x 10-7). In an effort to gain some insight into this 
discrepancy, we asked whether the macrocycle within the AgrD(1-32)-thiolactone was 
somehow stabilized under the reaction conditions. With this in mind, we compared the 
susceptibility of AIP-I and FlagHis6-AgrD-I(1-32)-thiolactone to ring-opening thiolysis 
by NAC to give the respective linear thioesters (Figure 5.8a). Equilibration between 
thiolactone and linear thioester species was monitored at a series of NAC concentrations 
by RP-HPLC/MS. Treating NAC as a ligand that reversibly binds to the thiolactones, its 
dissociation constant, KD, NAC, was calculated from the equilibrium positions. Importantly 
for the following discussion, we observed essentially unbiased partitioning of NAC 
between aqueous and 1-octanol phases at pH = 7.5 (logP = -0.03, Figure 5.8b). Thus, the 
effective concentration of NAC should stay constant across the bulk solution and the 
membrane environment.  
 
To begin, we treated AIP-I with NAC ranging from 1.0 to 100 mM in aqueous solution 
buffered at pH 7.0 (Figure 5.8c, circles, dotted line and Table 5.1). The KD, NAC for AIP-I 
is 5.8 mM. Ring closure of AIP-I from its linear thioester is therefore less favorable than 
we estimated for the formation of an unstrained thiolactone, for which the equilibrium 
constant would be 24 mM (see Figure 5.1b). Since AgrD-I(1-32)-thiolactone is insoluble 
in the buffer system used to establish the thiolysis equilibrium for AIP-I, we dispersed 
this molecule in a suspension of lipid vesicles in the presence of different NAC 
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concentrations. With a calculated KD, NAC of 95 mM, this thiolactone appears to be much 
more stable than AIP-I (Figure 5.8c, squares, solid line and Table 5.1). The less favorable  
 
Figure 5.8 Ring-opening equilibrium of AIP-I and FlagHis6-AgrD-I(1-32)-
thiolactones.  
(a) Schematic representation of the ring-opening equilibrium. (b) The octanol-water 
partitioning equilibrium of NAC: 100 µL NAC was added to 2 mL aqueous PBS buffer 
(pH = 7.5) and 2 mL 1-octanol and the system was allowed to equilibrate at RT. The 
panel shows GC-MS chromatograms of equivolume samples from the aqueous and 1-
octanol phases. (c) Double-log plot showing equilibrium positions as a function of NAC 
concentration for AIP-I (circles) or AgrD-I(1-32)-thiolactone (squares) with the absence 
(dotted line) or presence (solid lines) of phospholipids. Error bars = SD (n = 4). TE, 
thioester; TL, thiolactone. (d) Time course of FlagHis6-AgrD-I(1-32)-NAC ring closure 
in HBS buffer, pH = 7.0 containing 1.5 mM POPC and 0.5 mM POPG in the presence of 
indicated level of NAC. Plot shows the molar fraction of the thioester (TE) as a function 
of time (dashed lines). The ring-opening time courses (solid lines) under each NAC 
concentration are overlaid. (e) As in (c), equilibrium positions were plotted for the AIP-I 
(closed circles, solid line) and FlagHis6-AgrD-I(1-32)-thiolactone (open squares, dashed 
line) in 6M GuHCl buffered at pH = 7.0. For (c) and (e), Error bars = range (n = 2) and 
are not visible due to the size of data symbols for most data points. 
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ring opening is not an effect of hysteresis, as reactions starting from the purified AgrD-
I(1-32)-NAC thioester reached roughly the same equilibrium positions (Figure 5.8d). 
Intriguingly, the stability of AIP-I towards ring opening was only slightly enhanced (1-
fold) in the presence of lipid vesicles (Figure 5.8c, circles, solid line and Table 5.1), 
despite the fact that it shares the identical macrocycle with AgrD-I(1-32)-thiolactone. It 
should also be noted that both thiolactones were equally susceptible to ring opening 
thiolysis in aqueous buffers containing chaotropic agents (Figure 5.8e and Table 5.1). 
Thus, the remarkable disparity in stability must originate from differential lipid-bilayer 
association of the macrocycle moiety. AgrD is thought to be targeted to the lipid bilayer 
by its N-terminal, amphipathic leader peptide (56). We confirmed this targeting effect 
using a co-migration assay on SEC, in which all AgrD constructs containing the N-
terminal leader peptide, showed strong interaction to bilayer nanodiscs (Figures 5.9a-c). 
By contrast, AIP-I does not co-migrate with nanodiscs (Figures 5.9d and e). Based on 
this, we speculate that the membrane targeting property of the leader peptide places the 
macrocycle into proximity with the lipid bilayer and hence induces its membrane 
partitioning and thereby stabilizes it against ring opening thiolysis.  
 
Table 5.1. Ring-closure equilibrium constants of thiolactones 
Thiolactone Condition* KD, NAC (mM) 
HBS 5.8 ± 0.2 
HBS, 2 mM POPC-POPG 11.4 ± 1.1 AIP-I 
6M GuHCl 21.9 ± 1.4 
HBS, 2 mM POPC-POPG 95 ± 31 
HBS, 2 mM DGDG 56 ± 7 AgrD-I(1-32) 
6M GuHCl 15.6 ± 2.2 
AIP-I tri-Ala** HBS 8.0 ± 0.4 
AgrD-I(1-32) tri-Ala** HBS, 2 mM POPC-POPG 11.0 ± 0.4 
* HBS, HEPES-buffer saline pH = 7.0; the POPC-POPG molar ratio is 3:1; 
** Constructs bearing mutations F30A/I31A/M32A (in AgrD-I numbering). 
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To explore the molecular determinants of this putative partitioning interaction, we 
examined atomic-resolution structures available for S. aureus AIPs. We noticed that in a  
 
Figure 5.9. Nanodisc co-migration assays for AIP-I and AgrD-I constructs.  
(a) SEC chromatograms: SEC sample (250 µL) contained 12 µM appropriate AgrD 
peptide and/or equimolar bilayer nanodiscs as indicated. The bilayer discs consisted of 
POPC-POPG in a molar ratio of 3:1. Shadow indicates the position at which nanodiscs 
(unbound or bound to AgrD) are eluted. FlagHis6-AgrD(1-32)-Cys is a linear peptide 
prepared from treating the FlagHis6-AgrD(1-32)-thiolactone with cysteine (see section 
7.3.3), and was used as the surrogate of FlagHis6-AgrD(1-32) in this experiment. (b) 
Recovery of AgrD peptides within eluate containing nanodiscs: for each sample 
containing AgrD peptide, the pre-SEC sample (denoted as S) and the combined fractions 
from the shadowed segment in (a) (denoted as F) were analyzed by SDS-PAGE. (c) 
Quantification of the gel in (b). Bar graph depicts the recovery of indicated AgrD peptide 
from the shadowed segment of elution after resolved on SEC alone (close bars) or in the 
presence of bilayer nanodiscs (open bars). (d) SEC chromatograms of the co-migration 
assay of indicated AIP-I peptide. Positions where nanodiscs and AIP-I were eluted are 
indicated by asterisk and shadow, respectively. (e) RP-HPLC traces showing the recovery 
of either AIP-I peptide from the shadowed segment of elution in (d) to be unaffected by 
the presence of nanodiscs in the SEC samples.   
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crystal structure determined for a monoclonal antibody in complex to AIP-IV (174), three 
endocyclic AIP amides donate hydrogen bonds to a glutamate residue of the antibody, 
while side chains of residues Phe6, Ile7 and Met8 (all shared between AIP-IV and AIP-I) 
are buried in a large, contiguous hydrophobic cleft on the antibody surface (Figures 5.10a 
 
Figure 5.10 Hydrophobic side chains on the ring-forming residues are required for 
the liposome-dependent stabilization of the thiolactone.  
(a and b) AIP-IV-antibody interface in a crystal structure (PDBID: 3QG6): An overview 
(panel a) and a zoom-in view at the interface (red rectangle in a, panel b) are shown. 
AIP-IV is presented as a stick model with the backbone carbons in cyan and side-chain 
carbons of Phe6, Ile7 and Met8 in gray. Side chains of Tyr1, Ser2, Thr3 and Asp4 are not 
shown for clarity. The ribbon diagram and electrostatic surface of the antibody are 
displayed. In (b), Hydrogen bonds between a glutamate residue in the antibody 
(highlighted in green) and the AIP backbone are highlighted by black dashes. (c) 
Arbitrarily positioned stick models of AIP-I and POPC depicting the proposed 
interactions by which lipid vesicles stabilize the macrocycle: carbon atoms in POPC, are 
shown in green, and hydrogen bonds are highlighted by black dashes. Note that all 
displayed side chains in the AIP-I model are identical in AIP-IV. (d) As in Figure 5.8c, 
equilibrium positions were plotted for the mutant (open symbols) or wild type (closed 
symbols) AIP-I (circles) or AgrD-I(1-32)-thiolactone (squares) in aqueous buffer alone 
(dotted lines) or that containing phospholipids (solid lines) or glycolipids (dashed lines). 
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and b). Based on this crystal structure, we envisioned that the putative partitioning of the 
macrocycle in the membrane might be driven by analogous interactions, specifically: the 
anionic phosphodiester motif in lipid head groups might form hydrogen bonds to the AIP 
endocyclic amide groups and hydrophobic side chains could be embedded in the greasy 
interior of the bilayer (Figure 5.10c). In line with this model, mutating all three 
endocyclic hydrophobic residues to Ala in AgrD-I(1-32)-thiolactone abolished 
stabilization of the macrocycle in the presence of liposomes (Figure 5.10d and Table 5.1), 
even though this mutant still associated with membranes, presumably through its leader 
sequence that remains intact (Figures 5.9a-c). Indeed, this mutant exhibited thiolysis 
equilibrium positions similar to that of AIP-I, either the wild type peptide or that bearing 
the triple-Ala mutant macrocycle (Figure 5.10d and Table 5.1). In addition, liposomes 
primarily composed of a non-charged glycolipid, digalactosidyldiacylglycerol (DGDG) 
conferred slightly weaker stabilization to wild-type AgrD-I(1-32)-thiolactone than did 
POPC-POPG liposomes (Figure 5.10d and Table 5.1). Collectively, these observations 
are consistent with a role for both hydrophobic and polar interactions in the stabilization 
of the thiolactone macrocycle as a consequence of membrane targeting.   
 
5.6 AgrD processing by AgrB is a reversible process in vivo  
Finally, we asked whether the reversibility of proteolytic cyclization observed in our in 
vitro reconstituted system had relevance to AIP production in S. aureus cells. To this end, 
we constructed S. aureus plasmids for production of two AgrD-IC peptides, one with 
wild-type sequence and the other a scrambled sequence. These AgrD-IC peptides were 
fused to a Flag-tagged ubiquitin (Ub-Flag2) for detection purposes (Figure 5.11a). Both 
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plasmids were introduced to a S. aureus strain carrying an agr-I locus, resulting in two 
transformants with similar growth rates (Figure 5.11b). Immuno-blotting revealed the 
presence of AgrD-I-Ub-Flag2, the expected ligation product between the AgrD-IC  
                   
Figure 5.11. Reversibility of the proteolytic cyclization in vivo.  
(a) Schematic showing the experimental design: production in S. aureus of wild-type 
AgrD-IC peptide (purple), but not the scrambled control (teal), is expected to give rise to 
AgrD-I-Ub-Flag2 (red) through the reverse activity of AgrB-I. (b) Growth curves of agr-I 
cells producing indicated AgrD-IC peptides at 30oC. Error bar = range (n = 2). (c) 
Western-blot analysis of cells producing AgrD-IC peptides: cells with indicated 
genotypes were grown at 30 oC to indicated optical density (OD600) prior to lysis. A high-
molecular-weight slice of the gel was Coomassie-stained as a loading-control. (d) Bar 
graph showing AIP-I activity in the medium isolated from agr-I cells producing indicated 
AgrD-IC peptides determined by an agr-I-specific reporter gene assay. Error bar = SD (n 
= 6). 
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construct and endogenous AgrD-I(1-32)-thiolactone, in cells expressing the wild-type 
construct (Figure 5.11c, lanes 4-7, red arrowhead) but, importantly, not the scrambled 
construct (Figure 5.11c, lanes 8-11). As expected, this ligation product was not present in 
transformed agr-knockout cells expressing the wild type AgrD-IC construct (Figure 
5.11c, lanes 13-15). Remarkably, AIP-I secretion was significantly lower in agr-I cells 
expressing the wild type AgrD-IC construct as compared to those expressing the 
scrambled construct, as determined using an agr-I-specific reporter gene assay (Fig. 5C). 
We interpret this as resulting from sequestration of AgrD-I(1-32)-thiolactone as a 
consequence of AgrB-I-mediated ligation with wild-type AgrD-IC-Ub-Flag2, but not the 
scrambled control.  
 
5.7 Summary and Discussion 
5.7.1 Factors that facilitate AgrD proteolytic cyclization 
When a polypeptide undergoes proteolysis, the peptidyl fragment N-terminal to the 
scissile bond is transferred to an acceptor nucleophile. While water is by far the most 
frequent acceptor, nature also efficiently harnesses a spectrum of N- or O-nucleophiles, 
leading to the formation of various branched, cyclic or C-terminally modified peptides or 
proteins (175). To the best of our knowledge, the first step in AIP biosynthesis is the only 
known proteolytic event where an S-nucleophile serves as the final acceptor of the 
peptidyl group – this definition excludes the transient, thioester-linked acyl-enzyme 
intermediates associated with the activity of cysteine proteases. It is noteworthy that 
nature typically couples ATP hydrolysis to the conversion of a carboxyl group (via an 
adenylation step) into a thioester, e.g. the activity of the ubiquitin activating enzyme, E1 
	   120	  
(176). In this study, we broke down the thiolactone-forming proteolysis reaction into the 
following half-reactions; (1) thiolysis of AgrD at the scissile peptide bond, and (2) ring 
closure from the resulted linear thioester (Fig. 1B). Employing chemical equilibrium 
approaches, we experimentally determined the ∆G0’ for the overall proteolytic 
cyclization reaction (7.1 kcal/mol) and the ring closure from the linear AgrD(1-32)-NAC 
thioester (1.4 kcal/mol, calculated from KD, NAC = 95 mM). The former reaction is 2.6 
kcal/mol more favorable than our estimation based on model reactions, whereas the latter 
is more favorable by 0.9 kcal/mol. This comparison indicates that the initial thiolysis step 
is also more facile (by 1.7 kcal/mol) than might be expected. To account for this, we 
propose that the scissile bond in AgrD is more sensitive to proteolysis than a generic 
peptide bond. Indeed, it has been shown that the free energy of hydrolysis for an 
individual peptide bond may vary by a few kcal/mol as a function of sequence context in 
folded proteins (177). Conceivably, targeting of AgrD to the lipid bilayer by the N-
terminal leader peptide could also help sensitize the scissile amide to proteolysis due to 
changes in the local chemical environment around this bond (e.g. changes in the 
dielectric of the medium, electrostatic effects and so on). Additional experiments will be 
required to test this idea. 
 
5.7.2 Physiological implications of the ∆G0’ of thiolactone formation 
Autoinduction of the agr locus in S. aureus features an abrupt up-regulation of the 
effector RNA levels during the exponential growth phase (29). A recent report showed 
that the pheromone concentration in a liquid-medium culture of a group-I strain reaches 5 
µM in two hours (178). By definition, this generates the same number of AgrDC 
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fragments in the cytoplasm, which leads to a considerably elevated intracellular 
concentration because of the much smaller volume of the cytoplasm compared to the 
medium. For example, AgrDC production would reach an accumulative concentration of 
5 mM in two hours, at a rate of 700 nM per second, assuming 1 mL cytoplasm is present 
in a one liter cell culture in late exponential phase (179). Constant and efficient AIP 
production therefore necessitates simultaneous removal of AgrDC since, as we have 
shown, elevating the levels of this fragment can perturb the equilibrium of AgrB-
mediated proteolytic cyclization (Fig. 5C) (Figure 5.12). Assuming that equimolar 
amounts of AgrD and AgrD(1-32)-thiolactone are present in a quasi-equilibrium with 
AgrDC in post-induction S. aureus cells, the steady-state concentration of AgrDC should 
be equal to the equilibrium constant for the proteolytic cyclization, Keq = 10 µM. The  
 
Figure 5.12 Summary of the driving forces that power the formation of the AgrD- 
(1-32)-thiolactone intermediate  
The AAA+ protease proposed to degrade AgrDC, ClpXP, is highlighted in a cartoon 
portraying its tertiary structure, with a hexameric ClpX ring stacking on two heptameric 
ClpP rings.  
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half-life of AgrDC would therefore be on the order of 10 seconds given a production (and 
degradation) rate of 700 nM per second. This short lifetime of AgrD-IC indicates a 
pathway in S. aureus that actively targets the peptide for degradation.  
 
The above estimation of the in vivo lifetime of AgrDC sheds light upon two long-standing 
puzzles with respect to the production of staphylococcal AIPs. The first of these involves 
the observation that AIP-production is greatly reduced as a consequence of genetic or 
chemical knockout of ClpP, the catalytic subunit of certain major AAA+ proteases in S. 
aureus (180, 181). While this phenotype has been known for more than a decade, the 
underlying mechanism has been elusive. We propose that ClpP constitutes the AAA+ 
protease that catalyzes the degradation of AgrDC and thus fuels the proteolytic cyclization 
of AgrD (Figure 5.12). The second puzzle relates to the remarkable sequence 
conservation of AgrDC (Figure 5.13). Surprisingly, mutations at most highly conserved 
positions on AgrDC have no affect on the substrate recognition by AgrB (55). Given the 
necessity for rapid degradation of AgrDC on agr induction, we hypothesize that a 
conserved motif within AgrDC targets the peptide to the degradation machinery, either 
through direct binding or mediated by a dedicated adaptor protein. Experimental tests of 
this hypothesis are currently in progress.  
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Figure 5.13 Multiple sequence alignment of Staphylococcal AgrDs.  
All AgrD sequences from the genus Staphylococcus in the pfam database (05931) are 
subject to an identity cutoff at 80%. The resulting 25 non-redundant sequences were 
aligned to the hidden-Markov model of the AgrD family. Invariable and highly conserved 
positions are highlighted in red and blue, respectively. Two red stars indicate positions at 
which mutation to alanine abolishes AgrB-catalyzed processing in vivo. 
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Chapter Six: Outlook 
The work presented in this dissertation established in vitro reconstitution systems for the 
quantitative biochemical and biophysical characterization of two pivotal membrane 
proteins, namely, AgrC and AgrB, involved in the QS in S. aureus. Prior to our study on 
AgrC, RHKs are in general believed to work as two-state switches that can be activated 
only with highly specific conformational input. The discovery of a gradual conformation-
activity landscape for the AgrC-I HK domain employing the GCN4-AgrC-I chimera 
protein series raises an alternative model in which the signal-response properties of TCSs 
are more amenable to fine adjustments in evolutionary processes. Furthermore, guided by 
our thermodynamic analysis of the AgrB-mediated proteolytic cyclization of AgrD, we 
found that constant and efficient degradation of the C-terminal cleavage fragment, 
AgrDC, is required to power the formation of the high-energy thiolactone N-fragment. In 
this chapter, opportunities to further explore the AgrC conformation-activity landscape 
are discussed and experiments are proposed for the identification of the protease(s) 
responsible for the turnover of AgrDC. At the end of this chapter, a chemical tagging 
approach harnessing the reactivity of the AIP thiolactones to identify AIPs from other 
Firmicutes species is described.  
 
6.1 The signal-response property of the AgrC-I HK domain 
In Chapter 4, the conformation of the interdomain helical linkers of AgrC-I has been 
subject to symmetric rotational input imposed by a GCN4 coiled-coil fused to the N-
terminus of the linkers. The auto-kinase activity changed gradually with the magnitude of 
the rotation, leading to the conclusion of a gradual conformation-activity landscape 
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(Figure 4.3). This understanding of the signal-response behavior of AgrC-I, however, is 
rather preliminary. Firstly, the auto-kinase activity was used as the sole readout in our 
analysis of the GCN4-AgrC-I chimera series, so there is no information concerning the 
response of, for instance, the trans-kinase (phospho-relay) activity to the rotation of 
interdomain linkers. Importantly, AIP-II, the inverse agonist of AgrC-I has been found to 
inhibit the trans-kinase activity while the underlying mechanism remains unknown. 
Secondly, given the vast diversity of sensor domains harnessed by RHKs in nature, it is 
very unlikely that they all impose symmetric, rotational input to the interdomain linkers 
that connect them to their respective HK domains. A fascinating project would therefore 
involve the systematic introduction of other types of conformational input to the AgrC-I 
linker pair followed by the analysis of the auto-kinase response. Thirdly, our inter-subunit 
disulfide crosslinking experiment on full-length AgrC-I favored the model in which the 
interdomain linker adopts a distinct, static conformation in each ligand state rather than 
distributes between two discrete conformations (Figures 4.4d and 4.9). This 
interpretation, however, needs to be restricted to the N-terminal half of the linker 
whereby Cys substitutions were performed (residues 205-209 out of 201-211). The HK 
domain, to which the C-terminus of the linker connects, on the other hand, is believed to 
distribute between as few as two conformations that corresponds to the kinase-off and 
kinase-on states captured in crystal structures (150). Thus, the interdomain linkers must 
somehow reconcile the discrepancy between the static conformation at its N-terminus and 
the conformation distribution at its C-terminus, by a yet unclear mechanism. Addressing 
the above three questions will significantly expand our knowledge on the signaling 
mechanism of TCSs. 
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6.1.1 The trans-kinase activity and the pHis stability in GCN4-AgrC-I chimeras 
As was alluded to in section 4.5.2, the AgrC-AgrA TCS would be exceptionally 
amenable to the analysis of phospho-relay kinetics because AgrC lacks the phosphatase 
activity that may otherwise complicate such analysis (see Figure 3.5). In reality, however, 
one drawback of this system comes from the instability of AgrA: all recombinant AgrA 
proteins containing the phospho-acceptor REC domain are prone to precipitation even 
when presented at low-µM concentrations (data not shown). Moreover, while the trans-
kinase kinetic data of all GCN4-AgrC-I chimeras are required to plot a conformation-
activity landscape, direct reconstitution of the phospho-relay involving the auto-kinase-
inactive chimeras is impractical because they cannot be pre-phosphorylated efficiently. 
To circumvent these issues, a three-component, phospho-equilibration system could be 
designed (Figure 6.1a), which harnesses the well-known thermodynamic reversibility of 
the His-to-Asp phospho-relay (84). This system contains equimolar quantities of a donor 
and an acceptor AgrC constructs, as well as a catalytic amount (less than 5% of the 
donor) of AgrA that shuttles the phosphoryl group between them (Figure 6.1a). 
Specifically, the phosphoryl donor should be a kinase-active AgrC-I construct that is 
phosphorylated to completion and purified from the auto-kinase reaction (so that it is 
nucleotide-free) and the acceptor is the subject GCN4-AgrC-I chimera. Assuming that the 
kinetics of the forward (AgrC to AgrA) and reverse (AgrA to AgrC) phospho-relays are 
much faster than the spontaneous dephosphorylation of AgrA (Figure 6.1a), this system is 
expected to reach a quasi-equilibrium state and the phosphorylation levels of the donor 
and the acceptor will approximate a thermodynamic equilibrium (Figure 6.1b, the 
equilibrium phase). Notably, the position of this equilibrium will reflect the 
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thermodynamic pHis stability on the subject chimera relative to the donor. These data, if 
successfully obtained, will reveal the dependence of the pHis stability on the 
conformation of the interdomain linkers. Meanwhile, phosphorylation of the catalyst, 
AgrA, is expected to reach a steady state shortly after the reaction begins (Figure 6.1b, 
the equilibration phase). The kinetic constant of the phospho-transfer from AgrA to the 
subject chimera will therefore be determined based on the reaction velocity and the 
steady-state phosphorylation level of AgrA. Kinetic parameters of the chimera-to-AgrA 
transfer will then be derived from the quasi-equilibrium position at the equilibrium phase. 
 Finally, it is important to point out that the faster kinetics of phospho-relays versus  
 
Figure 6.1 The three-component phospho-equilibration system 
(a) The reaction scheme. See text for details. (b) A simulated kinetic plot depicting 
phosphorylation levels of all three components as a function of time. The 
phosphorylation of two His residues in each HK dimer are treated as independent events. 
In panel (b), The simulation begins with an equimolar amount of the donor and the 
acceptor. The parameters are arbitrarily set such that the pHis in the acceptor is 0.3kB 
more stable than that in the donor. 
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AgrA dephosphorylation and the AgrA stability in solution are both critical to the 
predicted behavior of this phospho-equilibration system. Preliminary experiments should 
be performed to confirm these prerequisites.  
 
6.1.2 Introduction of scissoring motions to the AgrC-I interdomain linker helices  
Geometrically, modifying the distance between the N-termini of the interdomain linkers 
will cause the scissoring motions (Figure 6.2a, top panel). Thus, a conformation-activity  
 
Figure 6.2 Strategies to introduce scissoring movements to the helical interdomain 
linkers.  
(a) Color codes of AgrC-I intracellular structural elements (top panel) and the definition 
of the conformation-activity landscape about scissoring movements of the linkers (bottom 
panel). The conformation descriptor could be the inter-linker distance between any two 
positions close to the linker N-terminus. (b) The spacer-domain strategy: steric bulks of 
the spacer-domain dimers separate the N-termini of the TM domains by a series of 
distances, which is expected to translate into different scissoring conformations of the 
interdomain linkers. (c) The rigid-crosslinker strategy: the N-termini of the interdomain 
linkers are directly separated by a crosslinker acting as a molecular ruler.  
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landscape with such motions could be plotted in the form of auto-kinase activity versus a 
distance descriptor (Figure 6.2a, bottom panel). Modification of inter-linker distance can 
be achieved employing two strategies. The first strategy will rely on the use of 
homodimeric protein domains, herein referred to as spacer domains (Figure 6.2b). These 
domains are fused to the N-terminus of an AgrC-I construct to separate the interdomain 
linker pair by their steric bulk (Figure 6.2b). The fusion protein will also consist of the 
last TM domain (TM-VI) and the cytosolic portion of AgrC-I. TM-VI is included due to 
its critical role in the activation of the constitutive mutant, AgrC-IR238H, which 
presumably occurs through promoting α-helicity in the interdomain linker (see Figures 
4.1b and 4.7). Spacer domains are selected on two criteria: (i) that they homodimerize 
with mid-nM or higher affinity and (ii) that the C-termini in the homodimer structure are 
separated by a unique distance (Figure 6.2b). To chart the landscape, a series of spacer-
AgrC-I chimeras will be prepared recombinantly, reconstituted to nanodiscs for auto-
kinase analysis, and the distance between the interdomain linkers will be gauged through 
Förster resonance energy transfer (FRET)-based approaches. The second strategy will 
employ chemical crosslinkers, each containing two reactive groups separated by a 
conformationally rigid linker (Figure 6.2c, orange bars). These crosslinkers will be 
installed between the two subunits at an interdomain-linker position and are expected to 
separate the crosslinked positions by a defined distance (Figure 6.2c). For the same 
aforementioned reason, the AgrC-I construct used here will also include the TM-VI. 
Crosslinking may be achieved directly on the recombinantly prepared AgrC-I construct. 
Alternatively, the crosslinked protein could be prepared from the expressed chemical 
ligation (EPL) of two fragments: a synthetic N fragment containing the crosslinking site 
and a recombinant C-fragment. Crosslinkers will be installed to the N-fragment prior to 
the EPL reaction. Crosslinked AgrC-I dimers prepared in either way will be refolded and 
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incorporated to nanodiscs for autokinase analysis. The distance descriptor of scissoring 
will be calculated directly from the chemical structure of the crosslinkers.  
 
6.1.3 Is the interdomain linker pair an analog-to-digital converter? 
As was discussed in Section 4.5.1, the interdomain linker needs to transmit the 
conformational input imposed at its N-terminus to an output discernible for the HK 
domain. In the full-length AgrC-I bound to a certain ligand or a GCN4-AgrC-I chimera, 
the input conformation should be constant over time (Figure 6.3a). This input fits the 
definition of an analog signal in that it is a continuous function of time (see Figure 6.3c). 
By stark contrast, the HK-domain dimer to which the C-termini of the linker pair connect 
is believed to distribute between as few as two discrete conformational states (Figure 
6.3b), each exhibiting a distinct level of auto-kinase activity (150). This notion is in part 
based on the packing principle of four-helix bundles, in which gradual rotation or tilting 
of the participating α-helices is not permitted (182). The auto-kinase regulation would 
therefore depend on the redistribution of the HK-dimer ensemble between/among its 
possible conformations (Figure 6.3b). At the single-molecule level, however, the HK 
domain conformation is expected to be a discrete function of time—a property 
reminiscent of a digital signal (see Figure 6.3c). In this regard, the interdomain linker pair 
acts as an analog-to-digital converter. 
 
As a future endeavor of the Muir Lab, the above model will be further elucidated 
employing single-molecule FRET strategies (183), which have, to our best knowledge, 
not been applied to any RHK to study the conformational ensemble of its participant 
modules. The crystal structure of at least one GCN4-AgrC-I chimera is required to direct 
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the placement of fluorophores, and this work is currently in progress. To confirm our 
assumptions on the conformational states of the GCN4 coiled coil and the DHp four-helix 
bundle, the donor-acceptor pair will first be introduced to these modules and the FRET 
signal will be recorded as a function of time (Figure 6.3c). If the FRET data match our 
 
Figure 6.3 Putative conformational distributions of the two modules flanking the 
interdomain linker 
(a) The static conformation introduced by the rigid-body GCN4 module. (b) The 
conformation distribution discernible by the four-helix DHp module. In panels (a) and 
(b), conformation distribution of seven hypothetical signaling states, A through G, are 
shown. In (b), the output is arbitrarily distributed between two conformations 
corresponding to kinase-active and –inactive states, respectively. (c) Predicted FRET 
trace for two GCN4-AgrC-I chimeras, one kinase-active (top panels) and the other 
inactive (bottom panels), given the FRET pair is installed in the GCN4 (left plots) or 
DHp modules (right plots).  
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expectation on their respective analog and digital behaviors, a few more GCN4-AgrC-I 
chimeras exhibiting distinct auto-kinase activities will then be analyzed using the same 
sets of labeling sites (Figure 6.3c). Notably, the apparent kinase activity of a chimera 
should be equal to the average of all its major conformers weighed by their distribution 
probabilities. In this regard, the activity level of major DHp conformers could be solved 
employing simultaneous equations. If necessary, fluorophores may be moved to the N- or 
C- termini of the interdomain linkers to further elucidate the conformational states at 
these positions. Furthermore, once an input-output correlation of the wild-type linker is 
established, its native length or sequence could be altered through mutagenesis in order to 
investigate the influence of the perturbed factors on the linker’s signal transmission 
property.  
 
6.2 Degradation of the AgrD C-terminal cleavage fragment  
As was discussed in section 5.7.2, the ClpXP AAA+ protease machinery is a favorable 
candidate for the degradation of AgrDC. Several experiments are proposed to test this 
idea. Firstly, the AgrDC-Ub-Flag2 construct (section 5.6, Figure 5.11a) will be over-
produced in the wild-type S. aureus or the clpPS98A mutant that expresses a catalytically 
inactive version of ClpP (Figures 6.4a and b). Assuming that AgrDC-Ub-Flag2 is also 
actively degraded by ClpXP, a stronger accumulation of this AgrDC construct should be 
seen in the mutant. Consequently, an increase of AgrDFL-Ub-Flag2 and a decrease of AIP 
production should also be expected (Figure 6.4b). In addition, the recombinant S. aureus 
ClpXP is expected to degrade the AgrDC peptide in vitro (Figure 6.4c). If both 
experiments support the role of ClpXP, efforts will be made to understand the recognition 
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of AgrDC by ClpXP. Specifically, previous studies have shown that most conserved 
residues within AgrDC are not required for substrate recognition by AgrB (55). 
Intuitively, these positions may conserve for the interaction that targets AgrDC to ClpXP. 
In light of this idea, these positions will be Ala-scanned for mutations that confer 
resistance to ClpXP degradation (Figure 6.4d). Once such mutations are successfully 
identified, the role of the residue and its effect on the physical interaction with the AAA+ 
protease will be confirmed with immuno-precipitation (IP) studies (Figure 6.4e).  
 
Figure 6.4 Identification of AgrDC degradation proteases 
(a) The sequence and cartoon presentation of AgrD-IC. (b and c) Preliminary genetic (b) 
and in vitro biochemical (c) experiments to validate the AgrDC degradation activity of 
ClpXP. See text for details. (d and e) The alanine-scan mutagenesis approach in search of 
AgrDC residues essential for ClpXP targeting. The site of Ala-mutation is highlighted in 
black. (f and g) An unbiased strategy to enrich AgrDC-degrading proteases through 
fractionation. In (f), the fluorescein- and dabsyl- labels are indicated in green and gray, 
respectively. Any cleavage occurring between the two labeling sites is expected to 
generate green fluorescence.   
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While the ClpXP system is a strong candidate as an AgrDC protease, it is possible that 
other cellular proteases also contribute to the degradation of this peptide. Therefore, an 
unbiased, activity-guided fractionation strategy will be taken to identify them. 
Accordingly, we will use an AgrDC peptide modified with a fluorescein-dabsyl donor-
quencher FRET pair as the substrate to follow the biochemical enrichment of protease 
activity in S. aureus cell-lysate fractions (Figures 6.4f and g). Once the protease activity 
has been suitably enriched, the responsible protease will be identified using mass 
spectrometry.  
 
6.3 Detection of AIP thiolactones from other Firmicutes species 
The phylum Firmicutes includes not only causative agents of various infective diseases 
but also a vast diversity of mutualistic symbionts of human beings. As a prime example, 
metagenomic analysis of human gut revealed that Firmicutes comprises nearly 40% of 
the bacterial population, and abnormalities in the abundance of key genus or species have 
been related to disease states (184). Intriguingly, homologs of the agr system can be 
identified in several prominent Firmicutes constituents in the gut microbiota (Figure 
6.5a). Remarkably, a Eubacterium rectale strain possesses 7 AgrB homologs, each 
accompanied by a unique AgrD sequence sharing the prominent features required for 
AgrB recognition as well as the (thio)lactone formation (Figure 6.5a) (136). Inspired by 
the cross-group inhibitory effect of S. aureus AIPs, we hypothesize that the AIPs 
putatively produced by these AgrB-AgrD protease-substrate pairs are employed as 
weapons for the competition among Firmicutes species that shapes their ecological niche 
in the nutrient-limiting gut environment (185). Given the strong specificity of AgrC-AIP 
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recognition seen in S. aureus, the signaling of each putative AIP is expected to affect the 
fitness of a narrow spectrum of bacterial species. Thus, these AIPs may be harnessed as 
useful tools to probe the interaction among species or manipulate the composition of the 
microbiota in a phylotype-specific manner. 
 
Because all AIP sequences are embedded in the middle of their AgrD precursors, it is 
necessary to determine the site of both proteolysis events required for their maturation. 
While the AgrB cleavage site can be identified with high confidence based on sequence  
 
Figure 6.5 Identification of thiolactone AIPs from complex systems 
(a) Gap-free sequence alignment of AgrD proteins from a few major Firmicutes species 
in human gut. The predicted AgrB cleavage site is shown with a blank in all sequences 
and indicated with an arrow. Three loci that defines the AgrB cleavage site, two enriched 
of Pro and one bearing the (thio)lactone-forming Cys or Ser are highlighted in blue and 
red, respectively. Two positions conserved for hydrophobic residues on the N-terminal 
side of the AgrB cleavage site are shadowed in grey. (b) A chemical tagging strategy that 
isolates AIP thiolactones from complex systems for MS sequencing. See text for details.  
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similarity (136), delineating the N-terminal cleavage junction is challenging due to its 
variability—this site is not conserved even among the closely-related S. aureus subgroups 
(refer to Figure 1.6a). To determine the exact sequence of AIPs produced by Firmicutes 
species in a complex system, a chemical-tagging approach harnessing the reactivity of the 
conserved thiolactone is proposed (Figure 6.5b). Thiolactone AIPs from human stool 
samples (or other complex systems) will be linearized by a biotin-tagged hydroxylamine 
and enriched with a streptavidin-agarose matrix. Peptides released from streptavidin will 
be sequenced based on mass spectrometry. A library of all AgrD genes encoded by the 
microbiome will be generated using the Human Microbiome Project database 
(hmpdacc.org/) and the sequences obtained for all tagged peptides will be mapped back 
to their host AgrD genes. It is noteworthy that, upon the ring-opening tagging reaction, 
AIPs will lose their strong proteolytic resistance conferred by the thiolactone macrocycle. 
In this regard, the samples will be pre-treated with protease-inhibitor cocktails, and casein 
will be included in the tagging and enrichment processes as a protective measure. Any 
AIP detected and sequenced in the above process will be synthesized and re-introduced to 
the complex system to dissect its impact on the fitness of its host species as well as other 
symbionts.  
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Chapter Seven: Methods 
In this dissertation, we include the reconstitution of two disparate biochemical systems, 
namely the AgrC-AgrA TCS that mediates phospho-relay, and the AgrB peptidase that 
carries out proteolysis on AgrD. Nonetheless, protein production and reconstitution of 
these system shares considerable similarity, as the key component in both systems is 
integral membrane proteins. As a consequence, the molecular cloning and recombinant 
protein production methods for all four Agr proteins are described combined, while the 
biochemical assays on each system are documented separately. 
 
7.1 Materials and Equipment 
7.1.1 General Materials 
All buffering salts, the LB broth, isopropyl-β-D-thiogalactopyranoside (IPTG), 1, 4-
dithiothreitol (DTT), tris-(2-carboxyethyl) phosphine hydrochloride (TCEP), 
iodoacetamide, Coomassie brilliant blue, phenylmethylsulfonyl fluoride (PMSF) and 
nitrocellulous membranes were purchased from Fisher Scientific (Pittsburgh, PA). All 
medium ingredients for S. aureus cultures were from Difco Biosciences, Inc. (San Diego, 
CA). All antibiotics, non-radioactive nucleotides for AgrC-I-related assays, N, N-
dimethylformamide (DMF), dimethylsulfoxide (DMSO), 2,2,2-trifluoroethanol (TFE), N, 
N-diisopropylethylamine (DIEA), piperidine, triisopropylsilane (TIS), β-mercaptoethanol 
(BME), N-Acetylcysteamine (NAC), lysostaphin, gluaraldehyde solution, guanidinium 
chloride (GuHCl) sodium 2-sulfanylethanesulfonate (MESNa), bovine serum albumin 
(BSA), and Eastman KODAK BioMax Film were purchased from Sigma-Aldrich (St. 
Louis, MO). All protected amino acids, coupling reagents and Rink-amide MBHA were 
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purchased from Novabiochem. [γ-32P]-Adenosine triphosphate and Ultima Gold Cocktail 
was from PerkinElmer (Waltham, MA). All lipids were purchased from Avanti Polar 
lipids (Alabaster, AL) and all detergents were obtained from Anatrace (Maumee, OH). 
Trifluoroacetic acid (TFA) was from Halocarbon (North Augusta, SC). Anhydrous HF 
was from Matheson. Nickel-nitrilotriacetic acid (Ni-NTA) resin and KOD polymerase 
was from Novagen (Gibbstown, NJ). Talon cobalt resin was from Clontech (Mountain 
View, CA). Glutathione Sepharose 4 Fast Flow (GS4FF) resin was from GE Healthcare 
(Piscataway, NJ). The QuikChange Site-Directed Mutagenesis kit was from Agilent (La 
Jolla, CA). tC2 Sep-Pak cartridges were from Waters (Milford, MA). T4 DNA ligase, 
restriction enzymes and the Phusion High-Fidelity PCR kit were from New England 
Biolabs (Ipswich, MA). DNA purification kits (QIAprep spin minikit, QIAquick gel 
extraction kit, QIAquick PCR purification kit) were from Qiagen (Valencia, CA). Sub-
cloning efficient DH5α competent cells and One Shot BL21(DE3) chemically competent 
E. coli were purchased from Invitrogen (Carlsbad, CA) and used to generate “in-house” 
high-competency cell lines. Oligonucleotides were purchased from Integrated DNA 
Technologies (Coralville, IA). Codon-optimized cDNAs were generated synthetically and 
purchased from GENEWIZ (South Plainfield, NJ). Plasmid-sequencing services were 
ordered from GENEWIZ. DNA purification kits (QIAprep spin minikit, QIAquick gel 
extraction kit, QIAquick PCR purification kit) were from Qiagen (Valencia, CA). All 
denaturing gels, PVDF membrane (0.2 µm), Bio-Beads SM2 Adsorbent and goat anti-
rabbit monoclonal antibody were from Bio-Rad (Hercules, CA). IRDye 800CW goat 
anti-rabbit IgG was from LI-COR Biotechnology (Lincoln, NE). The pan-specific 
antibody recognizing pHis (pHis) was purified from the anti-pHis polyclonal antiserum. 
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Some synthetic AIPs and their analogs were obtained from the Muir Lab storage freezers.  
 
7.1.2 General Equipments 
Solid-phase peptide synthesis (SPPS) was carried on a Liberty Synthesizer (CEM, 
Matthews, NC). Size exclusion chromatography was carried out on an ÄKTA FPLC 
system from GE Healthcare using a Superdex200 10/300 column or a Superose6 10/30 
HR column. For all runs, proteins were eluted over one column volume of buffer (flow 
rate: 0.5 mL/min). For SEC-MALS experiments, the ÄKTA FPLC system was connected 
in tandem to a DAWN HELEOS-II multi-angle light scattering instrument and OptiLab 
TrEX differential refractometer. Ion-exchange chromatography was performed on the 
same FPLC instrument system using a Hiprep Q FF 16/10 column. RP-HPLC was 
performed on Hewlett-Packard 1100 and 1200 series instruments equipped with an 
analytical C18 or C4 Vydac column (5µm, 4.6 x 150 mm) at a flow rate of 1 mL/min or a 
semiprep C18 or C4 Vydac column (5µm, 10 x 250 mm) at a flow rate of 4 mL/min. All 
runs used 0.1 % TFA (trifluoroacetic acid) in water (solvent A) and 90 % acetonitrile in 
water with 0.1% TFA (solvent B). Electrospray ionization (ESI) and matrix-assisted laser 
desorption ionization (MALDI) mass spectrometric analysis was performed on a Bruker 
Daltonics MicrOTOF-Q II and a PerSeptive Voyager DE STR MALDI-TOF 
spectrometer, respectively. Fluorescent anisotropy was measured using a fluorolog®-3 
Model FL3-11 fluorimeter (Horiba Jobin Yvon). Coomassie stained gels and dot blots 
were imaged on a LI-COR Odyssey Infrared Imager. In-gel fluorescence, 
chemoluminescence and autoradiogram were detecteed using the GE ImageQuant LAS 
4000. Scintillation counting was carried out on a Perkin Elmer 2450 microplate counter. 
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Concentration of DNA, peptide and protein samples was measured on a nanodrop2000 
intrument from Thermo scientific or a UV-vis 8453 spectrophotometer from Agilent.  
 
7.2 Molecular cloning 
7.2.1 cDNA sequence of Agr proteins 
Amino acid sequences of full-length AgrB-I (1-189), AgrD-I (1-46), AgrB-II (1-187) and 
AgrD-II (1-47), AgrC-I (1-430), AgrC-II (1-427), AgrC-III (1-430) and AgrA (1-238) 
were obtained from the NCBI protein database (Refseq/Genebank accession: 
YP_001332977.1, YP_001332978.1, NP_372560.1, NP_372561.1, YP_001332979.1, 
EFT84677.1, BAB95827.1 and YP_001332980.1). The cDNA sequences were back-
translated from the amino acid sequences with optimized codons according to the default 
E. coli codon usage table (186). cDNA was purchased from Genewiz. The cDNA were 
received in pUC57 vectors.  
 
7.2.2 Expression plasmids for AgrC and AgrA 
Coding sequences corresponding to the desired construct of AgrC were amplified with 
KOD polymerase using primers harboring appropriate restriction sites and cloned 
between NdeI and XhoI sites of a pET24b or a pET15b vector, respectively. Similarly, 
the coding sequence of full-length AgrA was cloned into a pACYCDuet vector between 
BamHI and XhoI restriction sites. Site-directed mutagenesis of the AgrC-I construct was 
performed using a QuikChange Site-Directed Mutagenesis kit using standard protocols. 
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In all GCN4-AgrC-I chimeras, the N-terminal portion corresponds to residues 250-274 of 
the Gcn4p protein in Saccharomyces cerevisiae (Refseq accession: NP_010907), to 
which we refer as GCN41-25. The coding sequence of GCN41-25 was fused immediately 
upstream to the appropriate AgrC-I coding sequence employing the overlap-extension 
strategy and inserted between the NdeI and XhoI sites of the pET15b vector.   
 
7.2.3 Expression plasmids for AgrB and AgrD constructs 
AgrB-I-His6 and AgrB-II-His6 
Coding sequences of full-length AgrB-I or AgrB-II were cloned between NdeI and XhoI 
sites of a pET24b vector (Novagen).  
 
Non-tagged AgrD-I and AgrD-II 
A 24-nucleotide (nt) sequence encoding seven histidines and a stop codon was inserted 
in-frame immediately downstream to the coding sequence of the Mxe GyrA intein in the 
pTXB1 vector (NEB) to generate pTXB1-His7. Coding sequences of full-length AgrD-I 
or AgrD-II were cloned between NdeI and SapI sites in pTXB1-His7.  
 
FlagHis6-AgrD-I and AgrD-II 
FlagHis6-AgrD-I and FlagHis6-AgrD-II was fused to GST within an intervening sequence 
for thrombin (LDKLVPRGSS) or PreScission protease (LDLEVLFQGPGS) recognition, 
respectively. Coding sequences of these two constructs was inserted between NdeI and 
XhoI sites in pET24b, with a stop codon immediately downstream to the XhoI site. 
Coding sequence of GST was from pGEX4T1 (GE Healthcare). 
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FlagHis6-AgrD-I(1-32)-thiolactone  
The coding sequence of FlagHis6-AgrD-I(1-32) was inserted into the pTXB1 vector. The 
amino acid sequence of the affinity tag is MDYKDDDDKHHHHHHGG.  
 
Plasmids for wild-type or scrambled AgrD-IC-Ub-Flag2 production in S. aureus  
Production of AgrD-IC-Ub-Flag2 was achieved by co-expression of two fusion proteins, 
Sumo-AgrD-IC-Ub-Flag2 and His6-Ulp1 from the pCN51 shuttle plasmid (187). The 
insert sequence begins with the strong, constitutive pblaZC promoter (50), followed by 
coding sequences of AgrD-IC-Ub-Flag2 and His6-Ulp1, both preceded by a consensus 
Shine-Dalgarno (SD) sequence and a short spacer. This insert sequence was synthesized 
by Genewiz and cloned between PstI and EcoRI sites of the vector. In a control plasmid, 
coding sequence of AgrD-I33-46 (DEVEVPKELTQLHE) was substituted with that of a 
scrambled peptide, TLEVKEVQELPEHD. The above substitution and insertion were 
both achieved using an overlap extension PCR technique.  
 
Site-directed mutagenesis 
Expression plasmids bearing point mutations were generated from the parental, wild-type 
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7.3 Recombinant protein production and reconstitution 
7.3.1 Soluble proteins 
With an exception of AgrA, all soluble proteins in this dissertation were prepared as 
follows. E. coli BL21(DE3) cells transformed with the appropriate expression plasmid 
were grown at 37 °C in one liter of LB medium containing selection antibiotics at 
appropriate concentrations (100 µg/mL ampicillin, 50 µg/mL kanamycin or 35 µg/mL 
chloramphenicol). When the OD600 reached 0.6, the medium was cooled down to 22°C 
and overnight expression was induced by addition of 0.5 mM IPTG. Cells were harvested 
at 6000 G for 20 min and the cell pellets were resuspended in 20 mL of lysis buffer (20 
mM Tris, 100 mM NaCl, 1mM TECP and 1mM PMSF, pH 8.0). Cells were lysed by four 
passages through a French-press homogenizer. After centrifugation at 30000 G for 
30min, supernatant from the cell lysate was mixed with 4 mL of Ni-NTA resin. After 
incubation at 4 °C for 60 minutes, the resin was repacked in a 25-mL Bio-Rad disposable 
plastic column. The flow-through was discarded and the column was washed with 5 
column volumes (CVs) of wash buffer 1 (20 mM Tris, 500 mM NaCl, 1mM TECP and 
15 mM imidazole, pH 8.0) and 10 CVs of wash buffer 2 (20 mM Tris, 100 mM NaCl, 
1mM TECP and 25 mM imidazole, pH 8.0). Bound protein was eluted with 1.5 CVs of 
elution buffer (wash buffer 2 with 300 mM imidazole). The elution containing up to 10 
mg protein was concentrated to 1mL and further purified on Superdex200 size-exclusion 
chromatography, from which the desired peak fractions were collected. All GCN4-AgrC-
I chimera proteins were treated with thrombin for His6-tag removal prior to the size-
exclusion chromatography step. For purification of AgrA, modification to the above 
	   144	  
protocol involved a lowered expression temperature (at 16 °C) and inclusion of glycerol 
at 20% (v/v) in all buffers. 
 
7.3.2 Integral membrane proteins 
For membrane-bound AgrB and AgrC constructs, E. coli C43(DE3) cells transformed 
with the appropriate expression plasmids were grown in LB broth to an OD600 of 1.0 and 
then induced at 22oC with 0.5 mM IPTG overnight expression.  Cells collected from one 
liter of culture were resuspended in 18  mL lysis buffer and disrupted in four passages 
through a French-press homogenizer. Cell-wall debris was spun down at 15000 G for 
10  min and removed. Cell-membrane vesicles were then pelleted by ultracentrifugation at 
200,000 G for 1  h. The membrane fraction was extracted using 5mL of buffer containing 
20  mM Tris-HCl pH 8.0, 100  mM NaCl, 5 mM BME and the detergent of choice for 3  h 
at 4  °C (see below). Another ultracentrifugation step at 100,000 G for 20  min was 
undertaken to clear the membrane extract.  
 
Membrane fractions containing recombinant AgrC proteins were extracted with a buffer 
containing 2% (w/v) Fos-choline-12 (FC-12). The cleared extract was subjected to Ni-
NTA affinity chromatography as described above for soluble proteins, and the elution 
containing the target protein were further purified over a Superdex200 size-exclusion 
column. 0.05% (w/v) Fos-choline-14 (FC-14) was included in all buffers used in these 
chromatographic steps. 
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Extraction of AgrB out of E. coli membrane was performed with a buffer containing 2% 
(w/v) n-dodecyl-β-D-maltopyranoside (DDM). The cleared extract was subjected to 
Talon-cobalt affinity chromatography. After the loading and flow-through processes, the 
column was washed with 20 CVs of wash buffer (20 mM sodium phosphate, 100 mM 
NaCl, 5mM BME, 0.1% (w/v) FC-12 and 25 mM imidazole, pH 7.5). Bound protein was 
eluted with 3 CVs of elution buffer (wash buffer with 500 mM imidazole). The elution 
was concentrated to 1 mL and further purified on Superdex200 size-exclusion 
chromatography with running buffer (20 mM phosphate, 100 mM NaCl, 0.14% (w/v) 
FC-12, 1 mM TECP, pH 7.0), from which the desired peak fractions were collected. 
 
7.3.3 AgrD constructs 
Figure 7.1 shows a schematic presentation of the expression construct and the proteolytic 
processing site for all recombinant AgrD constructs. In general, these constructs are 
either soluble or directed to inclusion bodies when expressed in E. coli, and are affinity-
purified under native or denatured conditions accordingly. After purification and 
refolding (if necessary), DDM is included in the buffers for stabilization purposes and 
these AgrD constructs, either before or after the autocatalytic or proteolytic processing, 
are handled similarly to integral membrane proteins.  
 
Non-tagged AgrD-I and AgrD-II  
Both constructs were expressed as C-terminal GyrA-His7 fusion proteins in E. coli 
BL21(DE3) cells. Transformed cells harboring the appropriate expression vector were 
grown at 37oC to an OD600 = 0.6 and then induced by addition of 1.0mM IPTG. The 
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culture was shaken at 37oC for 4 additional hours post-induction and cells were collected 
through centrifugation. Cells were resuspended in PBS (20 mM Phosphate pH=7.5, 100 
mM NaCl). PMSF (100 mM stock in ethanol) was added to the cell suspension 
immediately prior to lysis at a final concentration of 1 mM. Cells were disrupted by four 
passages through a French-Press. The lysate was centrifuged at 30000 G for 1hr and the 
pellet resuspended in a buffer containing 7.5 M GuHCl, 50 mM phosphate buffer, pH = 
7.5 and 2 mM TCEP. The suspension was homogenized, gently shaken at 4oC for 1hr and 
then spun at 30000 G for 1hr. The supernatant was loaded to a column packed with Ni-
NTA resin (Qiagen), and the resin was washed with buffer containing 25 mM imidazole 
and 6 M GuHCl and eluted using a buffer containing 300 mM imidazole, 7.2 M urea and 
0.05% (w/v) DDM. The eluted protein was immediately chilled in an ice-water bath and 
refolded through dialysis against a series of phosphate buffers with decreasing urea  
 
Figure 7.1 Preparation of recombinant AgrD constructs.  
See text for detail protocols. GyrA, the Mxe GyrA intein; GST, glutathione S-transferase; 
DTT, dithiothreitol; MESNa, 2-mercaptoethanesulfonate (MESNa).  
 
	   147	  
concentrations at 4oC. Upon dialysis, refolded AgrD-intein-His7 proteins were cleaved by 
treatment with 50 mM DTT and 5 mM TCEP in the presence of 0.1% (w/v) DDM under 
an argon atmosphere at RT for 12 hrs. Free intein released from DTT treatment as well as 
uncleaved fusion protein was removed in a reverse-Ni-NTA affinity process. To the 
combined flow-through and wash fractions (containing predominantly AgrD-DTT esters) 
was then added 0.1% (v/v) FC-12. Residual urea in this solution was removed through 
two concentration-dilution cycles. In each cycle, the solution was concentrated by ten 
folds and and then diluted back to the original volume using a buffer containing 50 mM 
phosphate pH=7.5, 50 mM DTT and 0.07% (v/v) FC-12. The solution after the second 
dilution was concentrated to <5mL, to which GuHCl was added to a give a final 
concentration of 6 M. EDTA was added at 10 mM and NaOH was used to basify the 
solution to pH=9.5. The solution was incubated under argon atmosphere at 37oC for 4hrs 
for complete saponification of the DTT ester, acidified to pH < 2 using neat TFA, 
filtered, and purified over a semi-prep C4 RP-HPLC column.  
 
FlagHis6-AgrD-I and FlagHis6-AgrD-II  
Both constructs were expressed as C-terminal GST fusion proteins in E. coli BL21(DE3) 
host cells. The expression culture was grown at 37oC to an OD600 = 0.6 and then was 
cooled down to 16°C prior to induction by the addition of 0.4 mM IPTG. After overnight 
incubation, cells were isolated from the culture medium, resuspended in lysis buffer (20 
mM sodium phosphate, 100 mM NaCl, pH 7.5), and lysed by four passages through a 
French-press homogenizer. After centrifugation at 30000 G for 30min, the cleared lysate 
was supplemented with 0.1% (v/v) DDM and then incubated with GS4FF resin in a 
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plastic column at 4 °C for 60 minutes. The lysate was then drained, and the resin was 
washed by 20 CVs of lysis buffer, resuspended in 2 CVs of lysis buffer, and treated with 
10 units of thrombin for AgrD-I or 0.2 mg/mL GST-tagged HRV3C protease for AgrD-II 
at room temperature with gentle shaking for 3hrs(188). The released AgrD product was 
collected and allowed to flow through a 4-mL bed packed with Ni-NTA resin. The Ni-
NTA bed was washed with 10 CVs of lysis buffer with 15 mM imidazole, 10 CVs of 6 M 
GuHCl buffered by Na-phosphate at pH = 7.5 and eluted with 3 CV of elution buffer (6 
M GuHCl, 0.2 M acetic acid and 5 mM TCEP). Elution was purified over a semiprep-
scale C18 RP-HPLC column. 
 
FlagHis6-AgrD-I(1-32)-thiolactone and its tri-Ala (F30A/I31A/M32A) mutant 
Both constructs were expressed as C-terminal GyrA-CBD fusion proteins in E. coli 
BL21(DE3) host cells. Protein expression and cell lysis procedures were identical to that 
used for FlagHis6-AgrD preparation. Cleared cell lysate was supplemented with 0.05% 
(w/v) DDM and subject to Ni-NTA purification. Upon flowing the lysate through the Ni-
NTA column, the bed was washed with 5 CVs of wash buffer 1 (20 mM phosphate, 500 
mM NaCl, 1 mM TECP 15 mM imidazole and 0.05% (w/v) DDM, pH 7.5) and 10 CVs 
of wash buffer 2 (20 mM phosphate, 100 mM NaCl, 1 mM TECP 25 mM imidazole and 
0.05% (w/v) DDM, pH 7.5). Bound protein was eluted with 4 CVs of elution buffer 
(wash buffer 2 with 300 mM imidazole). The elution was dialyzed against a buffer 
containing (20 mM phosphate, 1 mM TECP and 0.01% (w/v) DDM, pH 7.5), and then 
cleaved after the addition of 100 mM MESNa and 5 mM TCEP. After an overnight 
incubation, a Ni-NTA affinity step was employed to remove the GyrA-CBD generated 
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during cleavage. Upon washing with MESNa-free buffers, the bound FlagHis6-AgrD-I(1-
32)-MESNa thioester spontaneously cyclized into the thiolactone. All His-tag-containing 
constructs, primarily the thiolactone and the intact fusion protein, were eluted in 100 mM 
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)-Na, 50mM EDTA, 1mM 
TECP and  0.1% SDS, pH = 7.0. Concentrated elution was submitted, in 1-mL aliquots, 
to Superdex200 SEC purification with running buffer (20 mM 2-(N-
morpholino)ethanesulfonic acid (MES)-Na, 100 mM NaCl, 0.1%SDS, 5mM L-
methionine, pH = 6.1). Fractions free from intact fusion protein were pooled and dialyzed 
extensively against a buffer containing 0.1% (v/v) TFA and 5mM L-methionine until 
precipitate emerged. GuHCl was added to a final molarity of 6 M, and the solution was 
filtered and purified on a semiprep-scale C18 RP-HPLC column. 
 
FlagHis6-AgrD-I(1-32)-Cys and FlagHis6-AgrD-I(1-32)-NAC 
FlagHis6-AgrD-I(1-32)-thioactone (1 mg) was dissolved in 1mL 7.5 M GuHCl buffered 
at pH = 7.5 with sodium phosphate. To the solution was added 50 µL 1 M TCEP together 
with 100 µL 1 M L-cysteine or N-acetylcysteamine (NAC). The reaction reached 
maximal conversion after 1-hr incubation at RT as analyzed by analytical RP-HPLC (not 
shown). The reaction was then purified using semi-prep C18 RP-HPLC.  
 
7.3.4 Nanodisc reconstitution and SEC-MALS analysis 
The membrane scaffold protein, MSP1E3D1, was prepared as reported (139). The His7-
tag on the recombinant protein was removed through TEV-protease digestion followed 
by anion exchange chromatography with a Hiprep Q FF 16/10 column (GE Healthcare). 
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DLPC (1,2-dilauryl-sn-glycero-3-phosphocholine), DLPG (1,2-dilauryl-sn-glycero-3-
phospho-(1'-rac-glycerol)), DMPC, DMPG, and DMPS, POPC and POPG were dried 
from organic solvents as described on the Avanti Polar Lipids website and prepared in 
50mM-stocks solubilized in a buffer containing 20 mM Tris pH = 8.0, 100 mM NaCl, 5 
mM TCEP and 150 mM sodium cholate. 
 
Nanodiscs were assembled according to the general considerations described previously 
(139). Lipid stocks were mixed at appropriate ratios to match the desired composition. 
For empty nanodisc reconstitution employing MSP1E3D1 as the scaffold, the MSP-to-
lipid ratio is 1:200 for dilauryl (DL)-phospholipids, 1:150 for dimyristoyl (DM)-
phospholipids and 1:120 for 1-palmitoyl-2-oleoyl (PO)-phospholipids. Each TM domain 
to be incorporated would displace six DL-phospholipids, five DM-phospholipids or four 
PO-phospholipids. Full-length AgrC and AgrB are considered to possess six and five TM 
domains, respectively. For instance, a typical reconstitution of full-length AgrC-I dimers 
entails two nanodiscs being formed for the incorporation of each copy of AgrC-I dimer. 
To calculate the scaffold-dimer-lipid molar ratio in the pre-assembly mixture, we first 
found that two empty nanodiscs would contain four copies of MSP1E3D1 and 600 DM-
phospholipids. The incorporation of a 12-TM AgrC dimer is expected to display 60 lipid 
molecules. Therefore, the usage of MSPE3D1, AgrC-I dimer and DM-phospholipids 
should follow the molar ratio of 4:1:540. 
 
Upon detergent removal using SM-2 Adsorbent Bio-Beads (Bio-Rad), the post-assembly 
mixture was subjected to Ni-NTA affinity purification. Elutions containing AgrC-I-
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incorporated nanodiscs were resolved on a Superose6 column using the nanodisc buffer 
(20 mM HEPES, 100 mM NaCl, 1 mM TCEP, pH 7.0) from which peak fractions were 
pooled as product. 
 
For SEC-MALS analysis, nanodisc samples were resolved on a Superose6 size-exclusion 
column equilibrated with the nanodisc buffer. The eluate was directed to a DAWN 
HELEOS-II multi-angle light scattering instrument in tandem with OptiLab TrEX 
differential refractometer for real-time analysis. Flow-cells of all instruments were set at 
4 oC. Fitting was accomplished using the “protein conjugate” method in the ASTRA 6.0 
software package, which calculates both the averaged particle size and the protein content 
utilizing UV, MALS and dRI signals simultaneously (159). Input for refractive index 
increment, dn / dc, was 0.185 mL / g for protein and 0.135 mL / g for the modifier 
(treating lipids as the modifier). Input for extinction coefficient of protein was 0.898 for 
empty discs (corresponding to MSP1E3D1), 0.806 in an equimolar mixture of 
MSP1E3D1 and AgrC-I for AgrC-I discs, and 0.840 as in an equimolar mixture of 
MSP1E3D1 and AgrB-II for AgrB-II discs, all in the unit of mL / (mg · cm). 
 
7.3.5 AgrB proteoliposome assembly 
A 3:1 mixture of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG 
(1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1’-rac-glycerol)) was dried from organic 
solvents and then hydrated with PBST buffer containing 20 mM sodium phosphate, 
100mM NaCl and 2mM TCEP pH 7.5. The liposome suspension (1.0% w/v) was stored 
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at -20 oC, and thawed and ultrasound-treated in a sonicator water bath immediately prior 
to use.   
 
For proteoliposome reconstitution, liposome suspension was mixed with an equal volume 
of 3.0% (w/v) 7-cyclohexylheptyl-β-D-maltopyranoside (Cymal-7) in PBST buffer and 
incubated at RT until the mixture turns clear. A typical reconstitution reaction was started 
by mixing 400 µL Cyaml-7-solubilized lipid with 200 µL of a 15 µM solution of SEC-
purified AgrB-I-His6. The mixture was incubated with 250 mg of Bio-Beads SM2 at RT 
with gentle shaking for 1hr. The cloudy suspension was withdrawn from Bio-Beads and 
the proteolipsomes were spun down at 17000 G at 4oC for 30min. Upon removal of 
supernatant, the proteoliposomes were washed with 2 x 200 µL PBST buffer, re-
suspended in 450µL PBST buffer and gently sonicated before being used for biochemical 
assays. 
 
7.4 Characterization of the AgrC-AgrA TCS 
7.4.1 Auto-kinase and trans-kinase assays 
Detection of phosphorylated AgrC-I or AgrC-I variants: general considerations 
In this work, we employed a few different readouts to detect and quantify the 
phosphorylation levels of AgrC-I or AgrC-I variants. Anti-pHis dot blot was the method 
of choice due to the high throughput of analysis (137). Therefore, most kinetic studies for 
the forward and reverse auto-phosphorylation of AgrC-I were performed based on dot-
blot assays. We also employed anti-pHis western blotting in fixed time-point assays to 
identify the phosphorylated species based on band positions. For some experiments we 
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employed a more classic radiolabeling assay using [γ-32P]-ATP as the phosphoryl donor 
and employing autoradiograghy as the readout. This was found to be especially useful 
when comparing the activity of different AgrC-I constructs and GCN4-AgrC-I chimeras 
due to concerns that immunodetection assays might be unduly influenced by subtle 
differences in the transfer or detection properties of each construct.  
 
Auto-phosphorylation of AgrC-I  
All auto-kinase reactions were performed in reaction buffer containing 50 mM Tris-HCl, 
15 mM HEPES-Na pH = 7.8, 100 mM NaCl, 5 mM MgCl2 and 1 mM TCEP. AIPs were 
included as indicated (from DMSO stocks), and DMSO was added to make the overall 
DMSO concentration up to 1% (v/v). Typically, an auto-kinase reaction contained 20 µM 
[γ-32P]-ATP (1Ci/mmol) or 1 mM regular ATP or GTP and 1.4 µM dimeric receptor 
(full-length AgrC-I variants embedded in nanodiscs, or GCN4-AgrC-I chimeras) unless 
otherwise indicated. The reaction was incubated at 37 °C. In fixed time point assays, 
reactions were performed for 40min with [γ-32P]-ATP or 3min with regular nucleotides. 
For time courses, samples were withdrawn from the reaction at indicated time points and 
quenched with gel loading buffer. All samples were processed, according to the specified 
method of detection, as described in the following sections. 
 
Phospho-relay from AgrC-I to AgrA 
AgrC-I discs were phosphorylated in the absence of AIP with 50 µM [γ-32P]-ATP at 37oC 
for 90 min, and subsequently exchanged into an ATP-free reaction buffer (50 mM Tris-
HCl, 15 mM HEPES-Na pH = 7.8, 100 mM NaCl and 1 mM TCEP) using Bio-Rad 
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Micro Bio-Spin™ P-6 Gel Columns. This step gave rise to a stock containing 1.2 µM of 
AgrC-I disc with 0.25 µM of pHis as quantified through scintillation counting. The stock 
was equally divided into three portions, to which was added either AIP stocks or DMSO 
at equal volume. These pre-phosphorylated AgrC-I samples were mixed 1:1 with AgrA 
protein (3.6 µM stock in 50 mM Tris-HCl pH 8.0, 100 mM NaCl , 5 mM TCEP in 20% 
(v/v) glycerol) to initiate the phospho-relay. The AgrA buffer was used to mix with 
AgrC-I samples in mock reactions. All reactions were incubated at 37oC from which 
samples were withdrawn at indicated time points and quantified through autoradiography. 
 
Phospho-relay from GC214 to AgrA and AgrA dephosphorylation 
GC214 (10 µM dimer) was treated with 100 µM [γ-32P]-ATP in 20-µL volume at 37oC 
for 90 min, and subsequently exchanged into an ATP-free reaction buffer. The product 
was diluted to 180 µL for a stock containing 0.40 µM GC214 dimer (RP-HPLC) with 
0.73 µM of pHis (scintillation counting). To initiate the reaction, a mixture containing 
AgrA, AgrC-I discs and/or AIP peptide were pre-incubated at 37oC for 2min, to which 
32P-labeled GC214 was then added. Final concentration of each component (if present) 
was 0.1 µM for GC214 dimer, 2.0 µM for AgrA, 2.0 µM for AgrC-I discs and 10 µM for 
AIP-I or AIP-II. All reactions were incubated at 37oC from which samples were removed 
at indicated time points and quantified through autoradiography.  
 
Reverse Auto-phosphorylation of AgrC-I 
AgrC-I discs were phosphorylated in the absence of AIP with 2.0 mM of regular ATP at 
37oC for 60min and subsequently exchanged into an ATP-free reaction buffer (50 mM 
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Tris-HCl, 15 mM HEPES-Na pH = 7.8, 100 mM NaCl and 1 mM TCEP) using a 
Superose6 size-exclusion column (Figure 3.10c). This step gave rise to a stock containing 
4.0 µM of AgrC-I disc and 4.2 µM of pHis as quantified relative to an intermediate 
standard standardized with scintillation counting. The pHis level of this stock was stable 
at 4oC over 2 months (data not shown). The stock was diluted 4 fold in reaction buffer in 
the presence of varying levels of ADP (0-2 mM), MgCl2 (5mM) and either AIP-I (10 µM 
from a DMSO stock) or DMSO (1% v/v). The reaction was incubated at 37oC from 




Samples from each reaction were spotted on nitrocellulose membranes in triplicate. 
Samples from a mock reaction (in the absence of AgrC-I) under the same conditions were 
also spotted and used as the background. Each spot was 5 µL in volume. The membranes 
were air-dried and then washed 3x5min with TBST buffer (50mM Tris pH 8.5, 150 mM 
NaCl and 0.1% (v/v) Tween-20) and air-dried again. Each piece of membrane was 
subsequently transferred to a 4mL counting vial containing 3.5mL of Ultima Gold™ 
Cocktails (Perkin Elmer) and luminescence from the vial was quantified in a scintillation 
counter. For quantification purposes, an aliquot of the [γ-32P]-ATP stock used in the 
reactions was diluted into a series of samples of known concentration. These samples 
were spotted (5 µL) in duplicate on nitrocellulose membranes and counted after drying 
without TBST-wash. Correlations between count numbers (in count per minute, CPM) 
and concentrations of [γ-32P]-ATP dilutions were plotted to give a working curve which 
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was used to calculate the absolute pHis concentration in the background corrected 
experimental samples.  
 
Autoradiography 
For detection using autoradiography, samples from auto-kinase or phospho-relay 
reactions were mixed with 4x SDS sample buffer (1x concentration: 50 mM Tris-HCl pH 
8.0, 2 % (w/v) SDS, 10 (v/v) % glycerol, 10 mM dithiothreitol and 0.01 (w/v) % 
bromophenol blue) and immediately resolved on a 15% Tris-HCl SDS-polyacrylamide 
gel. The gel was then dried, and incubated with Eastman Kodak BIOMAX MR film at 
RT for an appropriate amount of time.  
 
For quantification purposes, a highly phosphorylated AgrC-I stock was diluted into a 
series of internal standards. pHis concentrations of these standards were assigned in 
arbitrary units based on the dilution process. These standards were resolved on a 
denaturing gel and exposed, along with gels bearing all experimental samples, to the 
same piece of film. Importantly, loading volumes of all experimental and standard 
samples was identical. The normalized, background-subtracted intensity of all bands on 
the autoradiogram was calculated using the ImageQuant TL program, and used to 
generate a working curve from which pHis levels (arbitrary units) of experimental 
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Anti-pHis western blot 
As in the autoradiography protocol, samples from auto-kinase reactions were mixed with 
4x SDS sample buffer and resolved on a 15% Tris-HCl SDS-polyacrylamide gel. Then, 
anti-pHis western blot was performed as reported (137). Briefly, the resolved proteins 
were electroblotted onto a PVDF membrane at 100 V for 1hr. The membrane was 
blocked with 3% BSA in TBST for 30min and incubated with anti-pHis antibody diluted 
1:500 in TBST with 3% BSA for 1 hr at RT. After washing with TBST (3 x 5 min), the 
membrane was then incubated with goat anti-rabbit IgG-HRP conjugate (diluted 1:5000 
in wash buffer with 3% BSA) for 1 hr at RT, followed by washing with TBST (3 x 5 
min). The membrane was incubated with ECL chemiluminescence solution for 1 min at 
RT and chemiluminescence from the membrane was imaged using ImageQuant LAS 
4000. The membrane was washed with water and stained with Coomassie blue for the 
visualization of loading control. 
 
Anti-pHis dot blot 
Nitrocellulose membrane (8cm x 8cm) was gridded 10 x 10 and heated on a 50oC heat 
block prior to use. 2-µL samples from forward or reverse auto-kinase reactions were 
directly spotted at the center of each small square. Internal standards of known absolute 
or normalized pHis levels were also spotted (2 µL) in duplicate on the same membrane. 
The membrane was allowed to dry, cooled to RT and blocked with 3% BSA in TBST for 
30min. Anti-pHis antibody diluted 1:500 in TBST with 3% BSA was added for 1 hr at 
RT. After washing with TBST (3 x 5 min) the membrane was incubated with IRDye 
800CW goat anti-rabbit IgG (diluted 1:15000 in wash buffer with 3% BSA) for 1 hr at 
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RT, followed by washing with TBST (3 x 5 min). The dot blot was imaged on a LI-COR 
Odyssey Infrared Imager and the intensity of each dot was calculated using the built-in 
densitometry software. The dot blot was washed with water and stained with Coomassie 
blue for the visualization and quantification of loading. The pHis concentration of each 
sample was determined using a working curve generated from the intensity-to-
concentration relationship of standard samples.   
 
7.4.2 Kinetic data processing 
For kinetic studies, time course experiment of a reaction was performed in multiplicate (n 
= 3 or 4). The time courses were averaged and fit to certain kinetic models, returning 
kinetic parameters of the subject reaction. Curve fitting were performed using Graphpad 
Prism Software. 
Phospho-relay from AgrC-I to AgrA (quantified using autoradiography) 
AgrC-I~P + AgrA ! AgrA~P + AgrC-I  
AgrA~P + H2O ! AgrA + Pi      (Scheme 7.1) 
where, AgrC-I~P and AgrA~P represent phosphorylated AgrC-I and AgrA, respectively. 
To study the decay of AgrC-I~P, only the kinetic equation of the first reaction is 
considered:  
     (Equation 7.1) 
where [AgrC-I~P] is the concentration of AgrC-I~P monomers, [AgrA] is the 
concentration of AgrA, k is the second-order kinetic constant and t is time. In the 
experimental setup, [AgrC-I~P] << [AgrA] at t = 0. Therefore, progress of the reaction 
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kinetics with respect to AgrC-I~P. Hence, [AgrC-I~P] (in arbitrary unit) was normalized 
to the [AgrC-I~P] at t = 0, and the time course was fit to the Equation 7.2: 
 
        (Equation 7.2) 
 
where kapp is the apparent first-order kinetic constant and plateau represents the un-
reactable fraction of AgrC-I~P at t = 0. The apparent half-life of AgrC-I~P, t1/2, was 
obtained from Equation 7.3: 
         (Equation 7.3) 
 
Phospho-relay from GC214 to AgrA and self-catalyzed dephosphorylation of AgrA 
(quantified using autoradiography)  
GC214~P + AgrA ! GC214 + AgrA~P 
AgrA~P + H2O ! AgrA + Pi                                                (Scheme 7.2) 
where, GC214~P and Pi represents phosphorylated GC214 and inorganic phosphate, 
respectively. This reaction scheme is similar to Scheme 7.1 but quantitatively different 
because the unmodified GC214 is present in much smaller amount. This drives the 
phospho-relay reaction to near completion in approximately one minute (Figure 3.6c). 
Thereafter, no change in [GC214~P] is observed and therefore the change in [AgrA~P] 
accounts only to the self-catalyzed dephosphorylation (the second reaction). Therefore, 
[AgrA~P] values (in arbitrary unit) after t = 1min were fit to the first-order decay model 
for the kinetic constant. The apparent half-life of AgrA-I~P was calculated based on 





= 1"plateau( )•exp "kapp•t( )+plateau
	   160	  
Auto-kinase reaction of AgrC-I (quantified using autoradiography) 
AgrC-I + ATP ! AgrC-I~P + ADP                 (Scheme 7.3) 
The initial velocity of the reaction follows Equation 7.4:  
 
(Equation 7.4)  
where [AgrC-I~P] is the concentration of AgrC-I~P monomers, [AgrC-I] is the 
concentration of free AgrC-I monomers, vi is the initial velocity and k1 is the apparent 
rate constant. The concentration of AgrC-I discs was 1.4 µM (2.8 µM of each monomer) 
and [γ-32P]-ATP was used at 20 µM. Thus, vi should be proportional to k1. In all 
reactions, [AgrC-I~P] (in arbitrary unit) increased linearly over the first 40 minutes; R2 > 
0.90. Therefore, vi was calculated as the slope of the [AgrC-I~P] time course. For ease of 
comparision, vi found under different conditions was normalized to the vi in the absence 
of AIP and plotted versus the equivalence of AIP-I (Figure 3.8a).    
 
Auto-kinase reaction of AgrC-I (quantified using anti-pHis dot blot) 
Taking the influence of substrate concentration, [ATP] into account, the initial velocity of 
the reaction is given in Equation 7.5:  
 
(Equation 7.5) 
where k1 is the first-order rate constant at a given ATP concentration, kmax is the first-
order rate constant assuming that ATP saturates the binding sites on AgrC-I and Km is the 
apparent Michaelis constant with respect to ATP. Under the conditions employed, 


















	   161	  
to AgrC-I. Determination of Km and kmax entails k1 values at a series of ATP 
concentrations to be calculated from vi and [AgrC-I]. vi values were either obtained from 
linear regression as described in section B or, in the case of saturable time courses, using 
Equation 7.6: 
 
        (Equation 7.6) 
where plateau is the saturation level of pHis, and t0 is a lag time used to offset the 
systematic error on the reaction time elapsed before sampling the first time point. 
The apparent rate constant k1 was calculated using Equation 7.7: 
 
        (Equation 7.7) 
The k1-[ATP] relationship of AgrC-I discs in different ligand states was fit to the 
Michaelis-Menten equation (Equation 7.8), returning kmax and Km values as fitting 
parameters: 
 
        (Equation 7.8)  
 
D. Reverse auto-kinase reaction (quantified using anti-pHis dot blot) 
AgrC-I~P + ADP ! AgrC-I + ATP                                 (Scheme 7.4) 
Taking the influence of substrate concentration, [ADP], into account, the initial velocity 
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where k-1 is the first-order rate constant at a given ADP concentration, kmax is the first-
order rate constant assuming that ADP saturates the binding sites on AgrC-I and Km is the 
apparent Michaelis constant with respect to ATP. In contrast to the forward reaction, the 
reverse reaction is first-order with respect to [AgrC-I~P] at any practical ADP 
concentration. Absolute quantification of [AgrC-I~P] is hence not required. Therefore, 
the starting material, pre-phosphorylated AgrC-I discs, was used for internal 
standardization, and [AgrC-I~P] at all time points was quantified relative to the starting 
point. As all time courses saturated at the end of the assays, they were fit to Equation 
7.10: 
        (Equation 7.10) 
The k1-[ADP] relationship of AgrC-I discs in different ligand states was fit to the 
Michaelis-Menten equation (Equation 7.11), returning kmax and Km values as fitting 
parameters: 
 
        (Equation 7.11) 
 
7.4.3 Determination of the dissociation constants between AgrC-I and AIP 
Measurement of fluorescent anisotropy 
Fluorescence measurements were performed in measurement buffer (20 mM HEPES, pH 
7.0, 100 mM NaCl, 1mM TCEP, 2 µM BSA and 100 nM of empty nanodiscs). All 
buffers were freshly degassed before use. Measurement of fluorescent anisotropy was 
performed on a Fluorolog-3 instrument (HORIBA Jobin Yvon) equipped with automated 
dual polarizers and using a Semi-Micro Fluorometer Cell (Starna Cells) with a 10-mm 
!
! 
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path length. The measurement chamber was held at a constant temperature of 30.0°C by 
an Advanced Series AC200 thermostat (Thermo Scientific) connected to an Arctic series 
refrigerated circulating water bath (Thermo Scientific). The excitation wavelength was 
490 nm and emission wavelength was recorded at 520 nM, both with a bandwidth of 5 
nm. Six to eight measurements were taken per titration point with an integration time of 2 
sec for V/V, V/H, H/H and H/V polarizer settings (excitation/emission, V: vertical 
polarization, H: horizontal polarization). The final anisotropy, r, was calculated from r = 
(IVV – G × IVH)/(IVV + 2 × G × IVH), with G = IHV/IHH.  
 
For titrations of FAM-AIP-I with AgrC-I discs, 750 µL of measurement buffer containing 
2.0 nM FAM-AIP-I was transferred to the cuvette and the fluorescent anisotropy was 
measured as a reference. AgrC-I discs were then added to the required concentration and 
the mixture allowed to equilibrate for 5 minutes before taking the anisotropy 
measurement. This process was repeated until measurement of the last titration point (at 
1.5 µM of AgrC-I discs). Each titration of FAM-AIP-I was performed simultaneously 
with a control titration, in which 2.0 nM of FAM-(lin)-AIP-I was included at the starting 
point.  
 
For competitive titrations with AIP-I or AIP-II, the fluorescent anisotropy of 750 µL of 
measurement buffer containing 20 nM FAM-AIP-I was first measured as a reference. The 
starting-point mixture was then prepared by addition of AgrC-I discs to a final 
concentration of 150 nM. The desired AIP was titrated into the cuvette and the anisotropy 
measured after 5 minutes equilibration.  
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Data processing of fluorescent-anisotropy-based binding assays  
Curve fitting were performed using Graphpad Prism Software. 
A. Titrations of FAM-AIP-I with AgrC-I discs 
The fluorescent anisotropy change, Δr, was calculated for each titration point as: 
Δr = r – rr                                                                                 (Equation 7.12) 
where rr is the reference anisotropy measured in the absence of AgrC-I discs. To correct 
the anisotropy increase due to the light-scattering effect of AgrC-I discs, observable only 
at high-nanomolar and above, the anisotropy change in the control titration (titration of 
FAM-(lin)-AIP-I), Δrc, was subtracted from the anisotropy change in the experimental 
titration, Δro at each AgrC-I concentration. This resulting correction, Δro - Δrc, reflects 
the anisotropy change caused by binding of FAM-AIP-I to the AgrC-I discs. Therefore, 
Δro - Δrc (referred to as ΔSSAc in Figures 3.8b and 4.5c) was plotted against [AgrC-I 
disc]. In titrations with AgrC-IS109VS116I mutant discs, no significant increase of Δro - Δrc 
was observed so that data points were connected with a smoothed line. In titrations with 




where [AIPIbound] is the concentration of FAM-AIP-I bound to AgrC-I, [AIPItotal] is the 
total concentration of FAM-AIP-I, Kd is the dissociation constant, h is the Hill coefficient 
with respect to AgrC-I, and Δrmax is the Δro - Δrc value assuming 100% binding of FAM-
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To obtain the Hill coefficient with respect to FAM-AIP-I, we considered the Hill 
equation treating FAM-AIP-I as ligand: 
 
(Equation 7.14) 
where [AgrCIfree] and [AgrC-Ibound] are the concentration of AgrC-I sites unoccupied and 
bound to FAM-AIP-I, respectively, and [AIPIfree] is the unbound FAM-AIP-I 
concentration. Importantly, AIP-I was found to bind AgrC-I in 2:2 stoichiometry. For 








Where Vtotal is the total volume of the titration system including the volume of titrant 
added.   
          was then plotted with [AIPIfree]. To avoid large relative errors in [AIPIfree] 
and [AgrC-Ibound], only data points meeting the criterion of                                       were 
included in the dataset. Fitting the dataset to the eq.14 returned values of Kd and h. Kd and 













AgrC"Ifree[ ]=2 # AgrC"I disc[ ] - AgrC"Ibound[ ]
	   166	  
B. Competitive titrations with native AIPs 
The fluorescent anisotropy change, Δr (referred to as ΔSSA in Figure 3.8d), was 
calculated for each titration point and plotted with the concentration of [AIP] in a semi-
log plot. Since FAM-AIP-I was found to bind AgrC-I non-cooperatively, we treated 
AgrC-I as independent monomers. The dataset was fit to Equation 7.18, which was 
simplified from the literature (189): 
 
         ,  
 
where        (Equation 7.18) 
In the above, Kd, FAM-AIP, the dissociation constant of FAM-AIP-I, was 122nM. Δrmax, the 
anisotropy change assuming 100% binding of FAM-AIP-I to AgrC-I disc, was calculated 
from the Δr and the concentration of FAM-AIP-I and AgrC-I disc at the starting point. 
Bmax was calculated as: 
(Equation 7.19) 
Kd, AIP, the dissociation constant of native AIP, was the only variable parameter in the 
fitting process. For each AIP, Kd values obtained from three individual titrations were 
pooled and shown as mean ± SD in the main text. 
 
7.4.4 Other methods related to the AgrC-AgrA TCS: 
Co-migration assays employing FAM-AIP-I 
AgrC-I discs or empty discs (1.5 nmol) were incubated with 10 nmol FAM-AIP-I in 500 
µL of nanodisc buffer at 30oC for 30min. The mixture was then resolved on Superose6 
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size-exclusion chromatography running with nanodisc buffer. The eluate was collected in 
0.25-mL size fractions, and fluorescence intensity (λex = 490 nm, λem = 520nm) of the 
fractions was recorded on a Molecular Devices Spectramax M3 micro plate reader. The 
fluorescence intensity was plotted with the elution volume of the fraction and connected 
with a smoothed line. This fluorescence chromatogram overlaid with the UV 
chromatogram recorded by the UV detector (λ= 280 nm) is shown in Figure 3.2b.  
 
AIP Stability Assays 
AIP-I or AIP-II (2 nmol) was incubated in 100 µL solution buffered at pH = 7.0 for 3hrs 
(AIP-I) or at pH = 8.0 for 1hr (AIP-II) at 37oC in the presence or absence of 0.2 nmol of 
AgrC-I discs. Control samples without incubation were also prepared. To each sample 
was added 50 µL of acetonitrile, and the mixture was centrifuged at 17000 G for 5 
minutes. Supernatant was analyzed by RP-HPLC on a C18 column using a 0-70B% 
gradient. The percentage of intact AIPs remaining after incubation with buffer or AgrC-I 
discs was determined from the peak area and plotted as mean ± SD (n=3) in Figure 3.7c. 
 
Iodoacetamide capture of the hypothetic AgrC-AIP-I covalent complex 
FAM-AIP-I (100 pmol) was incubated with AgrC-I discs (40 pmol) in 20 µL buffer (20 
mM HEPES pH 7.0, 100 mM NaCl and 1 mM TCEP) at 37oC for 30 minutes. 
Iodoacetamide was then added to 50 mM (final concentration) and the mixture was 
incubated at 37°C for additional 30 minutes. The mixture was then denatured with 4 x 
(v/v) thio-free loading buffer (50 mM Tris-HCl pH 7.5, 2 % (w/v) SDS, 10 % (v/v) 
glycerol and 0.01 % (w/v) bromophenol blue). Two control samples were prepared under 
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identical procedures in the absence of either FAM-AIP-I or iodoacetamide. All samples 
were resolved on Criterion 15% Tris-HCl SDS-polyacrylamide gel, which was first 
scanned for in-gel fluorescence and then stained with Coomassie blue to confirm the 
equal loading of AgrC-I protein. 
 
Circular-dichroism (CD) analysis of the TMH-DHp linker peptides 
CD spectra were taken on a ChirascanTM CD spectrometer equipped with a Quantum 
TC125 temperature control unit at 20oC. Path length of the cuvette was 1mm. The HPLC-
purified peptide was dissolved in a 100-µM stock solution. This stock was diluted into 
15-µM samples containing 10 mM sodium phosphate pH = 7.0, 50 mM NaF, and 0%, 
10%, 20%, 30%, 40% or 50% TFE (v/v).  For each peptide, CD spectra of six samples 
were corrected for buffer background and Helical content (H) was calculated as: 
 
       (Equation 7.20) 
where θ222 is the mean residue ellipticity at 222 nm in (deg·cm2·dmol-1), n is the length of 
the peptide (in residue) and T is temperature in oC (190). 
 
Inter-subunit disulfide formation within AgrC-I cysteine point mutant dimers 
Oxidized glutathione (GSSG) was dissolved at 60 mM in a buffer containing 20 mM 
HEPES and 100 mM NaCl, and pH of the solution was readjusted to 7.0. Nanodiscs 
incorporated with WT or cysteine-mutant AgrC-I proteins were prepared at 1.0 µM in a 
buffer containing 20 mM HEPES pH 7.0, 100 mM NaCl and 0.2 mM TCEP. These 
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concentration of each AIP was 10 µM. To initiate oxidation, 10 µL from each aliquot was 
mixed with 2µL GSSG solution. These mixtures were incubated at 37oC for 10min before 
mixing with 4 x thiol-free SDS sample buffer. A ‘non-oxidized’ control reaction was 
prepared by mixing 10 µL from the AIP-free aliquot with SDS sample buffer and 2 µL 
GSSG solution simultaneously; this procedure controlled for spurious oxidation post-
denaturation. Oxidation reactions were resolved on Criterion 15% Tris-HCl SDS-
polyacrylamide gel. The gel was stained with Coomassie blue, scanned with an LI-COR 
Odyssey Infrared Imager and quantified with the build-in densitometry software. 
Intensity of each AgrC dimer band was normalized to the MSP band in the same lane. 
Level of disulfide formation was calculated by subtracting normalized AgrC-I dimer 
band intensity of the mock-treated discs from the oxidized discs for each AgrC-I mutant.  
 
Lipidation of the AgrC-I208-430 construct 
To introduce lipid anchors using maleimide chemistry, an AgrC-I intracellular construct 
bearing an N-terminal cysteine need to be prepared. To ensure specificity, the native 
cysteine at position 371 was mutated to serine. The AgrC-I208-430 (M208C/C371S) with 
either a wild-type or an R238H mutant HK domain was expressed as an N-terminal His6-
Sumo fusion and purified using Ni-NTA affinity chromatography following standard 
methods (section 7.3.1). The elutate was first dialyzed to imidazole-free and then treated 
with the Sumo protease, Ulp1, at 16oC overnight. The His6-Sumo released upon 
proteolysis was removed through a reverse Ni-NTA step, and the AgrC-I208-430 was 
concentrated and further purified on Superdex200 size-exclusion chromatography with 
running buffer (20 mM HEPES, 100 mM NaCl, and 1mM TECP, pH 7.0) 
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For lipidation, the purified AgrC-I208-430 (M208C/C371S) proteins were adjusted to a 
concentration between 70-80uM (in dimer). 200uL of the substrate was added to 200uL 
of lipidation reagents containing 50mM of HEPES pH = 7.6, 2.5 mM of TCEP (pre-
neutralized), 10 mM DPPE:MCC and 5% (w/v) FC-12. The reaction was incubated at RT 
for 40min and quenched with 20 mM of BME (final concentration). Analytical HPLC-
MS revealed excellent conversion and specificity. The reaction was purified on 
Superdex200 size-exclusion chromatography with running buffer containing 0.05% FC-
14, and fractions containing the lipidated AgrC-I construct was used for nanodisc 
reconstitution following standard methods (section 7.3.4). 
 
Limited proteolysis of AgrC-I205-430 and GCN4-AgrC-I chimeras 
All substrate proteins were diluted to 100 µM (in dimer, 5-6 mg/mL) in cleavage buffer 
(20 mM Phosphate pH=7.5, 100 mM NaCl). Trypsin (5 mg/mL prepared in 1mM HCl) 
was serial-diluted in cleavage buffer to five concentrations, i.e. 1.0, 0.5, 0.25, 0.125 and 
0.062 in the unit of mg / mL. Each trypsin dilute (5 µL) was mixed with a 15-µL aliquot 
from each substrate protein, resulting in altogether 20 proteolysis reactions. Each reaction 
(20uL system) was incubated on ice for 20min and then stopped by adding 5 µL of 1M 
TFA. 5 µL of the acid-treated reaction was immediately transferred into 20 µL of 100 
mM phosphpate pH 7.5 containing cOmplete protease inhibitor cocktail (Roche) at 10X 
working concentration. To the rest 20 µL of each reaction was added 180 µL 7.5M 
guanidinium chloride to dissolve the emerging precipitate.All inhibitor-treated samples 
were denatured by the addition of 15 µL of 4X SDS-PAGE sample buffer. These samples 
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were subsequently analyzed on Criterion 15% Tris-HCl SDS-polyacrylamide gel with 
Coomassie staining. 
 
The guanidinium-chloride-solubilzed samples were used for HPLC analysis. RP-HPLC 
was performed with analytical C18 columns using a 0–70% B gradient over 20 minutes. 
For two reactions in which AgrC-I205-430 and GC206 was digested with the 0.5 mg/mL 
trypsin dilute, primary peaks eluted between 10 and 20 minute from the HPLC were 
analyzed with mass spectrometry. Trptic fragments were identified from the primary 
sequences of AgrC-I205-430 and GC206 using the FindPept tool. 
 
7.5 Characterization of the AgrB-AgrD peptidase-substrate pair 
7.5.1: Biochemical assays based on AgrB-I prteoliposomes 
Proteolysis/hydrolysis assays 
For a typical 100 µL reaction, to 45 µL PBST buffer was added 5µL of a 400 µM 
solution of AgrD-I or FlagHis6-AgrD(1-32)-thiolactone substrate in DMSO. At t = 0, 50 
µL AgrB-I proteoliposomes (containing 2 µM AgrB-I monomer as quantified by SDS-
PAGE) were added with rigorous mixing and the reaction tube was immediately 
transferred into a 37oC water bath. 20µL aliquots were withdrawn at indicated time points 
and mixed with 4 X SDS sample buffer before resolved on 16.5% Tris-Tricine SDS-
PAGE. For HPLC-MS analysis, the reaction could be linearly scaled up. At the indicated 
time points, 100 µL of the reconstitution system was mixed with 400 µL of a solution 
containing 7.5 M GuHCl, 0.1 M TFA and then subject to Sep-Pak solid phase extraction 
(SPE, see below). The Sep-Pak eluate was lyophilized, dissolved in the GuHCl-TFA 
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solution and resolved on a C4 (for non-tagged constructs) or C18 (for FlagHis6-tagged 
constructs) analytical RP-HPLC column. For proteolysis reactions, a linear gradient with 
increasing buffer B percentage from 0 to 90% between t = 5 min and 35 min was used. 
For hydrolysis reactions, a two-segment gradient was employed with buffer B percentage 
increasing from 0 to 50% in the first 5 min and from 50 to 90% between t = 5 min and 25 
min. Peaks with significant absorbance at 214 nm were collected for ESI-MS analysis.  
 
Ligation assays 
Immediately prior to ligation assays, AgrB-I proteolipsomes were spun down and re-
suspended in PBST buffer containing AgrD-IC-NH2 peptide at 2X final concentration. 
This suspension was mixed with PBST buffer and 400 µM DMSO stock of FlagHis6-
AgrD-I(1-32)-thiolactone at a volume ratio of 50:45:5 to initiate the reaction. At 
indicated time points, 100 µL aliquots from the reaction were acidified, Sep-Pak-
processed and analyzed using RP-HPLC-MS as described in the previous section.  
 
Sep-Pak SPE  
The tC2 Sep-Pak cartridge (100 mg adsorbant, Waters) was activated with 3 x 1 mL of 
HPLC solvent B and then equilibrated with 2 x 1 mL of HPLC solvent A. Samples 
acidified with the GuHCl-TFA solution (see section 7-5) were then load on to the 
cartridge. The cartridge was subsequently washed with 2 x 1 mL of HPLC solvent A and 
bound protein was eluted consecutively with 0.5 mL 50% (v/v) acetonitrile in water, 0.5 
mL 67% (v/v) acetonitrile in water and 1 mL of 75% (v/v) acetonitrile in water. All 
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solvents used for elution were buffered by 10 mM triethylammonium-acetate at pH = 8.0. 
The combined eluate was lyophilized.  
 
7.5.2 Ring-opening of FlagHis6-AgrD-I(1-32)-thiolactone and AIP-I  
A 3 M aqueous solution of N-acetylcysteamine (NAC) was prepared and buffered at pH 
= 7.0 using 100mM HEPES-Na. For each reaction, a 10X NAC solution was prepared 
from this concentrated stock through serial dilution using 100 mM HEPES-Na pH = 7.0. 
The following three buffers were used in the reaction:  
HBST buffer: 100 mM HEPES-Na, 100 mM NaCl, 2 mM TCEP, pH=7.0; 
Liposome buffer: 1 volume of the 1% (w/v) liposomal suspension diluted in 4 volumes of 
HBST buffer; 
GuHCl buffer: 100 mM HEPES-Na, 7.5 M GuHCl, 2 mM TCEP, pH=7.0; 
Each reaction was initiated by combining 50 µL 1M TCEP-Na (buffered at pH = 7.0), 
100µL 10X NAC solution and 50 µL of a 400 µM DMSO stock of FlagHis6-AgrD-I(1-
32)-thiolactone or AIP-I with 800 µL of one of the above three buffers. For reactions 
performed in HBST or GuHCl buffers, aliquots (100 µL for AIP-I or 20 µL for FlagHis6-
AgrD-I(1-32)-thiolactone) were removed and analyzed by C18 analytical RP-HPLC at 
indicated time points. For reactions containing liposomes, aliquots were added to 0.5 mL 
0.1 M aqueous TFA and freeze-dried. The lyophilized sample was triturated with 150 µL 
GuHCl-TFA solution. The extract was then cleared through centrifugation and 100 µL of 
the supernatant was analyzed on RP-HPLC. Ring-opening reactions of the tri-Ala 
mutants of FlagHis6-AgrD-I(1-32)-thiolactone and AIP-I were initiated, processed and 
analyzed using the same procedures.  
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Analytical HPLC columns and gradients: 
Samples from reactions involving AIP-I: solvent B percentage 20% to 50% over 15min; 
Samples from reactions involving tri-Ala mutant of AIP-I: solvent B percentage 0% to 
30% with 15min; 
Samples from reactions involving wild-type or tri-Ala mutant of FlagHis6-AgrD-I(1-32)-
thiolactone: two-segment gradient such that solvent B percentage increases from 0% to 
50% in 5 min and then to 80% in 15min.  
 
7.5.3 Quantification methods 
Quantification of all species in the proteolysis reaction from HPLC analysis 
The proteolysis reaction begins with 20 µM pure FlagHis6-AgrD-I. This AgrD-I construct 
has two tyrosines, both located in the N-fragment that results from AgrB-I cleavage. 
Therefore, the full-length AgrD-I, the linear and the thiolactone N-fragment should have 
identical extinction coefficients at 280 nm. Peak areas of these species in the 280-nm 
HPLC chromatogram are hence proportional to their respective molarities. The molar 
fraction of each species (out of the sum of three) was calculated accordingly after 
factoring in their respective SPE recovery (see below). The molarity of AgrD-IC is given 
by the sum of the molarity of both linear and thiolactone N-fragments as a consequence 
of mass balance.  
 
To determine the relative SPE recovery, FlagHis6-AgrD-I, FlagHis6-AgrD-I(1-32)-Cys 
[as a surrogate of FlagHis6-AgrD-I(1-32)] and the FlagHis6-AgrD-I(1-32)-thiolactone N-
fragment were mixed at a moderate ratio, and part of the mixture was diluted to an 
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overall molarity of 20µM in a buffer containing phospholipids. This sample was 
incubated at 37oC for 30min and then subject to the Sep-Pak SPE following the standard 
method provided in section 7.5.2. The SPE eluate and the mixture prior to dilution were 
resolved on HPLC and the molar fractions of each species were plotted (Figure 7.2a). 
Relative Sep-Pak recovery of each species is calculated as the ratio between its post- and 
pre-SPE molar fraction relative to the sum of three.  
 
Quantification of the ligation reaction based on HPLC-MS analysis 
The ligation reaction starts with 20 µM FlagHis6-AgrD-I(1-32)-thiolactone and a variable 
concentration of AgrD-IC-NH2. The starting thiolactone overlaps, on the RP-HPLC 
chromatogram, with the ligation product, but is separable from the linear FlagHis6-AgrD-
I(1-32). Again, due to the lack of a chromogenic residue in the AgrD-IC segment, the 
extinction coefficient at 280 nm is expected to be the same for the starting thiolactone, 
the linear AgrD(1-32) and the ligation product AgrD. Accordingly, the linear AgrD(1-32) 
was quantified based on RP-HPLC peak areas as described in the previous section. The 
molar ratio between the starting thiolactone and the ligation product was determined 
using MS. Briefly, MS spectra were recorded for the eluate containing AgrD and both 
AgrD(1-32) fragments and the profile between m/z = 600 and 2000 was de-convoluted 
using the “maximum entropy” method (191). Target MS range and instrument resolution 
were set at 3000-8000 Da and 10000, respectively. The peaks corresponding to the 
starting thiolactone (5694.2Da) and ligation product (7359.2Da) in the de-convoluted 
profile were integrated. The molar ratio between the two species was calculated from 
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their MS intensity after factoring in a coeffecient that accounts for their difference in 
ionization efficiency (see below).  
 
Figure 7.2 Correction of the systematic errors introduced by the Sep-Pak procedure 
or the ionization bias of the MS  
(a) The relative Sep-Pak recovery among FlagHis6-AgrD-I, FlagHis6-AgrD-I(1-32)-
thiolactone, and FlagHis6-AgrD-I1-32-Cys: bar graph shows the molar fraction of each 
species in a mixture of three before (open bars) or after (closed bars) solid-phase 
extraction (SPE) using Sep-Pak. Pre- and post-SPE samples were quantified using HPLC. 
Error bars = range (n = 2). (b to d) The relative ionization efficiency of FlagHis6-AgrD-I 
with respect to FlagHis6-AgrD-I(1-32)-thiolactone. (b) RP-HPLC preparation of standard 
samples A and B: 20µM of FlagHis6-AgrD-I(1-32)-thiolactone was treated with 300µM 
AgrDC in the presence of AgrB-I proteoliposomes or mock-treated and then subject to 
RP-HPLC. Shaded segments of elution were collected from the ligation (as sample A) 
and the mock treatment (as sample B). Both samples were diluted to the same molarity; 
(c) Deconvoluted mass spectra for mixtures of samples A and B at indicated ratios. (d) 
The working curve: plot shows the MS peak intensity ratio between FlagHis6-AgrD-I(1-
32) and FlagHis6-AgrD-I as a function of the reciprocal of the weight of sample A in the 
mixture. The inverse reciprocal of the y-intercept, k, converts MS peak intensity ratio to 
the molar ratio by simple multiplication. Error bars (range between two parallels) are not 
visible due to the size of data symbols. 
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Relative MS ionization efficiency of FlagHis6-AgrD-I with respect to FlagHis6-AgrD-
I(1-32)-thiolactone 
This procedure was used to empirically determine a coeffecient, k, that converts the MS 
peak intensity ratio between the starting thiolactone (TL) and the full-length ligation 
product (FL) (ITL/IFL) into the molarity ratio (cTL/cFL). Note that these two species cannot 
be resolved on RP-HPLC.   
                         (Equation 7.21) 
For simplicity, we prepared sample B containing pure TL and sample A as a mixture 
containing predominantly FL. To this end, 20µM of FlagHis6-AgrD-I(1-32)-thiolactone 
was treated with 300µM AgrDC in the presence of AgrB-I proteoliposomes or mock-
treated and then subject to RP-HPLC. The whole HPLC peak was collected from the 
ligation (as sample A) and the mock treatment (as sample B) (Figure 7.2b). Based on 
their peak areas on the 280-nm RP-HPLC chromatogram, both samples were diluted to 
the same molarity. Assuming the molar fraction of FL in sample A to be x (x<1), the TL-
to-FL molarity ratio in a A-B mixture is given by equation 22: 
                        (Equation 7.22) 
 
where VA and VB are the volume of A and B in the mixture. Equation 7.21 and Equation 
7.22 could be transformed into: 
                  (Equation 7.23) 
Therefore, after plotting the MS intensity ratio between TL and FL versus the overall 
volume of the A-B mixture divided by the participating sample A volume, linear 
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regression of the plot returns k as the inverse reciprocal of the y-intercept (Figure 7.2c 
and d).  
 
Quantification of the thioester/thiolactone in the ring-opening assays 
Molar ratios of AIP-I-NAC thioester versus AIP-I or FlagHis6-AgrD(1-32)-NAC 
thioester versus FlagHis6-AgrD(1-32)-thiolactone were quantified based on integration of 
280-nm RP-HPLC chromatograms. 
 
7.5.4 Construction of S. aureus strains and western blotting analysis thereof 
Shuttle plasmids for the pblaZC-driven co-expression of Sumo-AgrDC-Ub-Flag2 and 
His6-Ulp1 were first electroporated into strain RN4220 (a restriction-deficient host) and 
then transduced to strain RN6390 (agr-I wild type) or RN7206 (RN6390 carrying an agr 
locus deletion) via phage 80 using standard protocols (192). Transductants were grown in 
CYGP medium containing 10 µg/mL erythromycin at 37oC. Upon reaching the stationary 
phase, cells from a 1 mL culture were collected, washed twice with ice-cold water and 
finely resuspended in fresh CYGP medium on ice. 20 mL CYGP medium containing 10 
ug/mL erythromycin was inoculated with 40 µL cell suspension (c.a. 2x108 cfu) and then 
shaken at 250 rpm at 30oC. Cell density was measured every 30 min. When OD600 
exceeded 0.60, cell culture was diluted using fresh CYGP medium to give an OD600 of 
between 0.20 and 0.60 prior to measurement, and the readout was then corrected for the 
dilution.  
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For the detection of AgrDC-Ub-Flag2 and AgrD-Ub-Flag2 using anti-Flag western blot, 1 
mL cell culture was sampled when the culture OD600 reached 0.50, 1.00, 1.50 and 2.00. 
Cells were pelleted and resuspended in lysis buffer (10mM Tris-HCl 8.0, 1mM TCEP, 
100µM ZnCl2, supplemented with 50 µg/mL lysostaphin and 1X protease inhibitor 
cocktail). The volume of suspension was proportional to the cell density of the original 
sample (50 µL per 1.0 OD600). The suspension was incubated at 37oC for 30 min, mixed 
with appropriate amount of 3X SDS-PAGE loading dye and boiled at 95oC for 10min. 
Samples were then resolved on 15% Tris-HCl SDS-PAGE. To avoid interference of 
western blotting by endogenous protein A, the PAGE gel was cut at the level of the 
37.5kDa standard band and the upper half was stained with Coomassie blue for loading 
control. Proteins in the lower half of the gel were transferred to a PVDF membrane and 
blotted with Flag-specific mouse monoclonal antibody (Sigma-Aldrich) using standard 
protocols. After blotting the membrane with goat anti-mouse IgG HRP conjugate (Bio-
Rad), bands were visualized through chemiluminescence.  
 
Extracellular AIP-I activity in plasmid-free or transformed RN6390 culture was 
determined using a reporter gene assay (39). Briefly, RN9222 (an agr-I reporter strain 
harboring a β-lactamase gene driven by a P3 promoter) was grown in CYGP medium at 
37oC to OD600 = 0.60. A 50-µL aliquot of the culture was mixed with 50µL fresh CYGP 
(for background) or cell-free medium isolated from RN6390 samples. The mixture was 
cultured at 37oC for 1hr and cell density (OD600) was measured. Then, 50 µL of the 
mixture was transferred to a 96-well plate and mixed with 50 µL 200 µM nitrocephin in 
assay buffer (100 mM phosphate-Na pH = 5.9, 27% (v/v) propylene glycol, 5 mM 
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sodium azide). Progress of the substrate hydrolysis was monitored at 37oC in a plate 
reader. The slope of the linear increase of absorbance at 490 nm during the initial period 
of the reaction was designated as the β-lactamase activity in (0.001 absorbance unit/min). 
The final result was background-subtracted and normalized by the pre-reaction cell 
density of RN9222.  
 
7.5.5 Other experiments related to AgrB and AgrD 
Glutaraldehyde crosslinking of AgrB-II 
Crosslinking was performed on SEC-purified AgrB-II protein solubilized by FC-12. The 
protein was diluted in PBST buffer (20 mM sodium phosphate, 100 mM NaCl and 2 mM 
TCEP pH 7.5) supplemented with 0.14% FC-12 to 2.5 µM. 20 mM glutaraldehyde was 
prepared in 100 mM phosphate buffer (pH = 7.5) immediately prior to use. The 
crosslinking was performed at room temperature. 90µL of protein and 10µL crosslinker 
were mixed at t = 0, and 20µL aliquots were withdrawn at indicated time points and 
quenched by mixing with 2µL 1M Tris buffered at pH=8.7. The t = 0 control was 
prepared by adding first 2µL 1M Tris pH=8.7 and then 2µL crosslinker to 18µL protein 
stock. All quenched reactions were mixed with 4X SDS sample buffer and resolved on 4-
20% TGX SDS-PAGE.  
 
Proteolysis assays using AgrB-II nanodiscs 
SEC-purified AgrB-II nanodiscs were diluted in PBST such that each nanodisc sample 
contains 2 µM AgrB-II (counted as monomers). FlagHis6-AgrD-II was dissolved in 
DMSO at 0.5 mM, from which 1 µL was mixed with 25µL AgrB-II nanodisc sample. 
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Reactions were incubated at 37oC for 2hr before mixing with 4 X SDS sample buffer and 
resolved on Criterion 16.5% Tris-Tricine SDS-polyacrylamide gel. The gel was stained 
with Coomassie blue. 
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Appendix 
Appendix Table 1. All RHK hits from the database search for HPK10 homologs in 
Chapter 2 
Entry Accession Number Length TMH "G1-box" Residue Phylum Species 
1 WP_006147676.1 203 0 Asn Firmicutes Streptococcus infantis 
2 WP_010734516.1 224 0 Asn Firmicutes Enterococcus mundtii 
3 YP_004561998.1 233 0 Asn Firmicutes Lactobacillus kefiranofaciens ZW3 
4 YP_003602088.1 230 0 Asn Firmicutes Lactobacillus crispatus ST1 
5 WP_016623240.1 228 0 Asn Firmicutes Enterococcus faecalis 
6 YP_006621934.1 387 0 Asn Firmicutes Desulfosporosinus meridiei DSM 13257 
7 WP_002471760.1 220 0 Asn Firmicutes Staphylococcus pettenkoferi 
8 WP_009384255.1 240 0 Asn Firmicutes Staphylococcus massiliensis 
9 WP_010241734.1 256 1 Asn Firmicutes Clostridium arbusti 
10 WP_003037768.1 274 1 Asn Firmicutes Streptococcus anginosus 
11 WP_006701462.1 232 1 Asn Firmicutes Facklamia ignava 
12 WP_010170763.1 404 1 Asn Firmicutes Bacillus coahuilensis 
13 WP_010241389.1 291 2 Asn Firmicutes Clostridium arbusti 
14 WP_016230456.1 303 2 Asn Firmicutes Lachnospiraceae bacterium 10-1 
15 WP_010275906.1 283 2 Asn Firmicutes Leuconostoc pseudomesenteroides 
16 WP_005723496.1 343 2 Asn Firmicutes Lactobacillus crispatus 
17 YP_006920935.1 282 2 Asn Firmicutes Thermacetogenium phaeum DSM 12270 
18 YP_006462487.1 435 2 Asn Firmicutes Solibacillus silvestris StLB046 
19 WP_006837370.1 437 2 Asn Firmicutes Bacillus sp. SG-1 
20 WP_010861419.1 435 2 Asn Firmicutes Lysinibacillus sphaericus 
21 YP_001697754.1 435 2 Asn Firmicutes Lysinibacillus sphaericus C3-41 
22 YP_002771205.1 450 2 Asn Firmicutes Brevibacillus brevis NBRC 100599 
23 WP_005833804.1 441 2 Asn Firmicutes Brevibacillus 
24 WP_003094496.1 317 3 Asn Firmicutes Streptococcus vestibularis 
25 WP_004271011.1 316 3 Asn Firmicutes Lactobacillus curvatus 
26 WP_003069924.1 308 3 Asn Firmicutes Streptococcus intermedius 
27 WP_001872392.1 334 3 Asn Firmicutes Streptococcus agalactiae 
28 WP_002300816.1 352 3 Asn Firmicutes Enterococcus faecium 
29 WP_007126042.1 334 3 Asn Firmicutes Lactobacillus ultunensis 
30 WP_009999978.1 355 3 Asn Firmicutes Leuconostoc lactis 
31 YP_001699604.1 353 3 Asn Firmicutes Lysinibacillus sphaericus C3-41 
32 YP_003842650.1 379 4 Asn Firmicutes Clostridium cellulovorans 743B 
33 WP_009854992.1 454 4 Asn Firmicutes Streptococcus gallolyticus 
34 WP_004271266.1c 385 4 Asn Firmicutes Lactobacillus curvatus 
35 WP_004634648.1 430 4 Asn Firmicutes Dolosigranulum pigrum 
36 WP_016264937.1 398 4 Asn Firmicutes Lactobacillus sakei 
37 WP_010752094.1 365 4 Asn Firmicutes Enterococcus villorum 
38 WP_009557583.1 377 4 Asn Firmicutes Lactobacillus sp. 66c 
39 WP_005725782.1 395 4 Asn Firmicutes Lactobacillus crispatus 
40 WP_002482782.1 365 4 Asn Firmicutes Staphylococcus saprophyticus 
41 WP_009443765.1 404 5 Asn Firmicutes Streptococcus sp. oral taxon 056 
42 WP_010757654.1 397 5 Asn Firmicutes Enterococcus pallens 
43 YP_006991522.2 430 5 Asn Firmicutes Carnobacterium maltaromaticum LMA28 
44 WP_009535076.1 435 5 Asn Firmicutes Oribacterium 
45 WP_010781286.1 433 5 Asn Firmicutes Enterococcus gilvus 
46 WP_010742519.1 441 5 Asn Firmicutes Enterococcus malodoratus 
47 WP_016179641.1 441 5 Asn Firmicutes Enterococcus avium 
48 WP_016176172.1 436 5 Asn Firmicutes Enterococcus saccharolyticus 
49 YP_003926231.1 420 5 Asn Firmicutes Lactobacillus plantarum subsp. plantarum ST-III 
50 WP_018373329.1 443 5 Asn Firmicutes Streptococcus merionis 
51 WP_016624566.1 426 5 Asn Firmicutes Enterococcus faecalis 
52 WP_018380719.1 447 5 Asn Firmicutes Streptococcus thoraltensis 
53 WP_010736347.1 438 5 Asn Firmicutes Enterococcus mundtii 
54 WP_019782329.1 447 5 Asn Firmicutes Streptococcus sobrinus 
55 WP_004225929.1 442 5 Asn Firmicutes Streptococcus criceti 
56 YP_005004303.1 423 5 Asn Firmicutes Pediococcus claussenii ATCC BAA-344 
57 YP_003431422.1 435 5 Asn Firmicutes Streptococcus gallolyticus UCN34 
58 WP_003638473.1 422 5 Asn Firmicutes Lactobacillus pentosus 
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59 WP_004242076.1 448 5 Asn Firmicutes Streptococcus mitis 
60 WP_006917176.1 427 5 Asn Firmicutes Lactobacillus coleohominis 
61 WP_004049770.1 430 5 Asn Firmicutes Lactobacillus murinus 
62 WP_016623999.1 381 5 Asn Firmicutes Enterococcus faecalis 
63 WP_003665154.1 425 5 Asn Firmicutes Lactobacillus reuteri 
64 WP_007126043.1 432 5 Asn Firmicutes Lactobacillus ultunensis 
65 WP_009431292.1 366 5 Asn Firmicutes Peptoniphilus sp. oral taxon 375 
66 WP_016307854.1 439 5 Asn Firmicutes Lachnospiraceae bacterium A2 
67 YP_001307802.1 420 5 Asn Firmicutes Clostridium beijerinckii NCIMB 8052 
68 YP_004090305.1 433 5 Asn Firmicutes Ruminococcus albus 7 
69 WP_002847577.1 432 5 Asn Firmicutes Ruminococcus albus 
70 WP_005945720.1 424 5 Asn Firmicutes Faecalibacterium prausnitzii 
71 WP_016220195.1 440 5 Asn Firmicutes Dorea sp. 5-2 
72 WP_001639479.1 362 5 Asn Firmicutes Staphylococcus aureus 
73 YP_005119571.1 406 5 Asn Firmicutes Bacillus cereus F837/76 
74 WP_002579318.1 439 6 Asn Firmicutes Clostridium butyricum 
75 WP_003410367.1 435 6 Asn Firmicutes Clostridium butyricum 
76 YP_001311644.1 439 6 Asn Firmicutes Clostridium beijerinckii NCIMB 8052 
77 WP_003446201.1 445 6 Asn Firmicutes Clostridium pasteurianum 
78 WP_010766320.1 430 6 Asn Firmicutes Enterococcus moraviensis 
79 WP_004071405.1 433 6 Asn Firmicutes Clostridium sp. ASF502 
80 WP_010234544.1 451 6 Asn Firmicutes Clostridium arbusti 
81 WP_010772171.1 431 6 Asn Firmicutes Enterococcus caccae 
82 WP_016622707.1 434 6 Asn Firmicutes Enterococcus faecalis 
83 WP_016216882.1 440 6 Asn Firmicutes Dorea sp. 5-2 
84 WP_016226170.1 431 6 Asn Firmicutes Lachnospiraceae bacterium 3-2 
85 WP_016226738.1 428 6 Asn Firmicutes Lachnospiraceae bacterium 10-1 
86 WP_016292271.1 436 6 Asn Firmicutes Lachnospiraceae bacterium 28-4 
87 YP_003781661.1b 449 6 Asn Firmicutes Clostridium ljungdahlii DSM 13528 
88 YP_001786573.1 450 6 Asn Firmicutes Clostridium botulinum A3 str. Loch Maree 
89 WP_010750902.1 424 6 Asn Firmicutes Enterococcus villorum 
90 WP_010768675.1 430 6 Asn Firmicutes Enterococcus phoeniculicola 
91 WP_010719091.1 428 6 Asn Firmicutes Enterococcus faecium 
92 WP_016215903.1 434 6 Asn Firmicutes Eubacterium sp. 14-2 
93 WP_010779009.1 443 6 Asn Firmicutes Enterococcus gilvus 
94 WP_009732097.1 434 6 Asn Firmicutes Streptococcus sp. F0442 
95 WP_006596699.1 445 6 Asn Firmicutes Streptococcus australis 
96 WP_002885486.1 439 6 Asn Firmicutes Streptococcus salivarius 
97 WP_002889753.1 445 6 Asn Firmicutes Streptococcus salivarius 
98 YP_007988158.1 420 6 Asn Firmicutes Lactobacillus plantarum subsp. plantarum P-8 
99 WP_016287036.1 434 6 Asn Firmicutes Lachnospiraceae bacterium 3-1 
100 YP_004287481.1 435 6 Asn Firmicutes Streptococcus gallolyticus subsp. gallolyticus ATCC BAA-2069 
101 WP_016304832.1 434 6 Asn Firmicutes Lachnospiraceae bacterium A2 
102 WP_002604771.1 437 6 Asn Firmicutes Clostridium hathewayi 
103 WP_002280560.1 441 6 Asn Firmicutes Streptococcus mutans 
104 WP_010739752.1 433 6 Asn Firmicutes Enterococcus malodoratus 
105 YP_003064445.1 419 6 Asn Firmicutes Lactobacillus plantarum JDM1 
106 WP_018164077.1 450 6 Asn Firmicutes Streptococcus henryi 
107 WP_010744242.1 440 6 Asn Firmicutes Enterococcus raffinosus 
108 WP_002943511.1 445 6 Asn Firmicutes Streptococcus suis 
109 WP_018378535.1 444 6 Asn Firmicutes Streptococcus ovis 
110 WP_004058876.1 441 6 Asn Firmicutes Eubacterium plexicaudatum 
111 WP_003702872.1 426 6 Asn Firmicutes Lactobacillus salivarius 
112 WP_002313965.1 421 6 Asn Firmicutes Enterococcus faecium 
113 YP_006069688.1 438 6 Asn Firmicutes Streptococcus salivarius JIM8777 
114 WP_004255283.1c 441 6 Asn Firmicutes Streptococcus mitis 
115 WP_019787615.1 448 6 Asn Firmicutes Streptococcus sobrinus 
116 YP_878135.1 437 6 Asn Firmicutes Clostridium novyi NT 
117 WP_005880245.1 451 6 Asn Firmicutes Enterococcus durans 
118 WP_009553709.1b 422 6 Asn Firmicutes Lactobacillus saerimneri 
119 WP_003376164.1 439 6 Asn Firmicutes Clostridium botulinum 
120 WP_018375371.1 436 6 Asn Firmicutes Streptococcus orisratti 
121 WP_018376391.1 435 6 Asn Firmicutes Streptococcus orisratti 
122 WP_020992797.1 441 6 Asn Firmicutes Streptococcus sp. 2_1_36FAA 
123 WP_018373287.1 436 6 Asn Firmicutes Streptococcus merionis 
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124 WP_018164876.1 440 6 Asn Firmicutes Streptococcus henryi 
125 WP_010817845.1 437 6 Asn Firmicutes Enterococcus faecalis 
126 YP_002561848.1 439 6 Asn Firmicutes Streptococcus uberis 0140J 
127 WP_008535279.1 446 6 Asn Firmicutes Streptococcus sp. C150 
128 WP_009754525.1 447 6 Asn Firmicutes Streptococcus sp. oral taxon 056 
129 WP_004240956.1 444 6 Asn Firmicutes Streptococcus mitis 
130 WP_004195387.1 454 6 Asn Firmicutes Streptococcus suis 
131 YP_006067616.1 444 6 Asn Firmicutes Streptococcus salivarius 57.I 
132 WP_003139433.1 458 6 Asn Firmicutes Lactococcus raffinolactis 
133 YP_005173501.1 436 6 Asn Firmicutes Leuconostoc mesenteroides subsp. mesenteroides J18 
134 WP_016224073.1 435 6 Asn Firmicutes Lachnospiraceae bacterium 3-2 
135 WP_004049925.1 441 6 Asn Firmicutes Lactobacillus murinus 
136 WP_016184462.1 457 6 Asn Firmicutes Enterococcus columbae 
137 WP_016226189.1 438 6 Asn Firmicutes Lachnospiraceae bacterium 3-2 
138 WP_010815375.1 428 6 Asn Firmicutes Enterococcus faecalis 
139 WP_003646469.1b 446 6 Asn Firmicutes Lactobacillus plantarum 
140 YP_005004345.1 432 6 Asn Firmicutes Pediococcus claussenii ATCC BAA-344 
141 WP_007124555.1 453 6 Asn Firmicutes Lactobacillus antri 
142 WP_003641980.1
b
, c 442 6 Asn Firmicutes Lactobacillus plantarum 
143 YP_007986684.1 420 6 Asn Firmicutes Lactobacillus plantarum subsp. plantarum P-8 
144 YP_003621756.1 435 6 Asn Firmicutes Leuconostoc kimchii IMSNU 11154 
145 WP_004070366.1 454 6 Asn Firmicutes Clostridium sp. ASF502 
146 WP_003637608.1 440 6 Asn Firmicutes Lactobacillus pentosus 
147 WP_003637610.1 442 6 Asn Firmicutes Lactobacillus pentosus 
148 WP_007060938.1 432 6 Asn Firmicutes Clostridium carboxidivorans 
149 YP_003842389.1 434 6 Asn Firmicutes Clostridium cellulovorans 743B 
150 WP_016293822.1 457 6 Asn Firmicutes Lachnospiraceae bacterium M18-1 
151 WP_002834212.1 434 6 Asn Firmicutes Pediococcus pentosaceus 
152 WP_010751948.1 433 6 Asn Firmicutes Enterococcus villorum 
153 WP_003695050.1 439 6 Asn Firmicutes Lactobacillus ruminis 
154 WP_016184472.1 427 6 Asn Firmicutes Enterococcus columbae 
155 YP_005047496.1 441 6 Asn Firmicutes Clostridium clariflavum DSM 19732 
156 WP_004908337.1 434 6 Asn Firmicutes Leuconostoc citreum 
157 WP_002328140.1 427 6 Asn Firmicutes Enterococcus faecium 
158 WP_008469780.1 444 6 Asn Firmicutes Lactobacillus hominis 
159 YP_006796412.1 432 6 Asn Firmicutes Leuconostoc carnosum JB16 
160 WP_003708561.1 430 6 Asn Firmicutes Lactobacillus salivarius 
161 WP_007126030.1 445 6 Asn Firmicutes Lactobacillus ultunensis 
162 WP_010690030.1 420 6 Asn Firmicutes Lactobacillus animalis 
163 WP_003665180.1 420 6 Asn Firmicutes Lactobacillus reuteri 
164 NP_964473.1 419 6 Asn Firmicutes Lactobacillus johnsonii NCC 533 
165 WP_003692144.1 416 6 Asn Firmicutes Lactobacillus ruminis 
166 WP_003699415.1 430 6 Asn Firmicutes Lactobacillus salivarius 
167 YP_193512.1 426 6 Asn Firmicutes Lactobacillus acidophilus NCFM 
168 WP_010018224.1 435 6 Asn Firmicutes Lactobacillus farciminis 
169 WP_005720992.1 442 6 Asn Firmicutes Lactobacillus crispatus 
170 WP_009558353.1 440 6 Asn Firmicutes Lactobacillus sp. 66c 
171 WP_020806829.1 439 6 Asn Firmicutes Lactobacillus gasseri 
172 WP_002878748.1 443 6 Asn Firmicutes Lactobacillus delbrueckii 
173 WP_003616411.1 451 6 Asn Firmicutes Lactobacillus delbrueckii 
174 YP_004293001.1 442 6 Asn Firmicutes Lactobacillus acidophilus 30SC 
175 WP_010727102.1 419 6 Asn Firmicutes Enterococcus faecium 
176 WP_016624980.1 432 6 Asn Firmicutes Enterococcus faecalis 
177 WP_010816586.1 414 6 Asn Firmicutes Enterococcus faecalis 
178 WP_003616444.1b 417 6 Asn Firmicutes Lactobacillus delbrueckii 
179 WP_002373740.1 498 6 Asn Firmicutes Enterococcus faecium 
180 WP_010751677.1 412 6 Asn Firmicutes Enterococcus villorum 
181 WP_009461668.1 423 6 Asn Firmicutes Lachnospiraceae bacterium 2_1_46FAA 
182 WP_007714334.1 438 6 Asn Firmicutes Clostridium asparagiforme 
183 WP_009982749.1 402 6 Asn Firmicutes Ruminococcus flavefaciens 
184 WP_010761975.1 430 6 Asn Firmicutes Enterococcus haemoperoxidus 
185 WP_009172438.1 418 6 Asn Firmicutes Clostridium sp. DL-VIII 
186 WP_010718901.1 420 6 Asn Firmicutes Enterococcus faecium 
187 WP_010752108.1 420 6 Asn Firmicutes Enterococcus villorum 
	   185	  
188 WP_016250704.1 435 6 Asn Firmicutes Enterococcus cecorum 
189 WP_005338206.1 435 6 Asn Firmicutes Dorea formicigenerans 
190 WP_009982643.1 427 6 Asn Firmicutes Ruminococcus flavefaciens 
191 WP_005215399.1 427 6 Asn Firmicutes Clostridium celatum 
192 WP_005923174.1 438 6 Asn Firmicutes Faecalibacterium prausnitzii 
193 YP_001558714.1 446 6 Asn Firmicutes Clostridium phytofermentans ISDg 
194 WP_004610893.1 408 6 Asn Firmicutes Clostridium spiroforme 
195 WP_007867475.1 435 6 Asn Firmicutes Clostridium citroniae 
196 YP_001332979.1
a, 
c 430 6 Asn Firmicutes 
Staphylococcus aureus subsp. aureus str. 
Newman 
197 WP_000387802.1 430 6 Asn Firmicutes Staphylococcus aureus 
198 WP_002464788.1 429 6 Asn Firmicutes Staphylococcus simiae 
199 WP_002488053.1 429 6 Asn Firmicutes Staphylococcus hominis 
200 WP_002469368.1 432 6 Asn Firmicutes Staphylococcus epidermidis 
201 YP_007384612.1 429 6 Asn Firmicutes Staphylococcus warneri SG1 
202 WP_002481722.1 433 6 Asn Firmicutes Staphylococcus simulans 
203 WP_002509116.1 432 6 Asn Firmicutes Staphylococcus arlettae 
204 WP_002511407.1 431 6 Asn Firmicutes Staphylococcus equorum 
205 YP_004149866.1 430 6 Asn Firmicutes Staphylococcus pseudintermedius HKU10-03 
206 WP_007474155.1 435 6 Asn Firmicutes Listeria fleischmannii 
207 WP_000263507.1 431 6 Asn Firmicutes Bacillus cereus 
208 YP_006464114.1 433 6 Asn Firmicutes Solibacillus silvestris StLB046 
209 WP_002598585.1b 428 6 Asn Firmicutes Clostridium colicanis 
210 WP_010631760.1 437 6 Asn Firmicutes Sporolactobacillus vineae 
211 WP_002200091.1 447 6 Asn Firmicutes Bacillus cereus 
212 NP_346725.1 447 7 Asn Firmicutes Clostridium acetobutylicum ATCC 824 
213 YP_003845678.1 434 7 Asn Firmicutes Clostridium cellulovorans 743B 
214 WP_010294543.1 445 7 Asn Firmicutes Clostridium sp. JC122 
215 WP_007062817.1 465 7 Asn Firmicutes Clostridium carboxidivorans 
216 YP_007454888.1 454 7 Asn Firmicutes Clostridium saccharoperbutylacetonicum N1-4(HMT) 
217 WP_018371070.1 455 7 Asn Firmicutes Streptococcus massiliensis 
218 WP_009170117.1 441 7 Asn Firmicutes Clostridium sp. DL-VIII 
219 YP_006787706.1 416 7 Asn Firmicutes Clostridium acidurici 9a 
220 YP_007939695.1 444 7 Asn Firmicutes Clostridium pasteurianum BC1 
221 WP_010826789.1 442 7 Asn Firmicutes Enterococcus faecalis 
222 WP_002314968.1 425 7 Asn Firmicutes Enterococcus faecium 
223 YP_001451369.1c 453 7 Asn Firmicutes Streptococcus gordonii str. Challis substr. CH1 
224 YP_003822135.1 437 7 Asn Firmicutes Clostridium saccharolyticum WM1 
225 WP_009253846.1 441 7 Asn Firmicutes Lachnospiraceae bacterium 3_1_57FAA_CT1 
226 YP_007939348.1 444 7 Asn Firmicutes Clostridium pasteurianum BC1 
227 WP_010720219.1 425 7 Asn Firmicutes Enterococcus faecium 
228 WP_018380441.1 444 7 Asn Firmicutes Streptococcus thoraltensis 
229 WP_010723115.1 426 7 Asn Firmicutes Enterococcus faecium 
230 WP_005590517.1 444 7 Asn Firmicutes Streptococcus cristatus 
231 WP_003075490.1c 441 7 Asn Firmicutes Streptococcus intermedius 
232 WP_018380443.1 452 7 Asn Firmicutes Streptococcus thoraltensis 
233 WP_002830271.1 432 7 Asn Firmicutes Pediococcus acidilactici 
234 WP_003071652.1 440 7 Asn Firmicutes Streptococcus intermedius 
235 WP_000345272.1 439 7 Asn Firmicutes Streptococcus sp. oral taxon 058 
236 WP_002907623.1 444 7 Asn Firmicutes Streptococcus sanguinis 
237 WP_005591383.1 447 7 Asn Firmicutes Streptococcus cristatus 
238 WP_001054986.1 439 7 Asn Firmicutes Streptococcus sp. SK140 
239 WP_001048121.1b 439 7 Asn Firmicutes Streptococcus mitis 
240 WP_004455149.1 446 7 Asn Firmicutes Clostridium pasteurianum 
241 WP_006149098.1 440 7 Asn Firmicutes Streptococcus infantis 
242 WP_018367818.1 447 7 Asn Firmicutes Streptococcus entericus 
243 WP_003365114.1 440 7 Asn Firmicutes Clostridium botulinum 
244 WP_000362886.1 439 7 Asn Firmicutes Streptococcus sp. C300 
245 WP_006531892.1 439 7 Asn Firmicutes Streptococcus infantarius 
246 WP_004261048.1 449 7 Asn Firmicutes Streptococcus mitis 
247 WP_006595333.1b 441 7 Asn Firmicutes Streptococcus australis 
248 WP_000402607.1 445 7 Asn Firmicutes Streptococcus sp. SK643 
249 YP_006904098.1 444 7 Asn Firmicutes Streptococcus dysgalactiae subsp. equisimilis AC-2713 
250 WP_010758329.1 433 7 Asn Firmicutes Enterococcus pallens 
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251 WP_019278667.1 438 7 Asn Firmicutes Clostridium botulinum 
252 WP_018369941.1 444 7 Asn Firmicutes Streptococcus marimammalium 
253 WP_009004071.1 466 7 Asn Firmicutes Clostridium sp. D5 
254 YP_006003161.1 447 7 Asn Firmicutes Streptococcus thermophilus ND03 
255 YP_002743992.1 444 7 Asn Firmicutes Streptococcus equi subsp. zooepidemicus 
256 YP_006082817.1 447 7 Asn Firmicutes Streptococcus suis D12 
257 WP_010756667.1 423 7 Asn Firmicutes Enterococcus pallens 
258 WP_003643808.1 446 7 Asn Firmicutes Lactobacillus plantarum 
259 WP_003025428.1 435 7 Asn Firmicutes Streptococcus anginosus 
260 WP_016220081.1 432 7 Asn Firmicutes Dorea sp. 5-2 
261 WP_000231528.1 441 7 Asn Firmicutes Streptococcus mitis 
262 WP_003073361.1 438 7 Asn Firmicutes Streptococcus intermedius 
263 WP_016287680.1 458 7 Asn Firmicutes Lachnospiraceae bacterium 3-1 
264 YP_003621251.1b 437 7 Asn Firmicutes Leuconostoc kimchii IMSNU 11154 
265 WP_017285146.1 444 7 Asn Firmicutes Streptococcus agalactiae 
266 WP_016307158.1 454 7 Asn Firmicutes Lachnospiraceae bacterium A2 
267 WP_016282345.1 450 7 Asn Firmicutes Lachnospiraceae bacterium A4 
268 WP_016220284.1 454 7 Asn Firmicutes Dorea sp. 5-2 
269 WP_010770640.1 422 7 Asn Firmicutes Enterococcus caccae 
270 WP_016219150.1 513 7 Asn Firmicutes Dorea sp. 5-2 
271 YP_006744460.1 435 7 Asn Firmicutes Leuconostoc gelidum JB7 
272 WP_016295538.1 448 7 Asn Firmicutes Lachnospiraceae bacterium M18-1 
273 WP_010707474.1 475 7 Asn Firmicutes Enterococcus faecalis 
274 WP_003639720.1 442 7 Asn Firmicutes Lactobacillus pentosus 
275 WP_004079905.1 446 7 Asn Firmicutes Clostridium sp. ASF502 
276 WP_016623052.1 430 7 Asn Firmicutes Enterococcus faecalis 
277 WP_016625521.1 424 7 Asn Firmicutes Enterococcus faecalis 
278 WP_004635172.1 439 7 Asn Firmicutes Dolosigranulum pigrum 
279 WP_004635179.1 442 7 Asn Firmicutes Dolosigranulum pigrum 
280 WP_010770253.1 409 7 Asn Firmicutes Enterococcus caccae 
281 YP_536800.1 429 7 Asn Firmicutes Lactobacillus salivarius UCC118 
282 WP_004049677.1 442 7 Asn Firmicutes Lactobacillus murinus 
283 YP_007988137.1 445 7 Asn Firmicutes Lactobacillus plantarum subsp. plantarum P-8 
284 YP_005861339.1b 443 7 Asn Firmicutes Lactobacillus johnsonii DPC 6026 
285 WP_010771509.1 451 7 Asn Firmicutes Enterococcus caccae 
286 YP_003602296.1 447 7 Asn Firmicutes Lactobacillus crispatus ST1 
287 YP_194634.1 440 7 Asn Firmicutes Lactobacillus acidophilus NCFM 
288 WP_009896878.1 452 7 Asn Firmicutes Clostridium difficile 
289 WP_005718161.1 468 7 Asn Firmicutes Lactobacillus crispatus 
290 WP_010762052.1 436 7 Asn Firmicutes Enterococcus haemoperoxidus 
291 WP_008680295.1 416 7 Asn Firmicutes Clostridium sp. 7_2_43FAA 
292 WP_016208990.1 419 7 Asn Firmicutes Clostridium sartagoforme 
293 YP_007828746.1 442 7 Asn Firmicutes Ruminococcus champanellensis 18P13 
294 WP_009985441.1b 440 7 Asn Firmicutes Ruminococcus flavefaciens 
295 WP_008423253.1 420 7 Asn Firmicutes Clostridium sp. Maddingley MBC34-26 
296 YP_004104667.1 425 7 Asn Firmicutes Ruminococcus albus 7 
297 WP_006445121.1 445 7 Asn Firmicutes Clostridium hylemonae 
298 WP_005361465.1 425 7 Asn Firmicutes Eubacterium ventriosum 
299 WP_002586250.1 434 7 Asn Firmicutes Clostridium clostridioforme 
300 YP_007458077.1 416 7 Asn Firmicutes Clostridium saccharoperbutylacetonicum N1-4(HMT) 
301 WP_007863964.1 445 7 Asn Firmicutes Clostridium citroniae 
302 WP_006782132.1 432 7 Asn Firmicutes Clostridium hathewayi 
303 WP_006863055.1 460 7 Asn Firmicutes Marvinbryantia formatexigens 
304 WP_005331796.1 435 7 Asn Firmicutes Dorea formicigenerans 
305 WP_019679521.1 434 7 Asn Firmicutes Ruminococcus flavefaciens 
306 WP_003480616.1 420 7 Asn Firmicutes Clostridium perfringens 
307 WP_002847701.1 439 7 Asn Firmicutes Ruminococcus albus 
308 YP_004103515.1 448 7 Asn Firmicutes Ruminococcus albus 7 
309 WP_005353871.1 444 7 Asn Firmicutes Eubacterium siraeum 
310 YP_004545147.1b 439 7 Asn Firmicutes Desulfotomaculum ruminis DSM 2154 
311 YP_007790596.1 440 7 Asn Firmicutes butyrate-producing bacterium SSC/2 
312 WP_018702136.1 445 7 Asn Firmicutes Anaeromusa acidaminophila 
313 WP_016227154.1 438 7 Asn Firmicutes unclassified Lachnospiraceae 
314 WP_004801384.1 421 7 Asn Firmicutes Eggerthia catenaformis 
315 WP_016184116.1 434 7 Asn Firmicutes Enterococcus columbae 
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316 WP_016316494.1 445 7 Asn Firmicutes Anaerotruncus sp. G3(2012) 
317 WP_018579518.1 453 7 Asn Firmicutes Erysipelothrix tonsillarum 
318 YP_003820510.1 434 7 Asn Firmicutes Clostridium saccharolyticum WM1 
319 WP_000447891.1 427 7 Asn Firmicutes Staphylococcus aureus 
320 WP_002477479.1c 429 7 Asn Firmicutes Staphylococcus epidermidis 
321 YP_003471243.1 429 7 Asn Firmicutes Staphylococcus lugdunensis HKU09-01 
322 YP_006677599.1 436 7 Asn Firmicutes Listeria monocytogenes SLCC2540 
323 WP_002151242.1 439 7 Asn Firmicutes Bacillus cereus 
324 WP_007124101.1 450 7 Asn Firmicutes Lactobacillus antri 
325 YP_001621389.1 444 7 Asn Firmicutesd Acholeplasma laidlawii PG-8A 
326 YP_003821953.1 650 8 Asn Firmicutes Clostridium saccharolyticum WM1 
non-HPK10 hits 
327 WP_017024785.1 555 2 Asp Proteobacteria Vibrio rumoiensis 
328 WP_004396401.1 551 2 Asp Proteobacteria Vibrio metschnikovii 
329 WP_016545474.1 802 0 Asp Spirochaetes Leptospira wolffii 
330 YP_004340943.1 433 0 Asp Euryarchaeota Archaeoglobus veneficus SNP6 
a: The query sequence for the first round of database search; 
b: Query sequences for the second round of database search; 
c: Founding members of the HPK10 subfamily (125). 7 sequences in the table covers 12 
out of 15 founding with at >75% sequence identity. The rest 3 are not deposited in the 
Refseq database. 
d: There is controversy on whether the class Mollicutes should be placed in the phylum 
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Appendix Table 2. AgrD constructs prepared as starting materials or detected as 
products in Chapter 5. 
The sequence of full-length AgrD-I (residues 1-46) is 
MNTLFNLFFDFITGILKNIGNIAAYSTCDFIMDEVEVPKELTQLHE 
The sequence of full-length AgrD-II (residues 1-47) is 
MNTLVNMFFDFIIKLAKAIGIVGGVNACSSLFDEPKVPAELTNLYDK 
*: constructs prepared from recombinant proteins;  
**: constructs synthesized chemically; 
***: parenthesis indicates residues that form the thiolactone macrocycle.  
 
Entry Construct Name Tags/Terminal Groups 
R1-AgrD-R2 
1* AgrD-I R1= H-, R2 = -OH 
2* AgrD-II R1= H-, R2 = -OH 
3* FlagHis6-AgrD-I 
R1= H-MDYKDDDDKHHHHHHGG-; 
R2 = -LDKLVPR-OH 
4* FlagHis6-AgrD-II 
R1= H-MDYKDDDDKHHHHHHGG-; 
R2 = -LDLELVFQ-OH 
5 FlagHis6-AgrD-I-NH2 
R1= H-MDYKDDDDKHHHHHHGG-; 
R2 = -NH2 
AgrDC-R2 
6 AgrD-IC R2 = -OH 
7 AgrD-IIC R2 = -OH 
8 AgrD-IC-LDKLVPR R2 = -LDKLVPR-OH 
9** AgrD-IC-NH2 R2 = -NH2 
R1-AgrD(1-32)-thiolactone 
10 AgrD-I(1-32)-thiolactone R1= H-, 
11 AgrD-I(1-32)-thiolactone R1= H-, 
12* FlagHis6-AgrD-I- (1-32)-thiolactone 
R1= H-MDYKDDDDKHHHHHHGG-; 
R1-AgrD(1-32) 
13 AgrD-I(1-32) R1= H-, 
14 AgrD-II(1-32) R1= H-, 
15 FlagHis6-AgrD-I(1-32) R1= H-MDYKDDDDKHHHHHHGG-; 
Others 
16** AIP-I H-YST(CDFIM)*** 
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Appendix Figure 1. RP-HPLC-MS results of all synthetic or recombinantly 
prepared AgrD constructs described in Chapter 5 
 













0%B for 5min, then 0%-90%B in 30min 




Mw, calc = 5297.1Da 
Mw, obs = 5296.7Da 














0%B for 5min, then 0%-90%B in 30min 




Mw, calc = 5149.0Da 
Mw, obs = 5148.8Da 
















0%B for 5min, then 0%-90%B in 30min 
C18 analytical HPLC 
FlagHis6-AgrD-I Deconvoluted MS 
(average) 
Mw, calc = 8182.2Da 
Mw, obs = 8180.9Da 














0%B for 5min, then 0%-90%B in 30min 
C18 analytical HPLC 
FlagHis6-AgrD-II Deconvoluted MS 
(average) 
Mw, calc = 8170.3Da 
Mw, obs = 8169.9Da 















0%B for 5min, then 0%-90%B in 30min 






Mw, calc = 5694.4Da 
Mw, obs = 5693.7Da 
	   190	  



























0%B for 5min, then 0%-90%B in 30min 
C18 analytical HPLC 
FlagHis6- 
-AgrD-I(1-32)-Cys Deconvoluted MS 
(average) 
Mw, calc = 5815.5Da 
Mw, obs = 5816.4Da 















20%-50%B in 15min 




Mw, calc = 1663.8Da 
Mw, obs = 1663.8Da 














40%-80%B in 20min 







Mw, calc = 5516.1Da 
Mw, obs = 5515.6Da 
















0%-30%B in 15min 





Mw, calc = 782.3Da 
Mw, obs = 782.3Da 
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Appendix Figure 2. MS results of all AgrD products from the biochemical reactions 
described in Chapter 5.  
 
 
AgrD-IC Deconvoluted MS (monoisotopic) 
Mw, calc = 1664.8Da 
Mw, obs = 1664.8Da 
AgrD-IIC Deconvoluted MS (monoisotopic) 
Mw, calc = 1730.9Da 
Mw, obs = 1730.9Da 
Deconvoluted MS 
(monoisotopic) 
Mw, calc = 2486.4Da 






Mw, calc = 3631.2Da 
Mw, obs = 3630.8Da 
Deconvoluted MS 
(average) 
Mw, calc = 3417.1Da 
Mw, obs = 3416.8Da 
AgrD-II(1-32)- 
thiolactone 
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Mw, calc = 5694.4Da 




AgrD-I(1-32) Deconvoluted MS (average) 
Mw, calc = 3649.2Da 
Mw, obs = 3648.8Da 
Deconvoluted MS 
(average) 
Mw, calc = 3435.1Da 




Mw, calc = 5712.4Da 





Mw, calc = 1079.4Da 
Mw, obs = 1079.4Da AIP-I-NAC 
	   193	  
 















Mw, calc = 901.3Da 




Mw, calc = 5813.5Da 





Mw, calc = 5635.2Da 
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